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Abstract 
Previous research has provided evidence that CD8 T cells mediate immunity 
against infection with Theileria parva. However, the immunity induced by one 
parasite strain doesn‟t give complete protection against other strains and this is 
associated with parasite strain specificity of the CD8 T cell responses. There is 
evidence that such strain specificity is a consequence of the CD8 T cell responses of 
individual animals being focused on a limited number of immunodominant 
polymorphic peptide-MHC determinants. Dominant responses to the Tp2 antigen 
have been demonstrated in animals homozygous for the A10 MHC haplotype. Three 
Tp2 epitopes recognised by A10+ animals (Tp249-59, Tp250-59 and Tp298-106) have 
been defined. This project set out to investigate the dominance of these epitopes and 
to examine the T cell receptor (TCR) repertoires of the responding T cells.  
The specific objectives were to: (i) Determine the dominance hierarchies of the 
three defined Tp2 epitopes in both A10-homozygous and -heterozygous cattle. (ii) 
Examine the clonal repertoires of epitope-specific responses by analysis of TCR gene 
expression. (iii) Isolate full-length cDNAs encoding TCR α and β chain pairs from T 
cell clones of defined epitope specificity and use them to generate cells expressing 
the functional TCRs. Using MHC class I tetramers the relative dominance of CD8 T 
cell responses were found to differ between A10-homozygous and heterozygous 
cattle. All A10-homozygous cattle examined had detectable responses to all 3 Tp2 
epitopes, the Tp249-59 epitope consistently being the most dominant. By contrast, only 
some A10-heterozygous cattle had detectable responses to Tp2 and when present the 
response was specific only for the Tp298-106 epitope. Analyses of the sequences of 
expressed TCR β chains showed that the responses in individual animals were 
clonotypically diverse, but often contained a few large expanded clonotypes. The 
TCRs of Tp298-106–specific T cells showed preferential usage of the Vβ13.5 gene and 
the frequent presence of a “LGG” motif within the CDR3 of the B chain. A 
conserved (public) TCRβ clonotype shared by the Tp250-59-specific CD8 T cells from 
all A10-homozygous cattle was identified. The TCRα chains co-expressed with this 
public TCRβ clonotype were identified for a number of T cell clones. Lentivirus 
transduction of Jurkat cells with three full-length TCR α and β chain pairs resulted in 
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successful expression of one of the α/β chain pairs as a functional TCR, thus 
providing the basis for future work to generate bovine T cells expressing defined 
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Chapter 1: General introduction 
1.1 Theileria parva 
Theileria parva (T. parva) belongs to the Theileria genus of apicomplexa 
protozoa and is the causal agent of an acute and usually fatal lymphoproliferative 
disease in cattle known as East Coast fever (ECF). This disease is endemic in eastern, 
central and southern Africa (Figure 1.1) and causes economic losses, which were 
estimated over 300 million dollars annually [Gachohi et al., 2012]. The parasite is 
transmitted predominantly by the tick vector Rhipicephalus appendiculatus. Another 
closely related species, R. zambesiensis, also serves as vector in some parts of 
southern Africa [Lawrence et al., 1983, Purnell et al., 1974]. Climate conditions that 
influence survival and multiplication of the tick vectors influence the distribution and 
seasonal occurrence of the disease [Norval et al., 1991]. European Bos taurus breeds 
of cattle are highly susceptible to the disease, with mortality as high as 100% in the 
absence of control methods. Some indigenous breeds of Bos indicus cattle show a 
degree of resistance to T. parva infection. However, high level of experimental 
challenge can overcome the resistance and cause severe fatality in these animals 
[Ndungu et al., 2005]. The high morbidity and mortality of T. parva infections 
seriously constrain cattle production in areas of Africa where the parasite is present 
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Reproduced from the Annual Report of 
the International Laboratory of Research on Animal Diseases (ILRAD) 1990 
1.1.1 Life cycle of T. parva 
The life cycle of T. parva involves a series of intracellular developmental stages 
both in the tick vector R. appendiculatus and the mammalian host, as shown in 
Figure 1.2.   
After ingestion by nymphal ticks, the intra-erythrocytic piroplasms of T. parva 
differentiate into micro- and macro-gametes which fuse to form zygotes in the gut of 
the tick. Unlike all stages of development in the mammalian host, this stage has a 
diploid genome. Parasites derived from zygotes formed by two genotypically 
different T. parva parasites undergo recombination at this stage [McKeever, 2006]. 
The zygotes invade the gut epithelial cells and differentiate into kinetes which 
migrate to the salivary gland, where they invade a specific cell type known as the E 
cell, in which they undergo multiple nuclear divisions. During this process, known as 
sporogony, a meiotic division occurs resulting in a haploid genome. This process 
results in production of large numbers of sporozoites by each infected salivary gland 
cell [Fawcett et al., 1982].  
Sporogony and production of sporozoites is not completed until the adult stage 
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ticks and invade different lineages of lymphocytes of the mammalian hosts. Studies 
of cell tropisms of T. parva infected cells have shown that the vast majority of 
infected cells in infected cattle are CD4 and CD8 T lymphocytes, although both B 
and T lymphocytes can be infected with similar efficiency in vitro [Morrison et al., 
1996, Baldwin et al., 1988]. Unlike other apicomplexan protozoa, which reside in 
endocytic vacuoles, T. parva parasites enter the cytoplasm of host cells through 
dissolution of host endosomal cell membrane and associate with the host cell 
microtubules [Shaw, 2003, Shaw et al., 1991]. Within three days, sporozoites 
develop into multi-nuclear schizonts and induce host cell transformation and 
proliferation, with parasite division occurring simultaneously with host cell division. 
The mechanisms of parasite-induced host cell transformation have been explored 
extensively. Although the way in which the parasite mediates transformation remains 
unclear, research has indicated that up-regulation of signalling pathways involved in 
cell proliferation and down-regulation of apoptotic pathways result in continuous 
multiplication of parasitized host cells [Dobbelaere et al., 2000, Heussler et al., 2006]. 
A recent study carried out by Marsolier, J. et al. demonstrated that a peptidyl-prolyl 
isomerase secreted by T. parva is capable of degrading host ubiquitin ligase and 
stabilizing cell proliferation pathways to facilitate cell transformation [Marsolier et 
al., 2015]. In infected cattle, schizont-infected lymphocytes are detectable in the 
lymph node draining the site of infection 5-8 days after infection and their numbers 
increase rapidly over the subsequent 7-10 days. This rapid multiplication of schizont-
infected cells is responsible for most of the pathology of the disease. The infected 
cells disseminate throughout the lymphoid system and also invade non-lymphoid 
tissues including the lungs and gastro-intestinal tract. In fully susceptible breeds, 
death usually occurs within 3 weeks of infection, mainly due to respiratory distress 
as a consequence of pulmonary oedema [Irvin et al., 1983]. In the later stages of 
infection, a proportion of schizonts differentiate to merozoites, which, upon release, 
invade erythrocytes giving rise to the tick-infective piroplasm stage. Small numbers 
of both schizonts and piroplasms persist in recovered animals for months or years; 
the infected cells are usually not observed microscopically but can be detected by 
PCR [Skilton et al., 2002]. Tick transmission from animals with persistent infection 
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Figure 1.2 The life cycle of T. parva.  
is believed to be the predominant source of infection for cattle in ECF-endemic areas 










Reproduced from the Annual Report of the International 
Laboratory of Research on Animal Diseases (ILRAD) 1990. 
 
1.1.2 Control of T. parva 
Theilericidal compounds were introduced for treatment of theileriosis in the 
1980s. The most effective compound is buparvaquone [McHardy et al., 1985]. 
However, treatment needs to be applied relatively early in the disease to be effective, 
thus requiring early diagnosis. Treatment in the later stages can sometimes be 
effective but may require repeat treatment and recovered animals have reduced 
productivity. Chemotherapy is also expensive. Beside theilericidal treatment, regular 
application of acaricides to prevent tick infestation has been used to control the 
disease. However, this method also has shortcomings, namely the need for 
continuous application, the emergence of drug resistant tick populations and 
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concerns about chemical contamination of the environment [Morrison and McKeever, 
2006].  
Vaccination is considered to be a more sustainable way of controlling the 
disease, but current vaccines also have limitations [McKeever, 2007, Morrison and 
McKeever, 2006].   
1.1.2.1 Live parasite vaccination 
Since animals recovered from clinical disease are immune to subsequent 
challenge, early studies attempted to immunise cattle with materials derived from 
tissues of sick or recovered animals, including blood and cell suspensions of spleen 
and lymph node. However, this method sometimes resulted in disease and only about 
70% of surviving animals were protected against subsequent field challenge [Spreull, 
1914]. The failure to achieve full protection was later demonstrated to be due in 
some instances the insufficient numbers of infected cells administered and also the 
differences of major histocompatibility complex (MHC) genotypes between the 
donor cells and the recipient animals [Pirie et al., 1970, Buscher et al., 1984]. The 
development of in vitro culture of parasitized cells and cryopreservation of parasites 
in the 1960s and 1970s made it possible to produce live vaccines using standardised 
doses of parasites [Brown et al., 1973, Cunningham et al., 1973]. A method of 
infection and treatment was developed, which involves simultaneous administration 
of long-acting oxytetracycline and a defined dose of cryopreserved sporozoites. 
Animals immunised by this method show solid immunity against homologous 
parasite strains but variable protection against heterologous strains [Radley et al., 
1975a]. Because of this immunological diversity, various stocks of T. parva were 
tested for their ability to induce immunity against other stocks. A mixture of 3 stocks, 
known as the „Muguga cocktail‟ (containing the Serengeti-transformed, Kiambu 5 
and Muguga stocks) was found to provide wider protection than each of the 
individual stocks [Radley et al., 1975b, Radley et al., 1975a]. This Muguga cocktail 
has been used successfully for vaccinating cattle in the field in some areas of Africa 
[Marcotty et al., 2002, Di Giulio et al., 2009]. Two batches of the Muguga cocktail 
vaccines, produced in 1996 and 2008 respectively by ILRI, were proved to provide 
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95-100% protection against ECF. With the safety and effectiveness of the later batch 
during field trials in Kenya, it was launched in 2012 for national distribution 
[Gachohi et al., 2012]. However, it has a number of practical disadvantages, 
including the requirement of a cold chain for preserving and transporting vaccine 
stocks and the perceived threat of introducing the vaccine parasite strains into local 
tick populations [Uilenberg, 1999]. These shortcomings have limited the widespread 
use of this vaccination approach. 
1.1.2.2 Approaches to subunit vaccine development 
To overcome these obstacles, research has been focusing on analyses of the 
immune response to identify immunogenic parasite antigens that can induce 
protective humoral or cellular immune responses for vaccination.  
Although infection and treatment induces little or no antibody against the 
sporozoite stage, immunisation with a 67-kDa sporozoite surface protein (termed p67) 
was found to induce antibody that neutralised the infectivity of sporozoites in vitro 
[Musoke et al., 1984]. Experiments were carried out to investigate the protective 
efficiency of vaccination against the sporozoite stage of parasite. Experimental 
immunisation of cattle with recombinant p67 in adjuvant resulted in approximately 
50% protection against challenge with a lethal dose LD70 dose of cryopreserved 
sporozoites, but lower levels of protection were achieved after natural challenge 
[Musoke et al., 2005, Musoke et al., 1992]. No obvious correlation between the 
isotype or level of antibody induced and immunity to T. parva was obtained. In terms 
of epitope specificity, antibody responses showed no differences between protected 
and susceptible animals [Nene et al., 1999]. Moreover, immunization of cattle with 
recombinant p67 antigen produced in different expression systems (prokaryotic or 
eukaryotic) resulted in similar levels of protection [Kaba et al., 2005, Bishop et al., 
2003]. Subsequent studies of the MHC genotypes of vaccinated animals suggested 
that MHC class II (MHC II) genotype could influence the efficacy of protection 
provided by p67 vaccination [Ballingall et al., 2004]. 
The essential role of cell-mediated immunity against T. parva infection was 
observed by demonstrating protection following transfer of lymphocytes from 
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immune to naïve twin calves. The recipient animals receiving transferred cells in the 
period immediately following parasite challenge were able to eliminate parasite 
infection and subsequently showed solid immunity to challenge with a lethal dose of 
T. parva [Emery, 1981].  
The ability to establish T. parva-infected cell lines in vitro has greatly facilitated 
the investigation of parasite-specific T cell responses [Brown et al., 1973]. These 
cells have been demonstrated to be effective antigen-presenting cells for in vitro 
activation of T. parva-specific memory T cells from the blood of immune cattle 
[Pearson et al., 1979]. Responses by both CD4 and CD8 T cells specific for 
parasitized cells can be generated from cattle immunized with T. parva [Baldwin et 
al., 1987, Goddeeris et al., 1986] and these cells can be maintained as T cell lines by 
repeated antigenic stimulation and cloned, enabling detailed analyses of parasite-
specific T cell responses. The CD8 T cell lines show MHC class I (MHC I) -
restricted cytotoxic activity against T. parva-infected cells and similar cytotoxic 
activity is detected in PBMC assayed ex vivo from cattle undergoing immunisation or 
challenge [Morrison et al., 1987, Goddeeris et al., 1986]. Adoptive transfer of CD8 T 
cell enriched populations from immune to naïve twin calves following parasite 
challenge of the naïve twin was found to confer protection, providing clear evidence 
of an important role of the CD8 T cell response in immunity against T. parva 
[McKeever et al., 1994]. These results prompted subsequent studies to identify 
immunogenic antigens recognized by CD8 T cells for vaccine development. Several 
T. parva antigens were identified and used for immunization of cattle to test their 
vaccination potential. Using a prime-boost protocol, involving priming with 
recombinant plasmid DNA or canarypox viruses expressing 5 T. parva antigens and 
a single boost with recombinant vaccinia virus Ankara strain, most of the immunised 
animals were found to generate specific CD8 T cell responses, detected with an IFNγ 
ELISPOT assay, but less than 50% of them (10/24) survived parasite challenge 
[Graham et al., 2006]. These results suggested that the protective immune responses 
against T. parva are complex and that further understanding of T cell mediated 
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1.1.3 T cell mediated immunity against T. parva 
As discussed above, there is strong evidence that CD8 T cell responses play an 
important role in immunity to T. parva. However, CD4 T cells from immune cattle 
also show strong parasite-specific proliferative responses and results from cell 
mixing experiments in vitro suggest that they may provide help for CD8 T cell 
activation [Taracha et al., 1997, Baldwin et al., 1987, Baldwin et al., 1992].  
1.1.3.1 Strain specificity of CD8 T cell mediated immune responses 
against T. parva 
Parasite strain specificity of immunity to T. parva was observed when animals 
were immunized with one parasite strain and subsequently challenged with a second 
heterologous strain; while some animals were protected, others remained susceptible 
to the challenge [Radley et al., 1975a, Irvin et al., 1983]. This incomplete cross-
protection suggested the differential recognition of parasite strains by the protective 
immune response. Later studies demonstrated that parasite-specific CD8 T cells 
generated from animals immunized with one parasite strain showed variable 
recognition of cells infected with other parasite strains [Morrison et al., 1987, 
Goddeeris et al., 1986]. Moreover, for animals immunized with the same parasite 
strain, profiles of strain specificity of the responding CD8 T cells showed variation 
between individual animals, suggesting a possible influence of MHC I genotype 
[Goddeeris et al., 1990, Morrison et al., 1987]. The interpretation of these 
experiments was partly complicated by genotypic and antigenic heterogeneity of 
some of the parasite isolates used in the studies [Goddeeris et al., 1990]. This 
problem was later resolved by the production of cloned sporozoite stocks [Morzaria 
et al., 1995]. Further experiments were carried out to explore the relationship 
between parasite strain specificity of the CD8 T cell response and immunity to 
parasite challenge. Using the Muguga strain of T. parva, which was antigenically 
homogeneous, for immunisation followed by a cloned derivative of the Marikebuni 
stock (Marikebuni 3219) for challenge of the immunised animals, a close correlation 
was observed between the strain specificity of the CD8 T cell response induced by 
immunisation and the susceptibility of animals to challenge [Taracha et al., 1995a]. 
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Immunized animals with cross-reactive CD8 T cells were protected against the 
heterologous parasite challenge, while animals with CD8 T cell responses specific 
for the immunizing strain showed severe clinical reactions. These results provided 
further evidence for the direct involvement of CD8 T cell responses in immunity 
against T. parva infection and also indicated that different animals appear to respond 
to different antigens. Further analyses of the CD8 T cell response in animals that 
recovered from the severe challenge reactions (with the aid of treatment) showed that 
they included CD8 T cells that recognised both parasites. The absence of responses 
to these conserved antigens following the initial immunisation suggested that there is 
a hierarchy in dominance of antigens capable of generating a CD8 T cell response 
and based on these findings it was proposed that strain specificity is likely to be a 
consequence of recognition of a limited number of antigenic determinants by 
individual animals. The polymorphism of these antigens, together with an effect of 
MHC I genotype on antigen dominance, would explain both the variable CD8 T cell 
specificity between animals immunized with the same parasite isolate and the 
different cross-protection profiles of animals [Taracha et al., 1995a, Morrison et al., 
1987]. 
1.1.3.2 T. parva antigens recognized by CD8 T cells 
Identification of antigens recognized by CD8 T cells has greatly facilitated 
studies to elucidate the fine antigenic specificity of CD8 T cell responses against T. 
parva. The complete genome sequence of the T. parva Muguga strain provided 
important information for selection of candidate genes [Gardner et al., 2005]. Just 
over 4000 annotated genes were predicted to encode proteins, over 60% of which 
were later shown to have detectable transcripts in T. parva-infected lymphoblasts 
[Bishop et al., 2005]. Six T. parva antigens recognized by parasite-specific CD8 T 
cells were initially identified using two parallel approaches, both involving co-
transfection of cells with MHC I heavy chain cDNA along with parasite cDNA and 
screening for recognition of the transfected cells by parasite-specific CD8 T cell lines, 
using the measurement of interferon-γ (IFN γ) production [Graham et al., 2006]. The 
first approach used a series of pools, each containing 50 parasite cDNAs from a 
schizont cDNA library, while the second used single candidate cDNA of genes with 
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predicted signal peptides which indicate potential secretion into the host cell 
cytoplasm [Nacer et al., 2001]. For cDNA pools with positive responses, further 
testing was carried out to define the cDNA recognized by CD8 T cells. This antigen 
screening approach was adapted from a human system, where tumor antigens 
recognized by specific CD8 T cells were successfully identified [De Plaen et al., 
1997]. Of the six identified antigens, Tp4, Tp5, Tp7 and Tp8 were annotated to 
encode proteins with functional orthologues in other organisms, while Tp1 and Tp2 
were annotated as hypothetical proteins [Graham et al., 2006, Gardner et al., 2005]. 
Subsequent studies involving analysis of the sequences of the genes encoding Tp1 
and Tp2 in different parasite isolates demonstrated that these antigens are highly 
polymorphic and that CD8 T cells specific for them show parasite strain restriction 
[Pelle et al., 2011, MacHugh et al., 2009]. Of the 82 analyzed T. parva isolates, a 
number of 42 protein variants were observed for Tp2 antigen [Pelle et al., 2011].  
1.1.3.3 Immunodominance of parasite-specific CD8 T cell responses 
It has been proposed that parasite strain specificity of bovine CD8 T cell 
responses against T. parva was likely to be a result of dominant recognition of a 
limited number of peptide-MHC I (pMHC I) determinants by the responding CD8 T 
cells [Taracha et al., 1995b], a phenomenon that has been defined as 
immunodominance (see section 1.3). The identification of CD8 T cell antigens 
enabled further investigation of the antigen specificity of CD8 T cell responses. 
Studies of CD8 T cells from animals of defined MHC I genotypes known to 
recognize the six antigens identified nine epitopes together with their MHC I 
restriction elements [Graham et al., 2008]. Cattle expressing the BoLA-A18 (A18) 
and BoLA-A10 (A10) MHC I haplotypes were found to respond strongly to the Tp1 
and Tp2 antigens respectively [Graham et al., 2006, Graham et al., 2007, MacHugh 
et al., 2009]. In a study where cattle with defined BoLA haplotypes were immunized 
with respective T. parva antigens, ~50% of animals showed dominant responses to 
the antigens used for immunization. For cattle with A10 haplotype, CD8 T cell 
responses to the Tp2 antigen were found absent in some animals, which was 
suggested due to a lack of potency of vaccination protocols [Graham et al., 2008].  
Two epitopes in the Tp2 antigen, Tp249-59 and Tp298-106, were confirmed to be 
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restricted by the MHC I allele 2*01201 and in two immune A10-homozygous 
animals >60% of the responding CD8 T cells were specific for the Tp249-59 epitope 
with a small component of CD8 T cells specific for the Tp298-106 epitope [MacHugh 
et al., 2009]. These animals did not have detectable responses to 3 further antigens 
(Tp4, Tp5 and Tp8) examined in these experiments. These results supported the 
hypothesis that strain specificity of CD8 T cell responses against T. parva was 
associated with immunodominant responses against certain T. parva antigen in 
individual animals and that the antigen dominance is determined by MHC I genotype. 
The findings also suggested a strong hierarchy in dominance among the antigenic 
determinants that elicit a response in an animal of a particular MHC I type 
[MacHugh et al., 2009].  
1.1.3.4 CD8 T cell protection after T. parva antigen immunization  
Although the attempts to immunise cattle with recombinant T. parva antigens 
using viral vectors did not result in protection, most animals mounted a specific CD8 
T cell response. However, only in a few of these animals did the CD8 T cells show 
cytotoxic activity against autologous parasitized cells [Graham et al., 2006]. Studies 
of calves undergoing primary infection with T. parva following inoculation with a 
lethal dose of sporozoites demonstrated a potent CD8 T cell response in the draining 
lymph node coinciding with initial microscopic detection of parasitized cells. 
However, the responding cells did not show parasite-specific cytolytic activity and 
did not appear to exert any control of the infection [Houston et al., 2008]. These 
results suggest that appropriate functional differentiation of the induced antigen-
specific CD8 T cells may be a critical factor in determining their protective activity.  
1.2 CD8 T cell-mediated immune responses 
T cell-mediated immune responses have been demonstrated to be an important 
component of the vertebrate immune system and in mammals are essential for 
effective immune responses against many pathogens. They have the ability to 
recognize and respond to a vast array of different antigens that an individual may 
encounter during their life time [Kaech et al., 2002]. T cells recognize foreign 
antigens utilising a T cell receptor (TCR), a heterodimer molecule composed of α 
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and β chains, expressed on the cell surface [Davis and Bjorkman, 1988]. The 
recognition of diverse antigens depends on the diversity of the TCR repertoire, which 
is generated by a series of site-specific recombination events involving several gene 
segments during the maturation of T cells in the thymus [Schlissel, 2003, Spits, 2002, 
Lieber, 1991].  
Mature αβ T cells are composed of two subpopulations based on expression of 
different co-receptors, CD4 and CD8 [Germain, 2002]. CD4 T cells, also known as 
helper T cells, recognize antigenic epitopes generated in the endocytic pathway, most 
commonly from exogenous proteins, and presented by MHC II molecules on the 
surface of antigen presenting cells (APCs). CD8 T cells, also referred to as cytolytic 
T cells (CTL), respond to epitopes derived from endogenously produced antigenic 
proteins. Such proteins are degraded in the proteasome and peptide products are 
transported into the endoplasmic reticulum where they associate with newly 
synthesised MHC I molecules before moving to the surface of infected cells or APCs 
[Blum et al., 2013]. CD8 T cell-mediated immune responses have been demonstrated 
to have a critical role in immunity to many viruses, some parasites and bacteria [La 
Gruta and Turner, 2014, Corradin and Levitskaya, 2014, Nagata and Koide, 2010, 
Harty and Bevan, 1999]. Understanding the mechanisms by which CD8 T cell 
responses are induced and how they mediate immunity has important implications 
for rational design of T cell based vaccines [Pulendran et al., 2013, Hansen et al., 
2011, Yewdell, 2010, Kaech et al., 2002]. 
1.2.1 MHC I-associated antigen presentation 
During infection with intracellular pathogens, large numbers of peptides can be 
generated from pathogen derived antigenic proteins as a result of protein degradation 
by proteasomes. Peptides with 8-22 amino acids in length [Kisselev et al., 1999] 
located in the cytoplasm are transported by the transporter associated with antigen 
processing (TAP) into the endoplasmic reticulum (ER) where they are trimmed by 
aminopeptidases before associating with newly synthesised MHC I heterodimers 
[Reits et al., 2003, Rock et al., 1994, Serwold et al., 2002]. MHC I proteins possess 
pockets within the peptide-binding groove, which preferentially bind particular 
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amino acid residues, usually at position 2 and at the C terminus of the peptide. These 
pockets differ between MHC I alleles resulting in different amino acid binding 
preferences [Falk et al., 1991]. Peptides that are suitable for MHC I binding are 
normally 8-11 residues in length, but occasionally can be longer, up to 14 amino 
acids [Burrows et al., 2006, Falk et al., 1991]. The MHC I heavy chain, β2 
microglobulin and peptide are all required for assembly of the functional MHC I 
protein. Once assembled, the peptide-MHC I complexes (pMHC I) are transported 
via the Golgi apparatus to the cell surface. This whole process is referred to as 
classical MHC I-associated antigen presenting pathway [Yewdell et al., 2003], as 









 Endogenous proteins are degraded by 
proteasome into peptides, which are then transported by the transporter for antigen processing (TAP) 
into the lumen of endoplasmic reticulum (ER) for MHC I binding. Assembled peptide-MHC I 
complexes are released and translocated to the surface of infected cells for CD8 T cell recognition. 
The figure was copied from a review by [Yewdell et al., 2003] under the permission of publisher.     
In addition to the classical pathway, MHC I molecules on professional antigen 
presenting cells (APCs), mainly dendritic cells (DCs), can also process and present 
antigen from exogenous sources, by a process named as cross-presentation [Nair-
Gupta and Blander, 2013, Dolan et al., 2012, Heath and Carbone, 2001a]. Although 
Figure 1.3 Classical MHC I antigen presentation.   
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Figure 1.4 Schematic illustration of somatic recombination of TCR α and β genes.  
the precise mechanisms for cross-presentation are not yet fully understood, this 
pathway is now believed to be important in induction of CD8 T cell responses, 
particularly against pathogens that do not infect professional APCs [Joffre et al., 
2012]. 
1.2.2 Mechanism and regulation of TCR α and β chain 
rearrangement 
The genes encoding each chain of αβTCR are generated during T cell 
commitment in the thymus by a process of somatic recombination from several 
discontinuous gene segments, as shown in Figure 1.4. The β chain comprises 
variable (V), diversity (D), joining (J) and constant (C) gene segments, while the α 
chain comprises V, J and C segments. The diverse repertoire of TCR is produced, 
firstly, through recombination of different combinations of V-J (α) or V-D-J (β) gene 
segments, and second by removal and addition of nucleotides at the junctions 







αβTCR are generated by somatic gene recombination of variable (V) and joining (J) gene segments 
for TCRα chain and V, diversity (D) and J gene segments for TCRβ chain. Rearranged gene segments 
are then combined with constant (C) region to form the functional αβTCR. V, D, J and C gene 
segments are shown in pink, green, yellow and blue respectively. During somatic recombination, non-
germline (N, shown in black) regions are generated due to nucleotide additions and deletions. The 
figure was re-generated according to [Turner et al., 2006] . 
The initiation of gene segment recombination is triggered by the recognition of 
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encoded by recombination-activating genes 1 and 2 (RAG1 and RAG2) [Oettinger et 
al., 1990]. Gene segments of TCR α and β chains are flanked by RSS, which are 
composed of a conserved heptamer and nonamer separated by a spacer of either 12 
(12-RSS) or 23 (23-RSS) nucleotides in length. Different spacer lengths of RSS 
allows recombination to occur only between a 12-RSS and a 23-RSS, known as the 
12/23 rule. This rule prevents undesired rearrangement between different V gene 
segments and guarantees efficient V(D)J recombination [Bassing et al., 2002]. 
However, the 12/23 rule is avoided for Vβ-Jβ recombination of the TCR β chain. 
This mechanism is referred to as the “beyond 12/23 rule” [Drejer-Teel et al., 2007, 
Olaru et al., 2005, Tillman et al., 2004]. DNA double-strand ends are introduced 
during V(D)J rearrangement. Joining of these ends is under the control of the 
ubiquitously expressed non-homologous DNA end-joining (NHEJ) proteins [Kim et 
al., 2000].  
Regulation of gene segment rearrangement is essential to ensure that it only 
occurs during a specific developmental stage and (in the case of TCRβ) that only a 
single functional rearranged gene is expressed on the cell surface; rearrangement of 
TCR α chains permits expression of two α chains, one from each haplotype 
[Schlissel, 2003, Khor and Sleckman, 2002]. In developing αβ T cells, the TCRβ 
chain assembles before the TCRα chain. Progenitor cells with a successfully 
rearranged TCRβ chain co-express a pre-TCRα chain (pre-Tα) which facilitates cell 
surface expression, allowing selection and survival of those cells with a functional 
TCRβ chain. Successful rearrangement on one haplotype in most cases prevents 
rearrangement on the other haplotype, a mechanism known as allelic exclusion, so 
that only a single TCRβ chain is expressed on each T cell [Khor and Sleckman, 2002, 
Aifantis et al., 1997]. The rearrangement of TCRα chain occurs only after productive 
TCRβ rearrangement and is not subject to allelic exclusion; therefore, those T cells 
that generate in-frame α chains from both haplotypes can express two rearranged 
TCRα chains [Niederberger et al., 2003, Padovan et al., 1993]. Studies using mouse 
models have demonstrated that 30% of mature αβT cells express two in-frame TCRα 
chains [von Boehmer and Melchers, 2010, Brady et al., 2010]. 
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Rearrangement of the TCR occurs in the thymic cortex and during this stage of 
development the T cells co-express CD4 and CD8. T cells with fully rearranged 
αβTCRs undergo positive and negative selection in thymus and differentiate into 
mature CD4 or CD8 single-positive (SP) T cells before entering the peripheral 
circulation [Starr et al., 2003, Spits, 2002]. During positive selection, which occurs in 
the thymic cortex, αβT cells expressing TCRs with low or high affinity for self-
peptide-MHC complexes expressed on thymic epithelial cells are rescued from 
apoptosis. The cells then differentiate to CD4 and CD8 single positive T cells in the 
thymic medulla and undergo negative selection resulting in deletion of those αβT 
cells expressing TCRs with high-affinity for self-peptide-MHC complexes. This 
results in a repertoire of mature T cells with appropriate αβTCRs capable of 
interacting with self-MHC molecules without harmful auto-reactivity [Starr et al., 
2003]. Although only a small proportion (2%) of thymocytes survive the selection 
process, the resultant αβT cells show a very high level of clonal diversity [Nikolich-
Zugich et al., 2004].  
1.2.3 Diversity of the αβTCR repertoire 
1.2.3.1 Quantification of αβTCR diversity 
Clonal diversity of the αβTCR repertoire reflects the ability of T cell populations 
to respond efficiently to a vast array of antigens generated from infections with 
pathogens [Birnbaum et al., 2012, Turner et al., 2009]. This diversity is a 
consequence of the effects of somatic V(D)J recombination, including junctional 
diversity, and subsequent thymic selection based on the interaction of the TCRs with 
self-peptide-MHC complexes [Vrisekoop et al., 2014, Nikolich-Zugich et al., 2004]. 
The human genome contains 42 V and 61 J gene segments in the TCRα locus and 47 
V, two D, and 13 J segments in the TCRβ locus [Lefranc et al., 1999].  
In addition to the random recombination of the different gene segments, non-
germline nucleotide additions and deletions during the joining of gene segments 
substantially increases the diversity of the recombined genes. However, thymic 
selection markedly limits the diversity, with an estimated reduction of up to 100 fold 
[Bouneaud et al., 2000, Ignatowicz et al., 1996]. A theoretical diversity of 1×1013 
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possible TCRs (in the absence of thymic selection) has been calculated, which is 
greater than the 1×1012 T cells present in a single human individual [Arstila et al., 
1999]. However, based on experimental data, the actual αβTCR repertoire is 
estimated to be much lower. Applying the CDR3 spectratyping technique, it was 
calculated that human naïve T cells contain 2.5×107 αβTCRs [Arstila et al., 1999]. 
The diversity of the TCR repertoire in memory T cells was estimated as 2×106. 
The diversity of the bovine αβTCR repertoire is yet to be determined. Although 
the assemblies of the bovine TRA and TRB gene loci in the bovine genome are 
incomplete, comparison of available cDNA sequences with the genes so far 
identified in the genome assembly indicates that most variable gene subgroups have 
been identified [Connelley et al., 2009]. Analysis of the bovine TCRβ chain (TRB) 
locus has revealed 24 Vβ subgroups including 134 V genes, of which 79 were 
predicted to be functional. The locus contained 3 clusters of D, J and C genes, each 
comprising a single TRBD gene, 5-7 TRBJ genes and a single TRBC gene 
[Connelley et al., 2009]. Genomic analysis of the bovine TCRα locus identified 162 
functional V and 52 functional J gene segments within a 3.5Mbp region of 
chromosome 10 [Connelley et al., 2014]. The massive expansion of Vβ and Vα gene 
repertoires observed in the bovine genome, compared to humans and mice, has 
occurred as a result of tandem duplications of DNA regions containing several V 
gene segments. In the bovine TRB locus, extensive duplication of genes within the 
TRBV6, 9 and 21 subgroups has resulted in these subgroups accounting for 68% of 
the identified bovine Vβ genes [Connelley et al., 2014, Connelley et al., 2009]. The 
increased number of available genes for somatic recombination potentially increases 
the level of diversity of the bovine αβTCR repertoire. 
1.2.3.2 Factors influencing αβTCR diversity 
Both the genotype of host MHC and the complexity of self-peptides have been 
demonstrated to influence the diversity of the mature αβT cell repertoire. Crystal 
structures of TCR-peptide-MHC complexes show that contact between the TCR and 
pMHC occurs via 3 loops in each TCR chain, termed complementarity-determining 
regions (CDR) 1, 2 and 3. CDR1 and CDR2 are encoded within the V gene segments, 
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whereas CDR3 is encoded by the V-(D)-J junctional region [Bridgeman et al., 2012, 
Rudolph et al., 2006, Kjer-Nielsen et al., 2003, Garcia et al., 1996]. CDR1 and CDR2 
regions of the TCR primarily, but not exclusively, engage the alpha helices of the 
MHC molecule whereas CDR3 region of the TCR contact with the peptide presented 
by the MHC molecule [Garcia et al., 2009]. It has been observed that individuals 
with certain MHC allele showed a degree of bias in usage of V gene segments 
[Garcia et al., 2009, Sim et al., 1998]. However, αβTCR repertoires in inbred mice 
with identical genetic background showed limited overlap indicating that generation 
of the repertoire involves random events and that there is flexibility in the precise 
make-up of the TCRs capable of responding to any given antigen [Bousso et al., 
1998]. The peptide pool participated in thymic selection was illustrated to influence 
the TCR repertoire composition [Hogquist et al., 1993], which is consistent with the 
involvement of the CDR3 region in interacting with the MHC-bound peptide 
[Stewart-Jones et al., 2003]. In a controlled mouse model where a single peptide was 
used during thymic selection, the resultant naïve T cell repertoire was found to be 
impaired compared to the repertoires selected by diverse peptides [Barton and 
Rudensky, 1999].  
1.2.4 Naïve antigen-specific T cells 
Mature αβ T cells released from thymus make up the naïve repertoire of antigen-
specific T cells, which circulate between the blood and lymphatic systems to provide 
immune surveillance [Boyman et al., 2009, Spits, 2002]. Quantification studies of 
human and mouse repertoires have provide evidence that the frequency of antigen-
specific naïve T cells ranges from 1 to 100 per million [Jenkins and Moon, 2012, 
Alanio et al., 2010, Obar et al., 2008, Moon et al., 2007]. Upon antigen activation, 
naïve antigen-specific T cells undergo extensive clonal expansion and differentiation 
to become effector and memory T cells [Kaech et al., 2002].  
Both the quantity and quality of naïve antigen-specific T cell precursors have 
been investigated to understand their influences on the initiation and maintenance of 
T cell responses against a given antigen [Turner et al., 2009, Davenport et al., 2007, 
La Gruta et al., 2006a]. 
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These studies indicate that in some model systems the frequency of naïve T cell 
precursors can be a predictor of the magnitude of the primary antigen-specific T cell 
response [Jenkins and Moon, 2012, Davis et al., 2011, Kotturi et al., 2008]. In a 
lymphocytic choriomeningitis virus (LCMV) mouse model, in which CD8 T cells 
responding to three dominant epitopes account for a third of the total response, the 
magnitude of CD8 T cell responses to each of 28 identified epitopes was found to be 
closely related to the numbers of naïve T cell precursors [Kotturi et al., 2008]. The 
same phenomenon has also been reported for responses to other viruses, including an 
experimental model of influenza virus infection in humanized HLA-transgenic mice 
and humans infected with hepatitis C virus [Tan et al., 2011, Schmidt et al., 2011]. 
These studies indicated that a large number of naïve T cell precursors is 
advantageous for generating a T cell response against the respective pathogen 
epitopes. There is also evidence that the frequency of naïve T cell precursors has an 
effect on differentiation of the memory T cell populations [Marzo et al., 2005]. 
Central (TCM) and effector (TEM) memory T cell subsets have been defined according 
to the expression of homing and chemokine receptors including CD62L and CCR7 
[Farber et al., 2014, Masopust et al., 2001]. TCM cells (CD62L+CCR7+) preferentially 
recirculate through secondary lymphoid organs, are long-lived and proliferative 
strongly in response to antigen challenge, whereas TEM cells (CD62L-CCR7-) 
recirculate through non-lymphoid tissues and mediate rapid responses against re-
infection [Sallusto et al., 1999]. In an study involving adoptive transfer of naïve 
TCR-transgenic T cells, which showed a linear differentiation pathway from naive to 
TEM to TCM cells, a low-frequency of epitope-specific precursors was found to be 
associated with failure to differentiate TEM cells into TCM cells, whereas precursors 
present at high frequency differentiated into both TEM and TCM cells [Marzo et al., 
2005]. 
T cell avidity is a functional parameter, usually measured by determining 
theminimum concentration of antigenic epitope required to stimulate a T cell 
response. It reflects the combined effect of several biological variables, including 
TCR affinity for the peptide-MHC I, the level and type of co-receptor expression and 
sensitivity to cytokine stimulation, which collectively influence the functional 
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sensitivity of the T cells [Derby et al., 2001, La Gruta et al., 2006a, Price et al., 2005]. 
In a SCID (severe combined immunodeficiency) mice model inoculated with human 
CD8 T cells specific for an immunogenic epitope derived from human 
immunodeficiency virus (HIV), high-avidity CD8 T cells were found to provide 
better protection than low-avidity CD8 T cells against challenge with recombinant 
vaccinia virus expressing epitope-containing HIV antigen [Derby et al., 2001, 
Alexander-Miller et al., 1996]. High-avidity CD8 T cells were able to respond 
rapidly and kill early virus-infected cells.  
1.2.5 TCR repertoire of antigen-specific CD8 T cell responses 
1.2.5.1 Repertoire diversity with immune defense 
TCR repertoire diversity has been proposed to influence the magnitude and 
protective efficacy of antigen-specific CD8 T cell responses [Bousso et al., 1998, 
Campos-Lima et al., 1997]. The first direct evidence was reported using a mouse 
model of Herpes simplex virus (HSV) infection, which resulted in a dominant CD8 T 
cell response to a glycoprotein B-derived peptide (495-502; SSIEFARL) presented 
by H-2Kbm8. The CD8 T cell response showed variable TCR diversity and animals 
with a diverse repertoire survived virus infection while those with low diversity did 
not [Messaoudi et al., 2002]. A correlation between the magnitude of CD8 T cell 
responses and the diversity of the utilized TCR repertoire has also been observed in 
human HLA-A11-restricted CD8 T cell responses against Epstein-Barr virus (EBV) 
nuclear antigen-4. CD8 T cells specific for a dominant (EBNA4 416-424) epitope 
utilised a diverse TCR repertoire whereas CD8 T cells specific for a subdominant 
(EBNA4 399-408) epitope expressed a narrow range of TCRs [Campos-Lima et al., 
1997]. However, substantial variation of TCR repertoire usages by antigen-specific 
CD8 T cells was observed in other virus disease models [Koning et al., 2013, Utz et 
al., 1996, Argaet et al., 1994]. For example, in a murine influenza virus model, the 
TRB repertoire of CD8 T cells specific for a subdominant epitope PB1-F262-70 
showed relatively higher diversity than that of CD8 T cells specific for a dominant 
epitope NP366-374. Moreover, there was no obvious difference in the functional avidity 
of these CD8 T cell populations [La Gruta et al., 2008]. 
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For viruses with a rapid rate of evolution, such as HIV, several studies have 
presented evidence that diverse TCR repertoires of responding CD8 T cells provide 
enhanced immune protection against epitope variant escape [Price et al., 2004, 
Meyer-Olson et al., 2004, Charini et al., 2001]. However, other studies have reported 
that the affinity of TCRs for the pMHC I determine the likelihood of mutational 
escape from immune protection [Kloverpris et al., 2015, Ladell et al., 2013, Varela-
Rohena et al., 2008]. An affinity-enhanced TCR observed in CD8 T cells of HLA-A2 
individuals responding to an immunodominant epitope SL9 derived from HIV Gag 
antigen were found to recognise all common variants of the epitope, whereas the 
wild-type TCR provided protection to some but not all variants [Varela-Rohena et al., 
2008]. 
1.2.5.2 Sharing of antigen-specific TCRs by multiple individuals 
T cell responses to an epitope usually include T cells expressing different TCR 
chains involving diverse V, D and J gene rearrangements [Nikolich-Zugich et al., 
2004]. In some T cell responses, almost all TCR chains are unique to individual 
animals/humans. These TCRs are referred to as private TCRs [Kedzierska et al., 
2006, Kim et al., 2005, Cibotti et al., 1994]. However, in other responses, the 
responding cells contain TCRs that are apparently identical in multiple individuals 
and in some cases dominate the response to the respective antigenic epitope. These 
are referred to as public TCRs [Venturi et al., 2008a, Dong et al., 2010, Venturi et al., 
2008b, Venturi et al., 2006, Kedzierska et al., 2004]. Public TCRs have been 
detected in CD8 T cell responses specific for epitopes derived from HIV, SIV 
(Simian immunodeficiency virus) and influenza virus [Gillespie et al., 2006, Price et 
al., 2004, Kedzierska et al., 2004] and can serve as useful markers for following the 
antigen-specific CD8 T cell responses. The reasons for induction of public T-cell 
responses against specific antigens are poorly understood, but recently have been 
proposed to involve recombinatorial biases and convergent recombination, a process 
by which multiple recombination events converge to produce the same or similar 
TCRβ nucleotide sequences that encode the same TCRβ amino acid sequence [Li et 
al., 2012, Quigley et al., 2010, Venturi et al., 2006]. Public TCRs can be detected 
through analysis of the rearrangements of epitope-specific TCR α and β chains in 
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multiple individuals. The immune defence potential of public TCRs is still 
controversial. For example, conserved TRB clonotypes used by CD8 T cells specific 
for a Mamu-A*01 presented immunodominant epitope TL8 derived from SIV Tat 
antigen were found to facilitate epitope variant escape from TCR recognition as a 
consequence of residue substitution at potential TCR contact sites [Price et al., 2004]. 
Conversely, protective activity of a public TCR against naturally occurring variants 
of a Gag-derived CM9 epitope was reported for CD8 T cell responses against SIV 
[Price et al., 2004]. In a recent study, public TCRs were frequently found in CD8 T 
cells specific for the most dominant epitopes identified in HIV, whereas CD8 T cell 
responses to lower ranking epitopes included no or fewer public TCRs [Kloverpris et 
al., 2015].  
1.2.5.3 Correlation between naïve and immune repertoire of antigen-
specific CD8 T cells 
The development of methods for deep sequencing of TCR repertoires and 
generation of transgenic mice expressing epitope-specific TCRs, have facilitated 
studies to investigate the differentiation of naïve T cells following exposure to 
antigen and the influence of the naïve TCR repertoire on the composition of the 
responding antigen-specific CD8 T cells. Early studies of activation and 
differentiation of naïve T cells in TCR-transgenic mouse models revealed 
recruitment of a broad repertoire of TCR clonotypes into antigen-specific T cell 
response, with limited skewing of TCR diversity compared to the naïve repertoire 
[Zehn et al., 2009, Malherbe et al., 2004]. However, selective expansion of T cell 
clones with high-affinity TCRs for pMHC binding was observed, suggesting that the 
strength of the TCR/pMHC interaction influenced the clonal composition of 
responding T cells [Corse et al., 2011, Zehn et al., 2009]. Recently, use of magnetic 
beads based enrichment of antigen-specific CD8 T cells from conventional mice 
following staining with pMHC I tetramers has enabled the purification of naïve 
antigen-specific CD8 T cells for analysis of their TCR profiles [Obar et al., 2008, 
Moon et al., 2007]. Statistical analysis of epitope-specific TRB repertoires for naïve 
and immune pMHC I tetramer-positive CD8 T cells indicated that the TCR repertoire 
of the responding CD8 T cells reflected that in the naïve repertoire, although clear 
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evidence was observed for preferential expansion of particular clonotypes within the 
immune CD8 T cell pool [La Gruta et al., 2010]. These results indicate that, at least 
in some systems, the composition of the naïve epitope-specific TCR repertoire is 
predictive of the clonal composition of responding T cell populations, but that within 
this repertoire there is expansion of dominant clonotypes expressing TCRs with high 
affinity for pMHC I [La Gruta and Thomas, 2013]. It is possible that the extent to 
which these clonotypes dominate the response depends on the biology of the 
pathogen inducing the response.     
1.3 Immunodominance 
Immunodominance is the phenomenon whereby the CD8 T cell response of an 
individual host to a given pathogen is highly focused on a few antigenic peptides, 
despite the expression of several MHC I molecules capable of presenting a large 
number of peptides derived from the pathogen [Yewdell and Bennink, 1999]. This 
phenomenon has been reported as a common feature of CD8 T cell responses against 
many intracellular pathogens. Viruses are the most widely used models for studying 
the biological basis of immunodominance. Activated CD8 T cells proliferate and 
differentiate to express functional activities that eliminate infected cells or induce 
intracellular death of the pathogen. The active response is followed by a contraction 
phase, with substantial apoptosis of the reactive cells and return of surviving T cells 
to a resting state, resulting in survival of only 5-10% of the antigen-stimulated CD8 
T cells as memory cells. The memory CD8 T cells survive in recirculating T cell 
pool for prolonged time periods ranging from weeks to months in mice or years in 
humans [Kaech et al., 2002]. Immunodominant responses have been proposed to be 
advantageous, by allowing the immune system to accommodate a relatively narrow 
range of memory cell clonotypes specific for a wide range of pathogens encountered 
throughout life [Vezys et al., 2009]. 
A well-documented example for immunodominance is the CD8 T cell responses 
against HIV. Individual CD8 T cell responses have been reported to focus on one or 
few epitopes [Day et al., 2001, Goulder et al., 1997], and when the immune response 
selects mutated virus that escape the immune response, a new CD8 T cell response is 
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generated to a pre-existing epitope that had not previously induced a response [Im et 
al., 2011, McMichael and Phillips, 1997, Nowak et al., 1995]. The change of 
immunodominance illustrates an important biological feature of such CD8 T cell 
responses, namely their contribution to strain specificity.  
1.3.1 Epitope dominance hierarchy 
Epitope dominance hierarchy refers to the relative magnitude of CD8 T cell 
responses to different epitopes derived from the same pathogen. Such dominance 
hierarchies are profound in CD8 T cell responses to many pathogens, such that the 
detectable response may be focused entirely on 2 or 3 of the epitopes (referred to as 
immunodominant epitopes), among a larger number of epitopes to which the host is 
capable of responding. These additional epitopes that generate weak or undetectable 
responses  are referred to as subdominant epitopes [Yewdell and Bennink, 1999].  
The dominance hierarchy can have implications for immune protection of the 
resultant CD8 T cell response. In an influenza virus infected B6 (H-2b) mouse model, 
CD8 T cells preferentially respond to one dominant epitope NP366-374 derived from 
the nucleoprotein [Flynn et al., 1999]. The NP366-374 epitope-specific CD8 T cells 
displayed cytotoxic activity against influenza virus-infected cells and were shown to 
mediate immune protection [O'Neill et al., 2000, Christensen et al., 2000, Allan et al., 
1990]. Moreover, later work showed that CD8 T cell responses to a subdominant 
epitope in the influenza virus (i.e. PB1703 epitope derived from the polymerase B 
subunit) were unable to compensate the immune protection of this dominant epitope 
[Webby et al., 2003]. Despite the evidence of superior protective activity of 
dominant compared to subdominant epitopes in some systems, protection mediated 
by CD8 T cell responses to subdominant epitopes has been reported for some virus 
diseases, including HIV and LCMV [Im et al., 2011, Frahm et al., 2006, van der 
Most et al., 2003]. 
The degree to which dominance hierarchies are maintained in animals or humans 
expressing the relevant MHC I restriction element varies. Immunodominance tends 
to be consistent in MHC I-homozygous inbred strains of mice, but can differ in MHC 
I-heterozygous F1 mice. In some disease models, dominance of particular epitopes 
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identified in homozygous mice was retained in F1 mice [Kotturi et al., 2008, Liu et 
al., 2004], whereas inconsistent epitope dominance in different F1 progeny was 
observed in other disease models [Flesch et al., 2010, Belz et al., 2000, Rutigliano et 
al., 2007]. In humans expressing the MHC I molecule HLA-A2 (A*0201 allele), 
CD8 T cell responses to influenza virus are consistently dominated by CD8 T cells 
specific for the matrix protein epitope MP58-66, regardless of genetic background 
[Stewart-Jones et al., 2003, Gotch et al., 1987]. However, studies of human CD8 T 
cell responses to HIV demonstrated that the responses to epitopes, which were 
dominant in some individuals expressing the restricting MHC I allele, were not 
dominant in other individuals expressing the same MHC I allele [Betts et al., 2000]. 
A number of factors shown to influence this variation in epitope dominance are 
discussed further below. 
1.3.2 Factors influencing epitope dominance 
Extensive research has indicated that epitope dominance is influenced by 
multiple interdependent factors involved in almost every step of the antigen-specific 
CD8 T cell response [Chen et al., 2000, Yewdell and Bennink, 1999]. In general, 
these factors can be grouped into two broad categories: (1) factors influencing MHC 
I restricted epitope generation and cell surface expression and (2) factors affecting 
antigen-specific CD8 T cell activation, proliferation and establishment of memory 
[Yewdell, 2006, Akram and Inman, 2012]. The relative contribution of each factor 
appears to vary depending on the disease model. 
1.3.2.1 Factors that influence epitope abundance 
Studies of CD8 T cell responses to various intracellular pathogens have 
demonstrated that epitope abundance can influence the magnitude of CD8 T cell 
responses [Luciani et al., 2013, La Gruta et al., 2006b, Tenzer et al., 2009]. In some 
systems, this may relate to the levels of expression of the proteins from which the 
epitopes are generated. Dominant CD8 T cell responses to the intracellular parasite 
Trypanosoma cruzi were shown to be specific for identical epitopes present in 
several closely related proteins encoded by a multi-gene family [Martin et al., 2006]. 
The dominance was proposed to be due to the relatively high abundance of these 
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epitopes because of their presence in multiple proteins. Alternatively, some epitopes 
may be generated more efficiently than others by proteasome degradation. The 
amino acid sequences flanking epitopes within a protein have been shown to 
influence the epitope processing [Tenzer et al., 2009, Le Gall et al., 2007]. Another 
important factor in determining dominance in some pathogens is the stage of 
expression of proteins during infection. This is well illustrated by herpesviruses in 
which the proteins are expressed in an orderly manner – immediate early, early and 
late, and immunodominant CD8 T cell responses to the immediate early antigens 
have been reported [Abbott et al., 2013, St Leger et al., 2011, Reddehase and 
Koszinowski, 1984]. Down-regulation of MHC I expression later in infection was 
illustrated to partly contribute to this phenomenon. During antigen processing, the 
influence of TAP on epitope abundance was reported in an HIV model, in which the 
quantities of several defined epitope precursors were found differ substantially 
between the cytosol and ER, suggesting preferential transport of certain peptides by 
TAP [Tenzer et al., 2009]. 
1.3.2.2 Influence of CD8 T cell abundance and avidity 
Studies using several virus disease models have provided evidence that the 
frequency of naïve antigen-specific CD8 T cells influences the immunodominance 
hierarchy of antigenic epitopes [Tan et al., 2011, Schmidt et al., 2011, Kotturi et al., 
2008]. However, other studies contradicted these findings by demonstrating that the 
ability of the epitope-specific naïve T cells to proliferate and undergo differentiation 
following antigen recognition, rather than their frequency, determines the hierarchy 
of epitope-specific CD8 T cell responses [Cukalac et al., 2014b, Jenkins and Moon, 
2012, La Gruta et al., 2010]. For example, in the B6 (H-2b) mouse model of 
influenza virus infection, frequencies of naïve CD8 T cell precursors for two 
subdominant epitopes DbPB1-F262 and KbNS2114 were found to be higher than that of 
two dominant epitopes DbNP366 and DbPA224. By tracking the recruitment of naïve 
specific CD8 T cells during primary infection, it was demonstrated that the slow 
expansion and differentiation of DbPB1-F262 epitope-specific naïve CD8 T cells 
accounted for the subdominant status of this epitope [La Gruta et al., 2010]. A recent 
study, which analysed T cell affinity (a representative measurement of avidity) of 
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naïve and immune CD8 T cells for these four epitopes, observed that CD8 T cells 
specific for the dominant epitopes tend to have higher affinity for pMHC I 
complexes [Cukalac et al., 2014a]. All these results indicate that both the quality and 
quantity of naïve CD8 T cells have the potential to influence epitope dominance 
hierarchy. 
1.3.2.3 Influence of genetic background on the TCR repertoire  
As discussed above (section 1.2.5), the frequencies and TCR repertoire diversity 
of epitope-specific CD8 T cells in the naïve T cell pool can greatly influence the 
magnitude of antigen-specific CD8 T cell responses [Kloverpris et al., 2015, 
Balamurugan et al., 2010, Turner et al., 2006, Price et al., 2004, Messaoudi et al., 
2002]. Since generation of the TCR repertoire involves negative selection of 
specificities that recognise self, the genetic background of the host can have a strong 
influence on the composition of the repertoire. Gene products that are highly 
polymorphic, such as MHC I proteins, are particularly influential. The presence of 
other MHC I alleles along with the allele that restricts the CD8 T cell response to a 
particular epitope has been shown to alter the epitope dominance hierarchy in both 
humans and mice [Betts et al., 2000, Belz et al., 2000]. A reduction of up to 95% in 
the CD8 T cell response to an H-2Db-restricted influenza virus epitope was found in 
F1 MHC I-heterozygous mice compared to homozygous animals. TCR repertoire 
analysis of the epitope-specific CD8 T cells derived from these mice revealed the 
deletion of a predominant clonotype in the TCR repertoire of the F1 mice [Belz et al., 
2000]. Such deletions are referred to as a “hole” in the repertoire. MHC I-induced 
TCR repertoire alteration has also been demonstrated in human CD8 T cell responses 
to EBV; deletion of T cells expressing a dominant TCR β chain specific for an HLA-
B8-restricted EBV epitope (FLRGRAYGL) was observed in HLA-B8/HLA-B*4402 
heterozygous individuals. The EBV-specific T cells expressing this TRB clonotype 
were found to cross-react with the HLA-B*4402 alloantigen [Burrows et al., 1995, 
Argaet et al., 1994]. These results indicate that TCR clonotype can have profound 
effect on epitope-specific CD8 T cell responses.    
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1.4 Aims of the project 
Previous research has provided evidence that CD8 T cells mediate immunity 
against infection with Theileria parva [McKeever et al., 1994]. However, the 
immunity induced by one parasite strain doesn‟t give complete protection against 
other strains and this has been demonstrated to be associated with parasite strain 
specificity of the CD8 T cell responses [Taracha et al., 1995b, Morrison et al., 1987]. 
There is evidence that such strain specificity is a consequence of the CD8 T cell 
responses of individual animals being focused on a limited number of 
immunodominant polymorphic peptide-MHC I determinants. Dominant responses to 
the Tp2 antigen have been demonstrated in animals homozygous for the A10 MHC I 
haplotype [Connelley et al., 2011, MacHugh et al., 2009]. Three Tp2 epitopes 
recognised by A10 animals (Tp249-59, Tp250-59 and Tp298-106) have been defined. This 
project set out to investigate the dominance of these epitopes in A10 animals and, by 
sequencing of  T cell receptor (TCR) genes, investigate the clonal composition of the 
responding CD8 T cells, with the eventual aim of isolating pairs of TCR α and β 
chain cDNAs that can be used to generate cells expressing TCRs of defined epitope 
specificity.  
The specific objectives were to: (i) Determine the dominance hierarchies of the 
three defined Tp2 epitopes in both A10-homozygous and -heterozygous cattle 
(Chapter 3). To achieve this, MHC I tetramers incorporating epitope-related peptides 
were used for rapid quantification of epitope-specific CD8 T cells within responding 
populations. (ii) To determine the clonal repertoires of epitope-specific CD8 T cell 
populations by sequencing the expressed TRB genes, in order to examine the 
potential contribution of CD8 T cell clonal composition to epitope dominance 
hierarchy (Chapter 4 and 5). (iii) To isolate full-length cDNAs encoding TCR α and 
β chain pairs from T cell clones of defined epitope specificity and use them to 
generate cells expressing the functional TCRs. This part of the work (Chapter 6) 
aimed to provide the basic tools for generating naïve antigen-specific CD8 T cells, 
which could be used in further studies to investigate the requirements for induction 
of primary antigen-specific CD8 T cell responses in vitro.   
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Chapter 2: Material and methods 
2.1 Experimental animals 
Three MHC I A10 homozygous and six A10 heterozygous Holstein animals 
were immunized with the Muguga isolate of T. parva by the infection and treatment 
protocol as described previously [Radley et al., 1975b]. In brief, cattle were infected 
with cryopreserved T. parva (Muguga) sporozoites and at the same time given a 
long-acting formulation of oxytetracycline, at a dose of 20mg/ml intramuscularly. 
The MHC class I haplotypes of these animals were determined by initially screening 
with a panel of MHC I-specific monoclonal antibodies or class I allele-specific PCRs 
followed by sequencing of the PCR products and are shown in Table 2-1. 
Table 2-1 MHC class I haplotypes of animals used in this project. 
Animal MHC class I haplotype MHC class I alleles 
302186 A10/A10 2*01201, 3*00201 
403992 A10/A10 2*01201, 3*00201 
403957 A10/A10 2*01201, 3*00201 
102121 A10/A12 2*01201, 3*00201, 1*01901, 2*00801 
402145 A10/A12 2*01201, 3*00201, 1*01901, 2*00801 
102170 A10/N5 2*01201, 3*00201, 3*03601, 3*03701 
702162 A10/N5 2*01201, 3*00201, 3*03601, 3*03701 
402082 A10/A11 2*01201, 3*00201, 2*01801, 3*01701 
702197 A10/A11 2*01201, 3*00201, 2*01801, 3*01701 
2.2 Cellular techniques 
2.2.1 Isolation of peripheral blood mononuclear cells 
A volume of 60ml of blood was obtained by jugular venupuncture and collected 
into syringes containing 3-4ml of PBS with 0.5mM EDTA solution, which served as 
an anti-coagulant and diluent. Peripheral blood mononuclear cells (PBMC) were 
isolated by density gradient centrifugation over Ficoll-Paque as described before 
[Goddeeris and Morrison, 1988]. Aliquots of 30ml of the blood/EDTA solution 
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mixture were carefully overlaid onto 20ml of Ficoll-Paque Plus (GE Healthcare Life 
Sciences) in 50ml polypropylene tubes and centrifuged at 900×g for 30min at room 
temperature. PBMC were harvested from the Ficoll-Paque Plus/plasma interface and 
mixed with an equal volume of PBS containing 2mM EDTA before pelleting by 
centrifugation at 450×g for 10min at room temperature. The pellets were washed 
three times in PBS containing 2mM EDTA, counted and resuspended in a suitable 
volume of standard cell culture medium (SCM - RPMI 1640 containing 10% foetal 
bovine serum (FBS), 5×10-4 M 2-mercaptoethanol (2-ME), 100U/ml penicillin, 
100µg/ml streptomycin and 0.29mg/ml L-glutamine) for subsequent use. If necessary, 
PBMC containing residual red blood cells (RBCs) were subjected to osmotic lysis 
prior to the second wash by re-suspending the pellet in 5ml of RBC lysis buffer 
(17.5mM TRIS, pH7.4 with 144mM ammonium chloride) pre-heated to 37°C, and 
then incubating at 37°C for 2-3min, followed by the third wash as described above. 
2.2.2 CD8 T cell purification from PBMC  
Magnetic-activated cell sorting (MACS) was conducted according to the 
manufacturer‟s instructions (Miltenyi Biotec). Briefly, 1×108 PBMC were pelleted 
by centrifugation at 400×g for 5min at 4°C and re-suspended in 5ml of IL-A105 
hybridoma culture supernatant (antibody specific for CD8 T cells, titrated before use) 
at a pre-determined dilution. After incubation for 10min at room temperature, cells 
were washed twice with PBS and centrifuged at 400×g for 5min at 4°C. After the 
second wash, fluid above the cell pellet was removed completely. Pelleted cells were 
re-suspended directly in a suspension of micro-beads coated with anti-mouse IgG 
(Miltenyi Biotec, 100µl per 1×108 cells) and incubated for 10min at room 
temperature. Cells were washed twice with PBS (10mls/108 cells) and re-suspended 
in 0.5ml MACS buffer (PBS with 0.5% bovine serum albumin (BSA) and 2mM 
EDTA) for MACS purification. An MS column (reservoir volume 3.5ml) was placed 
on the separator magnet (Miltenyi Biotec) and washed with 0.5ml MACS buffer, 
before adding the prepared suspension of beads and cells to the reservoir at the top of 
the column. Cells bound to the column were washed three times with 0.5ml of 
MACS buffer to remove unbound cells and 2ml SCM added to the top of the column 
before it was removed from the magnet and placed to the top of a new 15ml tube 
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containing 5ml SCM. CD8 T cells were collected by plunging the SCM through the 
column. After centrifugation at 400×g for 5min, pelleted cells were re-suspended in 
appropriate SCM for subsequent use. The purity of sorted CD8 T cells was 
determined by flow cytometry cell analysis as described in section 2.2.8. 
2.2.3 Depletion of CD4 and γδ T cells from cultures 
Cells were re-suspended in monoclonal antibodies IL-A12 (specific for bovine 
CD4) and GB21A (specific for bovine γδ T cells) at predetermined dilutions with a 
final density of 1×107/ml in a 15-ml Falcon tube and incubated for 30min at 4°C on a 
rotating mixer at 20 rpm and washed once with SCM. 4×107 Dynal beads coated 
with anti-mouse Ig antibody (Life Technologies) were added per 1×107 cells in 1ml. 
Cell/bead mixture was re-suspended in SCM at 5×106 cells/ml in a 15-ml Falcon tube 
and incubated for 30min at 4°C on a rotating mixer at 20 rpm. The volume was 
expanded to 10ml with SCM and the tube placed in the magnet for 2min to 
immobilise the bead-bound labelled cells. Unlabelled cells were collected and re-
suspended in an appropriate volume of SCM. 
2.2.4 T. parva-infected cell lines 
Cell lines infected with T. parva (Muguga) (TpM) from the 6 animals 
heterozygous for the MHC I A10 haplotype listed in Table 2-1) and from an 
additional A10-homozygous animal (592) and an A14-homozygous animal (605) had 
been generated previously and were available from cryopreserved stocks. T. parva 
(Muguga) transformed cell lines (TpM) were established for 3 further A10-
homozygous animals (302186, 403957 and 403992, Table 2-1) by in vitro infection 
of PBMC with sporozoites. 2×107 PBMC were pelleted by centrifugation at 200×g 
for 5min, re-suspended in 1ml of a 1:3 dilution of T. parva (Muguga) sporozoites 
(stabilate 80) in SCM and incubated in a humidified atmosphere of 5% CO2 at 37°C 
for 1.5 h with gentle mixing every 30minutes. The cells were then washed once in 
10ml SCM, re-suspended in 10ml of SCM, distributed into a 24 well plate (2ml per 
well) and incubated in a humidified atmosphere of 5% CO2 at 37°C. The cells were 
monitored microscopically for growth of transformed lymphoid cells. Once 
established, TpM cell lines were expanded into culture flasks and kept in a 
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humidified atmosphere of 5% CO2 at 37°C. Established cultures were maintained by 
removal of 50-75% of the volume of the cultured cell suspensions every 2-3 days and 
replacing it with fresh SCM. The phenotypes of the TpM cell lines were determined 
by flow cytometry using a panel of monoclonal antibodies specific for CD3, CD4, 
CD8, γδ T cells and IgM as described below (section 2.2.8 and Table 2-2). 
2.2.5 In vitro generation of T. parva-specific CD8 T-cell 
enriched cell lines 
The protocol for generation of T. parva-specific CD8+ T cell enriched cell lines 
was adapted from that described previously [Goddeeris and Morrison, 1988]. The 
protocol involved 3 stimulations of PBMC with autologous irradiated infected cells 
at 7 day intervals. 
First stimulation: PBMC were isolated and counted as described above. 
Autologous TpM cells (stimulators) were harvested, counted and exposed to 60Gy of 
gamma irradiation from a 137Caesium source. Into each well of a 24-well plate were 
placed 2ml of SCM containing 2×106 PBMC/ml and 1×105/ml irradiated autologous 
stimulators. Plates were incubated for 7 days in a humidified atmosphere of 5% CO2 
at 37°C.  
Second stimulation: Cells from the first stimulation were harvested, counted and 
reseeded into 24-well plates in 2ml of SCM at a density of 2×106/ml together with 
irradiated autologous stimulators at 1×105/ml. Plates were incubated for 7 days in a 
humidified atmosphere of 5% CO2 at 37°C. 
Third stimulation: Cells from the second stimulation were harvested, counted 
and the CD4+ and γδ T cell populations depleted by antibodies and anti-mouse Ig 
coated beads as described in section 2.2.3. The remaining cells were washed, 
resuspended in SCM and re-seeded into 24-well plates in 2ml of SCM at a density of 
1×105/ml together with irradiated stimulators at a density of 5×105/ml and 100U/ml 
recombinant human IL2 (rIL2, Novartis international AG, USA), and incubated for 7 
days in a humidified atmosphere of 5% CO2 at 37°C. 
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Some experiments involved in vitro stimulation of CD8 T cells purified from 
PBMC by MACS separation as described above. The CD8 T cells were seeded into 
24-well plates in 2ml of SCM at a density of 1×105/ml together with autologous 
stimulators at a density of 5×105/ml and 100U/ml rIL2, and incubated in a 
humidified atmosphere of 5% CO2 at 37°C. 
The generated CD8 T cell lines, subjected to three in vitro stimulations, were 
cryopreserved (section 2.2.7), while some lines were maintained in culture by further 
in vitro stimulation at a density of 1×105/ml together with irradiated stimulators at a 
density of 5×105/ml and 100U/ml rIL2. 
2.2.6 Cloning of T. parva-specific CD8 T cells 
Cells obtained following the third stimulation and/or from the purified CD8 T 
cells after a single stimulation with infected cells were harvested and assessed for 
CD8 T cell purity by flow cytometry (see section 2.2.8). If there was significant 
contamination (>2%) with γδ T cells and/or CD4 T cells, the cell lines were subject 
to another round of depletion by staining with antibodies specific for CD4 and γδ 
TCR and removal with anti-mouse Ig-coated Dynal beads as described above (see 
section 2.2.3), until >98% of the population were CD8 T cells. The CD8 T cells were 
cloned by limiting dilution. They were  serially diluted in SCM to give cell densities 
of 40, 20, 10, 5, 2.5 cells/ml. Aliquots of 100μl of each of these suspensions were 
distributed into the wells of a 96-well round-bottom plate, to give final densities 
ranging from 4 to 0.25 cells/well. To each well, was added a 100μl aliquot of SCM 
containing 5×104/ml irradiated autologous stimulators, 2×105/ml irradiated 
autologous filler cells (PBMC) and 200U/ml rIL2. Plates were incubated for 2 weeks 
in a humidified atmosphere of 5% CO2 at 37°C, after which the wells were screened 
microscopically and wells displaying obvious cell growth were selected for further 
expansion of the cells. Only wells from plates showing growth in <30% of wells 
were selected, as they have greater than 83% possibility of being clonal [Goddeeris 
and Morrison, 1988]. 
For in vitro expansion of clones, selected clones were transferred to individual 
wells of 48-well plates containing 2.5×105 irradiated autologous stimulators and 
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100U/ml rIL2 in a total volume of 1ml SCM. Plates were incubated in a humidified 
atmosphere of 5% CO2 at 37°C and clones were re-stimulated in the same way every 
two weeks as required. 
2.2.7 Cryopreservation of cells 
Parasitized cell lines and T cell lines to be cryopreserved were pelleted, re-
suspended at 2×106 cells/ml in 90% heat-inactivated foetal bovine serum (FBS) 
containing 10% dimethylsulphoxide (DMSO) and 1ml aliquots transferred into 2ml 
polypropylene cryovials. These vials were placed into an isopropanol jacketed 
container and slowly frozen at -70°C before being transferred to liquid nitrogen 
storage. CD8 T cell lines were routinely cryopreserved two days after stimulation 
with irradiated parasitized cells. For further use of the cryopreserved cells, they were 
rapidly thawed by incubation in a water bath at 37°C, washed in SCM and re-
suspended in the original (pre-freeze) volume of SCM for further culture. 
2.2.8 Flow cytometry analysis 
The monoclonal antibodies (mAb) used for primary labelling of cells for 
phenotypic analysis are listed in Table 2-2. Hybridoma culture supernatants 
producing the mAb were used at a dilution of 1:5 in FACS medium (RPMI 1640 
medium with 2% foetal bovine serum and 0.2% Sodium Azide), while those 
available in the form of ascitic fluid were used diluted 1:1000 in FACS medium. 
Aliquots of 50μl of cell suspensions at 2×107 cells/ml were distributed in wells 
of 96-well round-bottom well plates and 50μl of the required primary mAb added. 
Plates were incubated at 4°C for 30min, washed three times in FACS medium and 
then re-suspended in 50μl of fluorescein-isothiocyanate (FITC)-labelled goat 
polyvalent anti-mouse immunoglobulin G, A and M antibody (Sigma-Aldrich, Poole, 
Dorset, UK). Following incubation at 4°C for 30min, the cells were washed three 
times in FACS medium and then re-suspended in 200μl FACS medium for analysis 
on a BD FACSCalibur cell analyser (BD Biosciences). Negative controls were 
incubated with FACS medium instead of primary labelling antibody. 
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2.2.9 Tetramer staining and cell sorting 
In vitro generated cell lines enriched for CD8 T cells were harvested and re-
suspended in SCM at a density of 1×107cells/ml. Aliquots of 100μl cell suspension 
were distributed in wells of 96-well round-bottom well plates, centrifuged briefly and 
re-suspended in 50μl of 20nM tetramers. Phycoerythrin (PE) labelled MHC I 
tetramers that incorporate three defined epitopes derived from the Tp2 antigen 
(Tp298-106, Tp249-59 and Tp250-59) associated with the BoLA 2*01201 heavy chain 
were used. After incubation at 4°C for 30min in the dark, cells were washed twice 
with FACS medium and re-suspended in 200μl FACS medium for analysis using a 
BD FACSCalibur. Negative controls were incubated with FACS medium instead of 
tetramers. 
For cell sorting of tetramer-specific CD8 T cells, preliminary tetramer staining 
was undertaken to quantify the Tet+CD8+ T cells to enable calculation of the total 
number of cells needed for staining with the respective tetramers for cell sorting. 
Cells were suspended in SCM medium at a density of 1×107cells/ml and stained with 
tetramers as described above. Keep cells sterile if subsequent culture is needed. Cell 
sorting was performed on BD FACSAria IIIu.  
2.2.10 Culture of 293T cells 
HEK 293T adherent cells were cultured in DMEM medium with 10% FBS, 
100U/ml penicillin, 100µg/ml streptomycin. Cells were subcultured when confluent,  
Antibody Isotype  Specificity  Cell distribution 
MM1A IgG1 CD3 T-cells 
IL-A12 IgG2a CD4 CD4+ T cells 
IL-A105 IgG2a CD8 CD8+ T cells, NK cells 
GB21A IgG2b γδ TCR All γδ T cells 
IL-A30 IgG1 IgM B cells 
Gr13 IgG1 Nkp46 NK cells 
QBEND-10 IgG1 Human CD34 Lentivirus-transduced cells 
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every 2-3 days. The 293T cells were harvested from T75 flasks with a volume of 
15ml medium per flask by first gently flushing them with PBS and then adding 3-
5ml of 0.25% Trypsin-EDTA dissociation reagent (Life Technologies) and 
incubating in a humidified atmosphere of 5% CO2 at 37°C for 1-2minutes. 10ml of 
DMEM medium was added immediately after incubation to wash off the cells. The 
cell suspension was harvested, pelleted by centrifugation and the cells counted and 
used as required. 
2.2.11 Culture of Jurkat cells 
The Jurkat cell line JRT3-T3.5, a human TCR-negative CD8 T cell line 
transfected with the luciferase reporter gene under the transcriptional control of 
NFAT (nuclear factor of activated T cells)-responsive elements and the Neomycin-
resistance gene, was generously provided by Dr. John Bridgeman, Cardiff University. 
The cell line was cultured in RPMI-1640 medium supplemented with 10% FBS, 
100U/ml penicillin, 100µg/ml streptomycin and 0.29mg/ml L-glutamine. Selective 
antibiotic G418 (for the Neomycin-resistance gene) with a final concentration of 
50μg/ml was added into the culture to maintain the cell line. 
2.2.12 Production of lentivirus in 293T cells  
For transfection, 1.5-2×107 293T cells were seeded into a T75 culture flask the 
day before transfection. Freshly prepared culture medium at pH7.1 (25mM HEPES 
Buffer in serum free DMEM medium, adjust pH to 7.1 and filter with 0.2μm filter), 
and at pH7.9 (25mM HEPES Buffer in DMEM medium+10% FBS, adjust pH to 7.9 
and filter with 0.2μm filter) were used for the transfection procedure. 1M CaCl2 was 
prepared by dissolving 7.35g hydrated CaCl2 in 50ml water, filtered through a 0.2μm 
filter and stored at -20°C in single use aliquots. For lentivirus production, 30μg 
pSxW lentiviral-TCR transfer vector, 30μg pCMVΔ8.91 and 15μg pMD2.G (vectors 
were given by Dr. John Bridgeman, volume for each vector was calculated according 
to the concentration of purified plasmid in 10mM Tris·Cl, pH 8.5) were added to a 
15ml Falcon tube in medium at pH 7.1 to a volume of 2.85ml; 150µl of CaCl2 was 
then added. The tube was vortexed and left for 10-30min at room temperature. 
Medium was removed from flasks of cultured 293T cells before gently adding 
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12.0ml of pH 7.9 medium. The transfection mix was briefly vortexed and added to 
the 293T cells dropwise. Cells were then cultured in a humidified atmosphere of 5% 
CO2 at 37°C for 24 hours. Replace the media with 20ml RPMI-1640 medium 
supplemented with 10% FBS, 4mM L-glutamine, 100U/ml penicillin and 100µg/ml 
streptomycin and cells were cultured for another 24 hours. Supernatant was then 
collected and filtered through a 0.45µm filter and stored at 4°C. Cells were 
continually cultured in 20ml of fresh RPMI-1640 medium supplemented with 10% 
FBS, 100U/ml penicillin, 100µg/ml streptomycin and 4mM L-glutamine. The second 
collection of supernatant was made after 24 hours and filtered through a 0.45µm 
filter. The two collections were centrifuged at 24000 xg for 2 hours at 4°C in ultra-
clear ultracentrifuge tubes (Beckman Coulter). Following centrifugation, the 
supernatant was decanted and the pellet was re-suspended in a 10-fold smaller 
volume than the original supernatant volume. Aliquots were snap frozen on dry-ice 
and stored at -80°C. 
2.2.13 Lentiviral transduction of Jurkat cells 
The day before transduction, 1ml of 1×106 JRT3-T3.5 cells were seeded into 
each well of a 24-well plate. After overnight culture at 37°C, the supernatant was 
replaced with 1ml of viral stock (virus titre was determined according to the 
description in section 6.2.3) for transduction. Polybrene (Hexadimethrine bromide, 
Sigma) was added to a final concentration of 6μg/ml.  A stock solution of Polybrene, 
prepared by dissolving in H2O at 6mg/ml, was filtered through 0.2μm filter and 
stored in aliquots at -20°C. 
Transcription of the TCR by transduced JRT3-T3.5 cells was determined 72h 
post-transduction, by staining the cells by indirect immunofluorescence for surface 
expression of the transcribed marker gene product human CD34. Transduced and un-
transduced Jurkat cells were stained with CD34-specific antibody QBEND-10 
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2.2.14 Lentiviral transduction of bovine CD8 T cells 
Bovine CD8 T cells were purified from PBMC by MACS sorting, as described 
in section 2.2.2. Purified CD8 T cells were activated by incubating the cells in anti-
bovine CD3-coated wells, to which SCM containing anti-bovine CD28 (5μg/ml) and 
rIL2 (100U/ml) were added, as described previously [Nijhuis et al., 1990, Hogg et al., 
2011]. The cells were incubated for 24 hours in a humidified atmosphere of 5% CO2 
at 37°C. The time line for pre-stimulation and transduction of bovine CD8 T cells 
was as follows: 
 Day 0 – Plate coating: Anti-bovine CD3 antibody (MM1A) diluted in PBS at a 
final concentration of 1μg/ml was added to a 96-well flat bottom untreated microtitre 
plate (Corning, #3370). The plate was incubated at 4°C overnight to allow antibody 
binding. 
Day 1 – Pre-stimulation of bovine CD8 T cells: The coating antibody was 
removed from each well of the coated plate and 5×104 purified CD8 T cells added 
along with anti-bovine CD28 antibody at 5μg/ml (AbD Serotec, clone CC220, Low 
Endotoxin) and rIL2 at 100U/ml (final concentrations) in 200ul of SCM. Cells were 
incubated at 37°C in 5% CO2 for 24 hours. 
Day 2 – Lentiviral transduction of bovine CD8 T cells: The supernatant was 
carefully removed from the wells and virus added directly to the cells at a 
multiplicity of infection (MOI) ranging from 1~10. For example, 250µl of virus with 
a titer 2×106 TU/ml added to 5×104 cells resulted in an MOI=10. Polybrene and rIL2 
were added to give final concentrations of 6μg/ml and 100U/ml respectively. Cells 
were cultured at 37°C in 5% CO2 for 48-72 hours before monitoring for transgene 
expression.  
2.3 Molecular techniques 
2.3.1 Template-switch anchored reverse transcription-
polymerase chain reaction (RT-PCR) for TRB repertoire 
analysis 
The method was adopted from previously published work about TCR repertoire 
analysis [Quigley et al., 2011, Douek et al., 2002]. As shown in Figure 2.1, the 
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involvement of a switching mechanism at the 5'-terminus of the RNA transcript 
(SMART) facilitates the enrichment of full-length TCR transcripts. The anchor 
sequence added during reverse transcription allows unbiased amplification of TCR 
rearrangements using the rapid amplification of cDNA ends (RACE) PCR. The 
whole procedure includes the following steps: (1) purification of antigen-specific T 
cell populations for TCR gene analysis; this step was done according to section 2.2.9; 
(2) mRNA isolation; (3) cDNA synthesis; (4) RACE-PCR amplification of 
rearranged TCR products; (5) gel extraction and purification of amplicons; (6) 
amplicon ligation into a TA cloning vector; (7) vector transformation into competent 








The reverse transcription and 
template switching properties of Moloney Murine Leukemia Virus (MMLV) reverse transcriptase 
enable the incorporation of an anchor sequence to the 5‟-end of full length mRNA during cDNA 
synthesis. When reverse transcription reaches to the 5‟-end of mRNA, the reverse transcriptase first 
add a short deoxcytidine (dC) sequence to the 3‟-end of cDNA. A modified oligonucleotide sequence 
with G ribonucleotides hybridizes to dC sequence and then reverse transcription switch template to 
complete cDNA synthesis. With designed forward and reverse primers according to the anchor 
sequence and constant region of TCR, rearrangements are amplified. 
2.3.1.1 mRNA isolation from cells 
Purification of mRNA was carried out using the Oligotex Direct mRNAmini Kit 
(Qiagen) according to the manufacturer‟s instructions. Briefly, 1×106 cultured or 
Forward primer 
Reverse primer 
Figure 2.1 Schematic instruction of the 5'-SMART-RACE PCR.  
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purified cells that were stored in RNAlater were partially thawed and centrifuged 
immediately at 11,000×g, 4 °C for 10min to remove supernatant. The pelleted white 
precipitate was lysed in buffer OL1 (1ml contains 30μl of β-ME, 600µl added to 
1×106 cells). The sample was homogenized using a QIAshredder spin column. 
Binding buffer ODB was added to the lysate, followed by addition of 20µl Oligotex 
suspension (containing polystyrene–latex beads coated with dT30 oligonucleotides) 
and the mixture incubated at room temperature for 10min to hybridize the oligo dT30 
on the beads with the polyA+ RNA. After centrifugation at 14,000×g for 5min, the 
pelleted beads were resuspended in 350µl washing buffer OW1 and the sample 
transferred on to a small spin column. The beads were collected from the column and 
washed twice with 350µl buffer OW2. mRNA was eluted from the beads by addition 
of 20µl hot (70°C) buffer OEB and used immediately for cDNA synthesis or stored 
at −80°C for future use. 
2.3.1.2 Reverse transcription – complementary DNA (cDNA) synthesis 
The SMARTerTM RACE cDNA Amplification Kit (Clontech) was used, which 
includes a modified anchor SMARTer II A Oligonucleotide 5‟-AAGCAGTGGTA 
TCAACGCAGAGTACGCGGG-3‟ with three G residues at the end and a 5‟- RACE 
CDS Primer A (5‟ CDS) 5‟-(T)25VN-3‟ (V=A,C,G; N=A, C, G, T). cDNA synthesis 
was performed according to the manufacturer‟s instructions. One microliter of  
5‟CDS primer and 2.75μl of mRNA were added to a 0.2ml PCR tube and incubated 
at 72°C for 3min and then 42°C for 2min. Following incubation, 1μl of SMARTer II 
A oligo and  a Master Mix composed of 2μl 5×First-Strand Buffer, 1μl DTT, 1μl 
dNTP Mix, 0.25μl RNase Inhibitor  and 1μl SMARTScribe Reverse Transcriptase 
were added in a total volume of 10μl. The mixture was incubated at 42°C for 90min 
and 70°C for 10min in a hot-lid thermal cycler. The product was then diluted by 
addition of 15μl Tricine-EDTA buffer and used immediately for RACE PCR 
amplification or stored at -20°C for future use. 
2.3.1.3 RACE PCR amplification of rearranged TRB products 
For amplification of rearranged bovine TRB products, a reverse primer located 
near the 5‟ end of the constant region of bovine TRB (TRBC) was synthesized as 5‟- 
GGAGATCTCTGCTTCCGAGGGTTC-3‟. The forward primer, provided in the 
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SMARTerTM RACE cDNA Amplification Kit and named as 10× Universal Primer A 
Mix (UPM), consisted of a mixture of Long (0.4 μM) 5‟-
CTAATACGACTCACTATAGGGCA AGCAGTGGTATCAACGCAGAGT -3‟ 
and Short (2 μM) 5‟- CTAATACGACTC ACTATAGGGC-3‟ versions of the primer. 
The Advantage® 2 PCR Kit (Clontech) was used for RACE PCR. The reaction was 
prepared as follows: 10×Advantage 2 PCR Buffer 5μl, 10×UPM 5μl, TRBC (25 μM) 
1μl, dNTP 1μl, cDNA 7-13μl, AdvanTaq2 1μl and PCR-Grade H2O made up to a 
total of 50μl. The reaction was run in a thymocycler under the following conditions: 
1 cycle of 95°C 30sec; 5 cycles of 95°C 5sec and 72°C 2min; 5 cycles of 95°C 5sec, 
70°C 10sec and 72°C 2min; 30 cycles of 95°C 5sec, 66°C 10sec and 72°C 2min. The 
entire product was loaded, along with a 100bp DNA ladder, on a 1.5% agarose gel 
made with 1×TAE Buffer containing GelRed DNA stain to allow visualization under 
UV light. The expected product should be within 500-700bp range. The band of 
interest (expected size range 500-700bp) was excised from the gel using a scalpel 
and transfered to a clean 1.5ml microcentrifuge tube. 
2.3.1.4 Purification of amplicons 
NucleoSpin® Gel and PCR Clean-up Kit (Macherey-Nagel) were used for 
purification of TRB amplicons from agarose gels, according to the manufacturer‟s 
instructions. Two volumes of NT buffer were added to one volume of gel and 
incubated at 50°C for 5-10min to dissolve the gel. The resultant solution was loaded 
onto the binding column and centrifuged at 11,000×g for 1min to bind DNA to the 
column membrane. The membrane was washed twice with NT3 buffer (with added 
ethanol) and DNA eluted with 15-30μl of DNase-free water. 
2.3.1.5 Ligation of PCR amplicons into pGEM-T Easy vector 
The pGEM-T Easy Vector System I Kit (Promega) was used for ligation. A 
reaction consisting of 5µl gel-extracted DNA product, 1µl pGEM-T Easy vector, 
1.5µl T4 Ligase and 7.5µl 2× Ligation buffer was set up in a 0.5ml microcentrifuge 
tube. A negative control tube used 5µl H2O in place of DNA and a positive control 
included a known positive insert. The reaction was incubated at 4°C for 12-18 h and 
the prduct used for transformation. 
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2.3.1.6 Transformation of ligation product into E.coli competent cells 
The E. coli JM109 strain was used for transformation. Ampicillin-containing LB 
agar plates were used to select transformed bacterial colonies and blue/white 
screening was used to identify colonies with inserts. The E. coli cells were slowly 
thawed on ice. An aliquot of 50μl competent cells was added to 7.5μl of ligation 
reaction and gently flicked to mix, avoiding pipetting. The sample was incubated on 
ice for 30min, heat-shocked for 50 sec at 42°C in a water bath, and placed on ice for 
a further 2min before adding 950μl SOC (Super Optimal broth with Catabolite 
repression, components are listed in Appendix A) medium. The sample was placed in 
a thermomixer (200 rpm), incubated  at 37°C for 1.5-2 h and the bacteria spread 
evenly over the surface of LB plates containing ampicillin (100μg/ml), isopropyl β -
D-1-thiogalactopyranoside (IPTG, 50μg/ml) and X-galactosidase (X-gal, 50μg/ml). 
The plates were inverted and incubated at 37°C overnight (16-24 h). 
2.3.1.7 Colony PCR and sequencing 
Single white colonies were selected to amplify and sequence the inserts. First, 
restreak plates were prepared by drawing a 96-well grid on LB plates containing 
ampicillin, IPTG and X-gal as above. Ninety-five white colonies and one dark blue 
colony were picked and spread gently within each grid square of a restreak plate. The 
plates were incubated at 37°C overnight (16-24 h) and a colony from each grid 
square selected for PCR amplification. The picked colonies were each added to 20μl 
PCR-grade water in the wells of a 96-well PCR plate and incubated at 98°C for 
10min. The plate was then centrifuged at 2000×g for 5min to remove bacterial debris 
and 2μl supernatant from each well was used as PCR template.  
The PCR utilized Master Mix consisting of 10×PCR Buffer 200μl, dNTP 100μl, 
M13F primer (2.5 μM) 100μl, M13R primer 100μl, BIOTAQ (5units/μl Bioline, 
London, UK) 10μl and H2O 1290μl. The Master Mix was distributed into a new 96-
well PCR plate, 18μl/well and add 2μl of the colony supernatant added. The PCR 
used M13F 5‟-TTTTCCCAGTCACGAC-3‟ and M13R 5‟-
CAGGAAACAGCTATGAC-3‟ass the forward and reverse primers respectively. 
The PCR reaction conditions were as follows: 1 cycle of 95°C for 5min; 35 cycles of 
95°C 30sec, 57°C 30sec and 72°C 3min; hold at 4°C. 
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After amplification, the products were diluted with 20μl sterile H2O and 5μl of 
several individual products electrophoresed on an agarose gel to assess the efficiency 
of amplification. Selection of individual wells was according to a published protocol 
[Quigley et al., 2011] and shown in Figure 2.2. Samples with the expected band size 
were selected for Sanger sequencing at Edinburgh Genomics.  
 
 
5μl of diluted PCR product 
from highlighted wells were used for running on a 1.5% agarose gel. Right bottom corner was PCR 
product amplified from negative control colony. Expected bands should be visible at approximately 
800bp for white colonies and 300bp for dark blue colony. 
 
2.3.2 Analysis of sequence data  
An „in-house‟ database for bovine TCR genes has been generated by Dr. 
Timothy Connelley using DNAsis V3.0 software (Miriabio Inc., Alameda, CA). The 
database includes 86 cDNA transcripts of Vβ genes assigned to 24 subgroups, 17 
genomic sequences of Jβ genes assigned to 3 subgroups, 3 genomic sequences of Dβ 
genes (genome accession number AC_000161 in assembly Bos_taurus_UMD_3.1.1) 
and 3 genomic sequences of Cβ genes [Connelley et al., 2009]. For bovine TCR α 
genes, the database includes 306 genomic sequences of Vα genes (GenBank 
accession numbers JX065635-JX065739) assigned to 36 subgroups, 62 genomic 
sequences of Jα genes and 1 genomic sequence for Cα gene. TRB transcripts 
obtained by Sanger sequencing were analysed using DNAsis Max V3.0 software 
according to the following steps and criteria. In line with previously published work 
on bovine TCRβ genes [Connelley et al., 2008, Houston et al., 2005], the WHO-IUIS 
nomenclature system has been used here [Kazatchkine, 1995].  
(i). Identification of Vβ genes. For convention, bovine Vβ genes in the database 
have been given subfamily names according to the human Vβ gene with which they 
share highest nucleotide similarity [Connelley et al., 2008, Houston and Morrison, 
Figure 2.2 Selection of wells for checking colony PCR efficiency.  
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1999]. Sequences obtained in this study were compared with identified bovine Vβ 
genes in the “in-house” database using the BLASTN algorithm and those sharing 
<98% nucleotide identity were treated as novel genes and added to the database. 
Features of the predicted mature Vβ polypeptide, including the presence of 
conserved amino acid residues at position 23 (cysteine, Cys/C), 41 (tryptophan, 
Trp/W), 42 (tyrosine, Tyr/Y) and 104 (cysteine, Cys/C), were confirmed. The 
sequence beyond amino acid 104 and the 3‟ end of the V gene could have been 
altered during somatic recombination. 
(ii). Identification of Jβ genes. The Jβ gene sequences in the database have been 
annotated according to the genomic location in the bovine TCRB locus [Connelley et 
al., 2009]. Using the BLASTN algorithm, sequences from this study were compared 
with identified bovine Jβ genes in the database. The conserved Phe-Gly-X-Gly (F-G-
X-G) motif represents germline Jβ sequence. Sequence beyond the 5‟ of this motif 
could have been altered during somatic recombination.  
(iii). Presentation of TCRβ chain sequence data: Sequences of bovine TRB 
transcripts were presented in the standardised format, in which the identified Vβ and 
Jβ gene segments expressed, the framework sequences flanking the CDR3β and the 
CDR3β itself are displayed [Chothia et al., 1988]. 
Bovine TCRα sequences obtained in this study were analysed following the 
same steps and also presented in the same standardised format. 
2.3.3 Prepare samples for high-throughput sequencing (HTS) 
2.3.3.1 CD8 T cells purification 
PBMC from T. parva-immunized or naïve A10+ cattle were prepared (see 
section 2.2.1) and used for CD8 T cell purification (see section 2.2.2). For high-
throughput sequencing, 1×107 CD8 T cells were purified from each sample. The 
purity of sorted CD8 T cells was analyzed by flow cytometry to check for CD4 T cell 
contamination. 
2.3.3.2 mRNA isolation from sorted CD8 T cells 
mRNA isolation was carried out according to details described in section 2.3.1.1. 
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2.3.3.3 Reverse transcription for cDNA synthesis 
The Promega® Reverse Transcription System (Promega, UK) was used 
according to the manufacturer‟s instructions. Briefly, the reagents listed in Table 2-3 
were added to a microcentrifuge tube (0.2µl) and the reaction incubated in a PCR 
machine as follows: 42°C for 1 hour, then heat at 95°C for 5min followed by 
incubation at 4°C for 5-10min. The last two stages inactivate the AMV (Avian 
Myeloblastosis Virus) reverse transcriptase and stop it binding to the cDNA. cDNA 
was stored at -20°C until use. 
Table 2-3 Reaction for Promega Reverse Transcription cDNA synthesis. 
Reagent  Volume (µl) 
MgCl2, 25mM 4 
10×Reverse Transcription Buffer 2 
dNTP mixture, 10mM 2 
Recombinant RNAsin Ribonuclease Inhibitor 0.5 
AMV reverse transcriptase (25 unit/µl) 0.6 
Oligo(dT)15 primer (0.5µg/µl) 1 
mRNA or RNA 1 µg 
Nuclease free water to a final volume of 20µl  
 
2.3.3.4 Preparation of amplicons for sequencing 
Primers were designed for amplifying TCR β chain rearrangements as described 
in chapter 4 section 4.2.3. The Phusion® high-fidelity PCR Kit was used for PCR 
amplification according to the manufacturer‟s instructions. The PCR reaction 
consisted of 5× Phusion HF Buffer 4µl, 10mM dNTP 0.4µl, 10µM Forward Primer 
0.4µl, 10µM Reverse Primer 0.4µl, template cDNA 2µl, DMSO 0.6µl, Phusion DNA 
Polymerase 0.2µl, nuclease-free water to a final volume of 20µl. The mixture was 
gently mixed and the PCR reaction run in a thermocycler under the following 
conditions: 98°C 30 sec; 30 cycles of 98°C 5 sec, 62°C 10 sec, 72°C 15 sec; 72°C 
5min and store at 4°C. Volumes were scaled up accordingly for 50µl or 100µl 
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reactions. The optimal PCR conditions had been determined by testing a range of 
primer concentrations, annealing temperatures and PCR cycles.  
2.3.3.5 Purification of PCR product 
Agencourt AMPure Beads (Beckman Coulter, High Wycombe, UK) were used 
to purify PCR amplicons. Briefly, beads equilibrated to room temperature were 
added to the PCR reaction. Preliminary testing of several volume ratios of beads to 
PCR reaction demonstrated that use of 1µl of beads for every 1µl of reaction was 
optimal. Here, 50µl beads were mixed thoroughly with 50µl PCR reaction for 10 
times and incubated at room temperature for 15min. The tube was placed on the 
magnetic stand at room temperature for 2min or until the fluid phase had cleared. 
The supernatant was removed and the beads were washed two times with 200µl of 
freshly prepared 75% ethanol. The tube was left to stand for 5min to dry and then 
removed from the magnetic stand. The dried beads were resuspended in 20µl of 
10mM Tris-HCL (pH8.0) buffer, incubated for 2min at room temperature and placed 
on the magnetic stand until the supernatant was clear. The clear supernatant was 
transferred to a fresh tube and sent for sequencing or stored at -20°C for future use. 
2.3.3.6 Sequencing on Illumina platform and data analysis 
Sequencing was carried out by Edinburgh Genomics and sequence data were 
analyzed in collaboration with bioinformaticians in the Edinburgh University 
according to the algorithms described in section 5.2.2.  
2.3.4 Generation of lentiviral constructs incorporating 
selected bovine TCR transcripts 
2.3.4.1 Identification of TCR α and β chains expressed by epitope-
specific CD8 T cell clones 
RNA was isolated from cultured CD8 T cell clones using TRI-reagent (Sigma) 
according to the manufacturer‟s instructions. 5-10×106 cells were resuspended in 
approximately 100µl of standard cell culture medium, to which was added 1ml of 
TRI-reagent, mixed thoroughly by repeated pipetting and incubated at room 
temperature for 5min to allow complete dissociation of nuclear-protein complexes. 
200µl chloroform was added and the tube was vortexed for at least 15 seconds and 
then incubated at room temperature for up to 15minutes. Following centrifugation for 
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15min at 12,000×g 4°C, the aqueous phase was transferred to a clean labelled 1.5ml 
tube and 500µl isopropanol added and mix. The tube was allowed to stand for 5-
10min at room temperature and then centrifuged for 10min at 12,000×g, 4°C. The 
supernatant was discarded and the pellet resuspended in 1ml ethanol before 
centrifugation for 10minutes at 12000×g, 4°C. The ethanol supernatant was carefully 
removed and the pellet allowed to air dry until almost transparent. The pellet was 
resuspended in 10-25µl nuclease-free water and the tube allowed to stand at room 
temperature for 5-10min to allow RNA to fully dissolve. cDNAs were synthesized 
using the Promega® Reverse Transcription System (see section 2.3.3.3).  
Specific primers (VB28F: 5‟-CGCCAA GATCCGGGATTTG-3‟, JB3.2R: 5‟-
CAGCACAGTCAGCTTGGAAC-3‟) were designed and used to amplify TCR 
transcripts from CD8 T cell clones with the desired TRB clonotype. cDNAs prepared 
from Tp250-59 epitope-specific CD8 T cell clones were used for PCR amplification. 
PCR reactions in 0.2ml microcentrifuge tubes were set up by adding 10× PCR Buffer 
2µl, 10µM VB28F 1µl, 10µM JB3.2R 1µl, template cDNA 2µl, Taq DNA 
Polymerase 0.1µl and nuclease-free water to give a final volume of 20µl. The 
reaction was gently mixed. The condition used in in the PCR reaction were: 95°C 
5min; 5 cycles of 95°C 1min, 60°C 1min, 72°C 1min; 30 cycles of 95°C 30min, 
60°C 1min, 72°C 1min; 72°C 5min. The PCR products were stored at 4°C and 
samples were run on gel electrophoresis to select clones with expected PCR product.  
For selected CD8 T cell clones, the paired TCR α chain genes were analyzed 
using a panel of forward primers previously designed to amplify known bovine Vα 
gene subgroups or sets of genes within the subgroups and a reverse primer specific 
for bovine Cα gene. All primers are shown in Table 2-4. PCR conditions were as 
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Table 2-4 Primers for TCR α chain analysis 
Vα Forward Reverse Cα 
1 5‟-CAGGAAAAGGCGTTAAGCAG-3‟ 5‟-GGGCTTCTCAGCTGGTACAC-3‟ TRAC 
2 5‟-GGTCTCTTTGGAGGGAGCTG-3‟    
3 5‟-CAGCCAGAAGCTGAGGTC-3‟    
4 5‟-AGTGACCGTGCTCCTGAC-3‟    
8.1 5‟-GGCTCTC(A/C)TGACCCTGAACT-3‟    
8.2 5‟-TGATGCTTGAGATGCTCCTG-3‟    
8.4 5‟-CGGTCACATCAACGTCTCTG-3‟    
8.5 5‟-ATTCCAGAGGCCAGTCAGTG-3‟    
9 5‟-CTTCTCCAGGCTTAGTGACTG-3‟    
10 5‟-TGAGTGGCAAAAACCAAGTG-3‟    
12 5‟-CACAGTGGAGCAGAGTCCTG-3‟    
13 5‟-CTTGTGGCT(A/G)CAGCTGGAC-3‟    
14 5‟-AGGTGGTCGTGGCTTCACT-3‟    
16 5‟-CAAGAGCCCAGACAGTGACTC-3‟    
17 5‟-GAGAAGCTTCTGGCCCTG-3‟    
18 5‟-GTTGTTACCCT(C/T)CCCGAGAAG-3‟    
19 5‟-G(G/C)ATGTA(A/G)CCTTGAACTGTGC-3‟    
20 5‟-CCAGGAGGGGGACAGTCT-3‟    
21 5‟-GCCTGCTCATCCTTTGGTTA-3‟    
22.1 5‟-CTT(C/T)TGTTTGCCCAGGTTTG-3‟    
22.2 5‟-GGTGGAGCAGA(A/G)TCCTTCAG-3‟    
23 5‟-AAGTGACCAA(G/C)AGCAGGTGA-3‟    
24 5‟-CCCTTGCTGTGGGTTCAG-3‟    
25 5‟-G(G/C)ACCAGTGTTGATCTTA(C/T)GGA-3‟    
26 5‟-TCCATGGATT(A/G)T(G/C)CTGAAGG-3‟    
27 5‟-TGGTCTTTTGGATTCAACTGG-3‟    
28 5‟-ACAAAGAAGAGTCTTGCTGAGTC-3‟    
29 5‟-GCTTCAGTCTGACTGGGTG-3‟    
33 5‟-GGCGGACAAAGTTACTGAAGC-3‟    
35 5‟-GACATGTGTGAGTGCCCAAC-3‟    
36 5‟-CCCCATCTCTGATTGTCCAT-3‟    
38 5‟-CACAGTGACCCTGGACTGTA-3‟    
41 5‟-AGGAAGGAGACCTCGTCACA-3‟    
Primers designed to amplify subfamily of bovine Vα genes are shown from 5‟ to 3‟ end. The reverse 
primer used to amplify bovine TCRα genes is specific for the constant gene of bovine TCR α chain. 
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2.3.4.2 Lentiviral constructs incorporating bovine TCR genes 
Full-length cDNAs of determined TCR α and β transcripts were amplified from 
epitope-specific CD8 T cell clones. Forward primers complementary to the 5‟ 
untranslated regions (5‟ UTR) of selected Vα and Vβ genes were used in 
combination with reverse primers (TRAC and TRBC) complementary to 5‟-end of 
Cα and Cβ genes respectively. The sequences of these α and β chain primers are 
shown in Table 2-5. The diagrammatic maps of mature TCR α and β transcripts and 






Mature αβT cells express TCR heterodimers composed of α chain (generated from germline VJ gene 
recombination) and β chain (generated from germline VDJ gene recombination). V, J and C gene 
segments of TCR α and β chains are shown in pink, yellow and blue respectively. Dβ gene segment is 
shown in green. Regions in black (N) represent non-germline nucleotide additions and deletions 
during gene rearrangement. Leader (L) sequences are shown in red. Forward primers were designed 
according to 5‟-untranslated region (5‟UTR). Reverse primers were complementary to the 5‟-end of C 
gene segments.  
The Phusion® high-fidelity PCR Kit (New England Biolabs) was used for PCR 
amplification according to the manufacturer‟s instructions (see section 2.3.3.4). The 
cDNAs encoding the TCR α and β chains were then combined into a single sequence 
(TCRβ-2A-TCRα) linked by an oligonucleotide sequence encoding the T2A “self-
cleaving” peptide from Thosea asigna virus. Restriction enzyme sites XbaI 
(TATGAG) and XhoI (CTCGAG) were added to the 5‟ and 3‟ ends of the construct 
respectively for cloning into the lentiviral vector. The designed sequences were 




































































Figure 2.3 Illustration of primer design for obtaining full-length TCR α and β transcripts.   
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glycoprotein (VSV-g)-pseudotyped HIV-based second-generation lentiviral vector 
pSxW.tCD34 (generously provided by Dr. John Bridgeman from Cardiff University, 
who also provided the packaging vectors pCMVΔ8.91 and pMD2.G). The gene 
expression is driven by a spleen focus-forming virus (SFFV) promoter. A human 
CD34 cDNA within the vector linked to the downstream of cloning site by a second 
2A oligonucleotide (P2A from porcine teschovirus-1) and controlled by the same 
SFFV promoter was used as a reporter marker to detect successful gene transcription. 
The generated pSxW-TCR lentiviral transfer vector, as well as the two packaging 
plasmids, were transformed into XL-10 Gold Ultracompetent cells according to the 
manufacturer‟s instructions. Maxipreps of the three plasmids, prepared using the 
EndoFree Plasmid Maxi Kit (Qiagen) according to the manufacturer‟s instructions, 
were used for transfection of 293T cells for pseudotyped lentivirus production as 
described in section 2.2.12. 
Table 2-5 Forward and reverse primers for cloning full-length cDNA of TCR α and β genes 
Name Sequences 
VB28 5‟ UTR 5‟-CATTTGACGCTACCATGTGC-3‟ 
VA8 5‟ UTR 5‟-ACATTCCTTCCTGCTCCTCA-3‟ 
VA13 5‟UTR 5‟-GGAGACTGCAGGTCCACAAT-3‟ 
VA26 5‟UTR 5‟-GGAKCAGWCRCAAKYCTGAGC(K=G,T; W=A,T; R=A,G; Y=C,T)-3‟ 
TRBC 5‟-GGAGATCTCTGCTTCCGAGGGTTC-3‟ 
TRAC 5‟-GGGCTTCTCAGCTGGTACAC-3‟ 
Forward primers including VB28 5‟ UTR, VA8 5‟ UTR, VA13 5‟UTR and VA26 5‟UTR are specific 
for the 5‟ untranslated regions (5‟ UTR) of selected Vα and Vβ genes. Reverse primers TRBC and 
TRAC are specific for the constant genes of bovine TCR β and α chains. 
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Chapter 3: Epitope dominance hierarchies 
restricted by a bovine MHC I allele differ 
between homozygous and heterozygous 
animals 
3.1 Introduction 
The participation of CD8 T cells in immunity against Theileria parva has been 
clearly demonstrated [Pearson et al., 1979, Eugui and Emery, 1981, Morrison et al., 
1987]. The protective ability of CD8 T cell mediated immune responses was 
illustrated by adoptive transfer of highly enriched CD8 T cells from immune to naïve 
twin calves [McKeever et al., 1994], although the involvement of responses by other 
cells can not be excluded [Taracha et al., 1997]. One feature of CD8 T cell responses 
against T. parva is strain specificity. When animals immunized with one parasite 
isolate are challenged with different parasite isolates, they show complete protection 
against challenge with the homologous isolate but variable patterns of protection 
against heterologous isolates [Irvin et al., 1983, Radley et al., 1975a]. Data from 
other studies suggest that incomplete cross-protection is due to a combination of 
polymorphism of the target antigens and immunodominance of the CD8 T cell 
responses [Taracha et al., 1995b]. Since the dominant antigens are determined by the 
presenting MHC class I (MHC I) alleles, both the antigen variants expressed by the 
parasite and the host MHC I genotypes influence the strain specificity of the CD8 T 
cell response against parasite infection [Goddeeris et al., 1990, Goddeeris et al., 
1986].  
Immunodominance has been observed as a general feature of CD8 T cell 
immunity against intracellular pathogens [Wilson and Hunter, 2008, Yewdell, 2006]. 
For individuals with a defined MHC I genotype, CD8 T cells tend to respond to only 
a few of the many 8-11-mer (generally) pathogen-derived peptides capable of 
binding to the expressed MHC I alleles. Among the limited number of epitopes 
recognised by the CD8 T cell response, some generate much stronger responses than 
others and this hierarchy is often reproducible between individuals of the same MHC 
I genotype. Such epitope dominance hierarchies have been observed in CD8 T cell 
responses against a number of viruses [Belz et al., 2000, Tscharke et al., 2005, 
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Brookes et al., 1995]. Identification of the most dominant epitopes was considered to 
be useful for the development of peptide-based vaccines, due to the immunogenicity 
of these epitopes and consistent dominance hierarchies in hosts with the respective 
MHC I genotypes [Chen et al., 2002, van der Most et al., 2003, Yu et al., 2002]. The 
mechanisms for immunodominance are not completely understood. However, results 
of research have suggested that a complex process involving factors determined by 
both the pathogen and the host determines immunodominance [Yewdell and Bennink, 
1999, Yewdell, 2006, Akram and Inman, 2012]. Generally, these factors can be 
grouped into two broad categories: (1) those involved in peptide-MHC presentation, 
such as antigen abundance, peptide processing (i.e. proteasome digestion, TAP 
transport, peptide trimming) and MHC class I binding affinity [Tenzer et al., 2009, 
Kotturi et al., 2008, La Gruta et al., 2006b]; and (2) factors that determine activation, 
proliferation and differentiation of naïve T cells, such as frequency of epitope-
specific naïve T cells and affinity of the T cell receptor for peptide-MHC I 
complexes [La Gruta et al., 2010, Denton et al., 2011, Chen et al., 2012]. The relative 
contribution of these factors to immunodominance appears to vary in different virus 
disease models [Kloverpris et al., 2013, Tenzer et al., 2009], illustrating the difficulty 
in drawing general conclusions on immunodominance.  
Six T. parva antigens recognised by CD8 T cells from immune cattle were 
identified by Graham et al. (2006) and subsequent work defined nine epitopes in 
these antigens, together with their MHC I restriction elements [Graham et al., 2006, 
Graham et al., 2008]. Highly dominant responses to two of these T. parva antigens, 
Tp2 and Tp1, were demonstrated by clonal analysis of in vitro-generated CD8 T cell 
lines from pairs of immune animals homozygous for the BoLA-A10 (abbreviated as 
A10) and A18 MHC I haplotypes respectively [MacHugh et al., 2009]. Screening of 
the CD8 T cells from these animals against 5 of the T. parva antigens showed that in 
each case they only recognised one of the antigens, both A18 animals recognising 
Tp1 and both A10 animals recognising Tp2. Moreover, over 50% of the CD8 T cell 
response of each animal was specific for the respective antigen. Two epitopes, Tp249-
59 (KSSHGMGKVGK) and Tp298-106 (QSLVCVLMK), were initially identified in 
the Tp2 antigen and both were determined to be presented by the same A10 MHC I 
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allele BoLA 2*01201 [Graham et al., 2008]. The response to the Tp249-59 epitope was 
highly dominant in both animals accounting for 59-74% of the response, with a small 
component (2-4%) responding to the Tp298-106 epitope [MacHugh et al., 2009]. Later 
studies revealed that the population of CD8 T cells that reacted with the Tp249-59 
peptide was actually composed of 2 distinct populations – one specific for Tp249-59  
and another specific for Tp250-59 (SSHGMGKVGK), which is also presented by 
BoLA 2*01201 (Connelley et al., - in preparation).  
To enable direct detection and quantification of epitope-specific CD8 T cell 
responses both in vitro and in vivo, peptide-MHC I (pMHC I) tetramers incorporating 
each of the three BoLA 2*01201-restricted Tp2 epitopes were generated. Soluble 
pMHC I tetramers were initially introduced in 1996 and have been used extensively 
for the study of antigen-specific CD8 T cell responses [Altman et al., 1996]. 
Comparing with techniques such as cytotoxicity and IFN-γ ELISPOT, which depend 
on the functional capacity of CD8 T cells, pMHC I tetramers requires only the 
expression of cognate TCR to define antigen specificity of responding CD8 T cells 
[Doherty, 2011]. Moreover, fluorochrome-conjugated pMHC I tetramers allows 
rapid quantification of epitope-specific CD8 T cell populations, which is less labour- 
and time-consuming in comparison to functional assays [Klenerman et al., 2002].     
The previous data demonstrating the dominant status of CD8 T cells specific for 
the Tp249-59 epitope were based on two BoLA-A10 homozygous cattle. In addition, 
the proportion of CD8 T cells that were specific for the distinct Tp249-59 and Tp250-59 
epitopes had not been determined. The work described in this chapter used pMHC I 
tetramer staining to determine the relative frequencies of CD8 T cells specific for the 
3 defined Tp2 epitopes in 11 A10 cattle immunised with T. parva, including both 
homozygous and heterozygous animals. The results showed that epitope dominance 
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3.2 Materials and methods 
3.2.1 Animals 
Animals used in this chapter are listed in section 2.1. 
3.2.2 In vitro generation of CD8 T cell enriched cell lines 
Details of the procedure for generating CD8 T cell lines are provided in section 
2.2.5. Briefly, PBMC isolated from T. parva-immunized A10-homozygous and -
heterozygous animals were stimulated with gamma-irradiated T. parva (Muguga 
isolate) infected cells (TpM cells), either from the autologous animal, or MHC-
matched or A10-homozygous animals. After a second stimulation, CD4 and γδ T 
cells were depleted from cell cultures. Purified CD8 T cells were maintained by 
stimulation at 7-14 day intervals with irradiated TpM cells, in the presence of rIL2 at 
a final concentration 100U/ml. Cell lines obtained after the third stimulation were 
cryopreserved. 
3.2.3 Generation of T cell cultures from purified CD8 T cells 
1×108 PBMC were pelleted by centrifugation at 400×g for 5min at 4°C and re-
suspended in 5ml of IL-A105 hybridoma culture supernatant (antibody specific for 
CD8). After incubation for 10min at room temperature, cells were washed twice with 
PBS and centrifuged at 400×g for 5min at 4°C. After the second wash, fluid above 
the cell pellet was removed completely. Pelleted cells were re-suspended directly 
with goat anti-mouse IgG micro-beads (100µl per 1×108 cells) and incubated for 
10min at room temperature. Cells were washed twice with PBS and re-suspended in 
2ml MACS buffer (PBS with 2mM EDTA and 0.5% BSA). The MS column was 
washed with 1ml MACS buffer before the addition of the prepared cells. The column 
was washed with 1ml of MACS buffer and the bound CD8 T cells then eluted in 2ml 
SCM into a 15ml tube containing 5ml SCM. After centrifugation at 400×g for 5min, 
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3.2.4 Tetramer staining of in vitro CD8 T cell cultures 
In vitro generated CD8 T cell-enriched cell lines were harvested and re-
suspended in SCM at a density of 1×107/ml. Aliquots of 100μl cell suspension were 
distributed in wells of 96-well round-bottom well plates, centrifuged briefly and re-
suspended in 50μl of 20nM pMHC I tetramers. PE labelled pMHC I 2*01201 
tetramers that incorporate the three defined epitopes derived from the Tp2 antigen 
(Tp298-106, Tp249-59 and Tp250-59) were generated by Pierre van der Bruggen and 
Didier Colau from Ludwig Institute for Cancer Research, Brussels, Belgium, 
according to the method described previously [Lonchay et al., 2004]. After 
incubation with pMHC I tetramers at 4°C for 30min in the dark, cells were washed 
twice with FACS medium and re-suspended in 200μl FACS medium for analysis 
using a BD FACSCalibur cell analyser. Negative controls were incubated with FACS 
medium instead of tetramers. 
3.2.5 Peptide stimulation of CD8 T cells 
For peptide stimulation, an A10-homozygous Theileria annulata-infected cell 
line (TA) 592TA was used as an antigen-presenting cell to assay T cell recognition 
of A10-restricted epitopes from T. parva. Previous experiments had shown that there 
was no antigenic cross-reactivity of T. parva-specific CD8 T cells with T. annulata. 
Peptides for the three defined Tp2 epitopes were produced by Pepscan Systems 
(Lelystad, Netherland). Target cells were re-suspended in SCM at 1×107/ml and 
incubated for 1 hour with 1μg/ml peptide at 37°C 5% CO2. Cells were washed once 
with PBS after incubation and exposed to 60Gy of gamma irradiation. In each well of 
a 24-well plate, 2×105 CD8 T cells were co-cultured with 1×106 peptide-loaded 
592TA cells for in vitro stimulation. 
3.2.6 Ex vivo detection of epitope-specific CD8 T cells 
PBMC from parasite challenged animals were isolated at chosen time points and 
then stained to enable two-colour flow cytometric analysis. Briefly, PBMC were 
initially stained with pMHC I tetramers at a final concentration of 20nM. After 
30min incubation at 4°C, cells were washed twice and stained with 50μl of primary 
antibody cocktail, including monoclonal antibodies specific for CD4 (IL-A12 IgG2a) 
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and γδ (GB21A, IgG2b) T cells, B cells (CD21, IgG1), NK cells (Gr13, IgG2b) and 
monocytes (IL-A24, IgG1). All mAbs had been titrated using PBMC to determine 
optimal dilutions prior to the experiment and it had been demonstrated that this 
combination of antibodies left CD8+ γδ- (i.e. αβ+) CD8 T cells as the only unstained 
population in PBMC. Cells were incubated at 4°C for 30min, washed three times in 
FACS medium and stained with 50μl of 1µg/ml Alexa Flour 647 labelled goat anti-
mouse IgG (H+L) antibody (Life technologies, Paisley, UK). Following incubation 
at 4°C for 30min, cells were washed three times in FACS medium and then re-
suspended in 200μl FACS medium. Tenminutes before FACS analysis, SYTOX Red 
Dead Cell Stain (Life technologies, Paisley, UK) was added at 1:1000 dilution 
according to the manufacture‟s recommendation.  
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3.3 Results  
3.3.1 Epitope-specificity of A10-homozygous animals shows 
consistent dominance hierarchies 
The antigen specificity of CD8 T cell responses were initially analysed in A10-
homozygous animals, which was aiming to determine whether Tp2 is consistently a 
dominant antigen and define the immunodominance hierarchies of the three defined 
BoLA 2*01201-restricted Tp2 epitopes. 
The results obtained by staining in vitro generated CD8 T cell lines from five 
immunized A10-homozygous cattle with Tp298-106, Tp249-59 and Tp250-59 pMHC I 
tetramers are shown in Figure 3.1. Cultures from all five animals, which had 
undergone 3 stimulations (animals 302186, 403992 and 403957), or ≥5 stimulations 
(animals 592 and 1011) were found to contain 20-46% CD8 T cells specific for the 
Tp249-59 epitope with smaller numbers of CD8 T cells specific for the Tp298-106 
epitope (0.7-3%). The percentages of CD8 T cells specific for the Tp250-59 epitope 
showed greater variation, ranging from 1.5% to 17% in the five animals. 
Nevertheless, overall the immunodominance hierarchy of the three defined Tp2 
epitopes showed a similar profile in all five animals.  
The results clearly showed that Tp249-59 was consistently the most dominant 



























































































































A, Flow cytometric 
analysis results of pMHC I tetramer (Tp298-106, Tp249-59 and Tp250-59/2*01201) staining of CD8 T cell 
lines generated from 5 T. parva immunized A10-homozygous animals. Animal numbers are labelled 
and shown on the left. Gated lymphocytes are used for analyses. Gating strategy is not shown. X axis, 
forward scatter (FSC); Y axis, Phycoerythrin (PE) -conjugated pMHC I tetramer (Tetramer-PE). 
Percentages of tetramer positive cells are shown in the upper right corner of each plot. B, Summary of 
Tp2 epitope frequency in the five A10-homozygous animals. 
3.3.2 The Tp2 epitope dominance hierarchy in A10-
heterozygous animals is different 
To investigate CD8 T cell epitope specificity and epitope dominance hierarchies 
of Tp2-specific responses in A10-heterozygous cattle, CD8 T cell lines were 
generated from 6 A10-heterozygous cattle following three in vitro stimulations with 
autologous parasitized cells.  
The T. parva (Muguga)-immunized animals comprise three pairs of MHC I-
matched A10-heterozygous animals expressing the A11, A12 and N5 MHC I 
haplotypes. Tp2 epitope-specific CD8 T cells were detected in CD8 T cell lines from 
only three of the six animals (one from each MHC I-matched pair). These cells only 
recognised the Tp298-106 epitope (Figure 3.2). The percentages of Tp298-106-specific 
CD8 T cells were 46.5%, 43.9% and 10.1% for animals 102121 (A10/A12), 102170 
(A10/N5) and 402082 (A10/A11), respectively. CD8 T cells specific for Tp249-59 and 
Tp250-59 epitopes were not detected in any of the six CD8 T cell lines. 
































Doctor of Philosophy – The University of Edinburgh – 2015 
The results demonstrated that in contrast to A10-homozygous animals, A10-
heterozygous animals i) do not all generate a detectable CD8 T cell response to Tp2 





















































































































A, flow cytomeric 
analysis results of pMHC I tetramer (Tp298-106, Tp249-59 and Tp250-59/2*01201) staining of CD8 T cell 
lines generated from 6 T. parva immunized A10-heterozygous animals. Animal numbers are labelled 
and shown on the left. Gated lymphocytes are used for analyses. Gating strategy is not shown. X axis, 
forward scatter (FSC); Y axis, Phycoerythrin (PE)-conjugated pMHC I tetramer (Tetramer-PE). 
Percentages of tetramer positive cells are shown in the upper right corner of each plot. B, summary of 
Tp2 epitope frequency in the 6 A10-heterozygous animals. 
 
3.3.3 The specificity of CD8 T cells stimulated once ex vivo is 
similar to that of T cell lines 
Since the results obtained for the A10-heterozygous animal were based on 
analyses of CD8 T cell lines generated following 3 in vitro stimulations, one concern 
was that the inconsistent detection of responses to the Tp298-106 epitope and the 
absence of Tp249-59 and Tp250-59 epitope-specific responses may have arisen as a 
result of changes in composition of CD8 T cell lines following in vitro passage as has 
been reported in other models (Koning et al., 2014, Belyakov et al., 2001). In order 
to detect epitope-specific CD8 T cells at the earliest time point in vitro, primary CD8 
T cell cultures generated by a single in vitro stimulation of purified CD8 T cells with 
irradiated parasitized cells were generated. Tetramer staining was applied on days 7, 
9 and 11 (or 12) after primary stimulation of purified CD8 T cells from three A10-
homozygous and all six A10-heterozygous animals. As shown in Figure 3.3, the 
numbers and intensity of staining of positive cells were optimal on day 9 for 
homozygous cattle and day 11 for heterozygous cattle.  
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The Tp249-59 epitope showed consistent dominance in the two homozygous 
animals (302186 and 403992) during the period of detection (Figure 3.4 A and B). 
The percentage of detectable Tp249-59 epitope-specific CD8 T cells increased from 
1.3% on day 9 to 6.8% on day 13 for 302186, while for 403992, they showed high 
percentages (7-12%) with the peak on day 12. Only small numbers of Tp250-59 
epitope-specific CD8 T cells were detected on day 12 for both animals (1% for 
302186 and 2% for 403992). For animal 403957, the relative dominance of epitopes 
Tp249-59 and Tp250-59 had changed during in vitro culture. As shown in Figure 3.4C, 
percentages of CD8 T cells specific for the Tp249-59 epitope on day 9 and 12 (2.8% 
and 4.2% respectively) were smaller than those for the Tp250-59 epitope (4.2% on day 
9 and 7.6% on day 12). However, on day 13, Tp249-59 epitope-specific CD8 T cells 
showed higher percentage (5.2%) than that for Tp250-59 epitope (4.4%). Low 
percentages (0.5-0.95%) of Tp298-106-specific CD8 T cells were detected for the three 
animals on day 12 or 13. 
The epitope specificity of the CD8 T cells from A10-heterozygous animals 
showed the same profile as in cultures subjected to 3 stimulations. Tp298-106 epitope-
specific CD8 T cells ranging from 0.7% to 13.7% (day 11 of stimulation) were 
detected from the three animals that had Tp298-106-specific responses in cultures 
following 3 in vitro stimulations, while CD8 T cells specific for Tp249-59 and Tp250-59 
epitopes were not detected  in any of the cultures. 
These findings indicate that repeated in vitro stimulations did not cause 
significant changes in the epitope specificities elicited in CD8 T cell lines from A10 








































































To reduce in vitro expansion, 
purified CD8 T cells from immunized animals were stimulated once with autologous TpM. A, The 
generated CD8 T cell lines were stained with pMHC I tetramers at chosen time points. The optimal 
detection of epitope-specific CD8 T cells was on day 9 or 11 of stimulation. B, Percentages of 
epitope-specific CD8 T cells detected at the optimal time point (i.e. highest frequency of tetramer 
positive cells) showed Tp249-59 epitope dominance in A10-homozygous cattle (except animal 403957) 
and Tp298-106 epitope dominance in A10-heterozygous cattle. 
 





































































































A and B, The responses against Tp249-59 was dominant in animals 302186 and 403992 throughout the 
time-course of the analysis. C, In animal 403957, the percentages of CD8 T cells specific for the 
Tp250-59 epitope were higher than that of Tp249-59 epitope upto day 12 post-stimulation but as a 
consequence of a rapid reduction in the frequency of Tp250-59 epitope-specific CD8 T cells on day 13 
(from 7.6% on day 12 to 4.4% on day 13), the Tp249-59-specific response became dominant. 
Figure 3.4 Kinetics of Tp2 epitope-specific responses in primary CD8 T cell cultures of A10-
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3.3.4 Epitope specificity variation between paired MHC I 
identical heterozygous cattle was not due to 
deficiencies in the stimulator cells 
In the above results, responses to the Tp2 antigen were consistently detected in 
only one of each pair of MHC I identical A10-heterozygous cattle. The possible 
deficiency of the autologous stimulator cell lines in the A10-heterozygous animals 
that did not show a Tp2-specific response was investigated by comparing CD8 T cell 
cultures generated by stimulation of purified CD8 T cells from each animal with the 
autologous infected cells or the MHC I-matched infected cells. MHC I-mismatched 
TpM cell lines were used as a negative control. The results of tetramer staining of the 
generated CD8 T cell primary cultures from the six A10-heterozygous animals are 
shown in Figure 3.5 A and B. For the A10-heterozygous cattle that showed Tp2-
specific responses, Tp298-106-specific CD8 T cells ranged from 2% to 11% were 
detected from primary CD8 T cell cultures subjected to autologous and MHC I-
matched stimulations, but not from MHC I-mismatched stimulations. For the A10-
heterozygous cattle that did not have a Tp2-specific response, Tp2 epitope-specific 
CD8 T cells were still not detectable in any of the primary CD8 T cell cultures 
subjected to autologous or MHC I-matched stimulations. These results suggested that 
the failure to detect Tp2-specific CD8 T cells was not due the deficiencies in the 
stimulator cells, but rather reflected genuine differences between the pairs of MHC I 


























A, Optimal detection of Tp298-106 specific CD8 T cells from one pair of MHC I matched heterozygous 
animals 102121 and 402145. B, Overall quantitative analysis of Tp298-106 epitope-specific CD8 T cells 
in the 6 A10 heterozygous cell lines stimulated with different stimulators. MHC I-matched TpM 
represents the TpM cell line derived from the other animal within each pair of MHC I-matched A10-
heterozygous cattle. 
 
Figure 3.5 Tp298-106 epitope specificities of A10-heterozygous CD8 T cell lines stimulated with 
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3.3.5 The same epitope specificity was detected for 
heterozygous CD8 T cell lines after homozygous TpM 
stimulation 
In the A10-heterozygous animals, the failure to detect a Tp2-specific response in 
some animals may be due to the presence of a strong CD8 T cell response restricted 
by the non-A10 MHC I haplotype, thus masking detection of a Tp2-specific response. 
To investigate this possibility, CD8 T cell cultures were generated from the 6 A10-
heterozygous cattle by stimulation with irradiated T. parva-infected A10-
homozygous cells (592 TpM). CD8 T cell lines were subjected to 3 stimulations to 
maximise the chance of detecting selectively expanded Tp2-specific CD8 T cells. 
The Tp2 antigen specificities detected in these CD8 T cell cultures are shown in 
Figure 3.6 A and B. The three cattle in which Tp298-106-specific responses had been 
observed previously again exhibited Tp298-106-specific CD8 T cell responses, with 
33-87% cells positive for the tetramer. Similarly, for the other 3 animals, in which 
Tp298-106-specific responses had not been observed previously, the use of the A10-
homozygous TpM for stimulation hadn‟t modified the Tp2-responses and there was 
no evidence of any Tp298-106-specific responses. Moreover, in none of the six A10-

































































































































A, Flow cytometric analysis results of pMHC I tetramer (Tp298-106, Tp249-59 and Tp250-59/2*01201) 
staining of CD8 T cell lines generated from 6 T. parva immunized A10-heterozygous animals 
subjected to A10-homozygous TpM stimulation. Animal numbers are labelled and shown on the left. 
Gated lymphocytes are used for analyses. Gating strategy is not shown. X axis, forward scatter (FSC); 
Y axis, Phycoerythrin (PE) -conjugated pMHC I tetramer (Tetramer-PE). Percentages of tetramer 
positive cells are shown in the upper right corner of each plot. B, Summary of Tp2 epitope-specific 









Figure 3.6 Tp2-specific responses of A10-heterozygous CD8 T cell cultures generated by 
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3.3.6 Ex vivo detection confirmed the differences in antigen 
specificities between homozygous and heterozygous 
animals 
 Epitope specificity and dominance hierarchies of the three defined Tp2 epitopes 
were examined directly during the in vivo response to T. parva in both BoLA-A10 
homozygous and heterozygous animals. Four immunized A10 animals consisting of 
two homozygous and two heterozygous animals were challenged with the same 
parasite strain used for immunization. Epitope specificities of CD8 T cells were 
tracked by pMHC I tetramer staining of freshly isolated PBMC at different time 
points after parasite challenge. Figure 3.7 illustrates the gating strategy for detection 
of epitope-specific CD8 T cells from PBMC. Negative selection of CD8 T cells by 
staining with a panel of antibodies specific for CD4 T cells, γδ T cells, NK cells, B 
cells and monocytes (as described in section 3.2.6) allows enumeration of tetramer-
stained CD8 T cells within the unstained population, avoiding interference of 
tetramer staining by anti-CD8 antibody [Wooldridge et al., 2006, Wooldridge et al., 
2003]. Preliminary results confirmed that negatively stained cells as gated in Figure 
























blue gate in A represents lymphocytes which are separated into two populations as shown in B. Cells 
in red gate represents CD8+ T cells which are negative for antibodies specific for CD4 T cells, γδ T 
cells, NK cells, B cells and monocytes. C, D, E showed tetramer positive CD8 T cells for the three 
defined Tp2 epitopes respectively. 
The kinetics of the epitope-specific CD8 T cell responses in both homozygous 
and heterozygous animals, as detected by pMHC I tetramer staining, are shown in 
Figure 3.8. Antigen-specific CD8 T cells were first detectable between day 10 and 
day 12 after challenge. For the two A10-homozygous animals 302186 and 403992, 
Tp249-59 epitope-specific CD8 T cells reached peak levels (7.5% of CD8 T cells for 
animal 302186 and 0.5% of CD8 T cells for animal 403992) on day 14 after parasite 
challenge. CD8 T cells specific for the subdominant epitope Tp298-106 were not 
detectable during challenge. Due to the low supply of Tp250-59 epitope-specific 
tetramer, staining for this epitope specificity was not carried out until day 13 of 
challenge. CD8 T cells specific for the Tp250-59 epitope were only detected in animal 

























Figure 3.7 Gating strategy for ex vivo detection of epitope-specific CD8 T cells in PBMC.  
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heterozygous animals 102121 and 402082, CD8 T cells specific for the Tp298-106 
epitope were detected reaching peak levels of 1.7% and 2.2% pMHC I tetramer-
positive cells (out of CD8 T cell populations) respectively on day 13 after challenge. 
CD8 T cells specific for epitopes Tp249-59 and Tp250-59 were not detected in the A10-
heterozygous animals (data not shown). Overall, ex vivo tetramer staining confirmed 
the dominance of the Tp249-59 epitope in A10-homozygous cattle and the Tp298-106 













A, Percentages of CD8 T cells specific for the Tp249-59 epitope in two A10-homozygous animals 
302186 and 403992 after parasite challenge. B, Percentages of CD8 T cells specific for the Tp298-106 
epitope in two A10-heterozygous animals 102121 and 402082 after parasite challenge. 
Figure 3.8 Ex vivo quantitative analysis of Tp2 epitope dominant CD8 T cell responses in A10-
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3.3.7 Initial attempt to detect antigen-specific CD8 T cells 
from negative A10 heterozygous animals 
pMHC I tetramers have been widely used for quantification of antigen-specific 
CD8 T cell responses both in vitro and in vivo [Altman et al., 1996, Flynn et al., 1998, 
La Gruta et al., 2010]. However, accurate identification of low frequency events is 
difficult, requiring extra care to distinguish true antigen-specific CD8 T cells from 
unspecific background [Chattopadhyay et al., 2008]. Cultures from 3 of the A10-
heterozygous animals (402145, 702162 and 702197) were defined as negative for the 
Tp298-106 epitope specificity because discrete pMHC I tetramer-positive populations 
could not be identified with certainty. However, as shown in Figure 3.2 and 3.6, 
small numbers of positive signals were sometimes detected in these animals   (e.g., 
702197 CD8 T cell line in Figure 3.6A). To determine whether these signals 
represented genuine epitope-specific cells or unspecific staining, an attempt was 
made to selectively induce epitope-specific CD8 T cell proliferation by stimulation 
of the cultures with T. annulata-infected cells pulsed with the respective peptides. 
However, as shown in Figure 3.9, there was no apparent expansion of Tp298-106 
tetramer-positive CD8 T cells after two rounds of peptide stimulation. Instead, the 
percentage of positive signals decreased from 2% before peptide stimulation to 0.5% 






Tetramer staining showed no expansion of detectable Tp298-106-specific CD8 T cells was evident in a 
CD8 T cell lines from animal 702197 after either 1 or 2 stimulations with Tp298-106 peptide. 
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Magnetic beads-based cell sorting (MACS) of pMHC I tetramer stained 
populations has been used successfully to detect and quantify low frequency antigen-
specific CD8 T cells from naïve mice [Obar et al., 2008]. As an alternative approach 
to determine if very low frequency tetramer positive CD8 T cells were present in the 
cultures derived from the 3 animals which had been considered to be Tp2 negative, a 
similar technique but employing flow cytometric cell sorting rather than MACS was 
used. Representative data from this analysis (from animal 402145) is presented in  
Figure 3.10. 1000 (0.1%) CD8+Tp298-106+, 3000 (0.3%) CD8+Tp249-59+ and 100 
(0.01%) CD8+Tp250-59+ cells (cells in red quadrants) were sorted from 106 cultured 
CD8 T cells, re-stimulated with autologous TpM and then tetramer staining 
performed 7 days later. As shown in Figure 3.10A, a clear positive population (10%) 
specific for the Tp298-106 epitope was detected for animal 402145, whereas neither 
clear Tp249-59 nor Tp250-59-specific responses were evident. From the above results, 
the percentage of Tp298-106 epitope-specific cells in the CD8 T cell enriched cell line 
from animal 402145 was estimated to be approximately 0.01% (0.1% sorted cells × 
10% tetramer+ cells). Identical analyses performed for animals 702162 (A10/N5) and 
702197 (A10/A11) failed to identify Tp298-106, Tp249-59 or Tp250-59-specific 
populations (data not shown).  
Together, these results suggested that i) an additional A10-heterozygous animal 
had a Tp298-106 epitope-specific CD8 T cell (although this was veryminor) but no 
Tp249-59 or Tp250-59-specific populations could be identified in any of the A10-
heterozygous animals analysed; and ii) using the FACS-enrichment technique, 





















A CD8 T cell line from animal 402145 was stained with tetramers specific for the three defined Tp2 
epitopes (A, Tp298-106; B, Tp249-59; C, Tp250-59) and antibodies specific for CD4, γδ T cells and NK 
cells. Cells in the red quadrants represent CD8 T cells positive for tetramers. After sorting and in vitro 
expansion, these CD8+tetramer+ cells were stained with the three defined tetramers to detect epitope-





Figure 3.10 In vitro enrichment and expansion of Tp298-106-specific CD8 T cells from A10 
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3.4 Discussion 
This chapter reports the results of quantitative analyses of CD8 T cells specific 
for the three defined BoLA 2*01201-restricted epitopes within the Tp2 antigen of T. 
parva in a series of A10-homozygous and -heterozygous animals. Previous work had 
been largely restricted to analysis of in vitro established CD8 T cell lines from two 
immunized A10-homozygous cattle [MacHugh et al., 2009], using recognition of 
peptide-pulsed targets to determine epitope-specificity. Such approaches due to their 
laborious nature limit the number of lines that can be effectively analysed and also 
have constraints with regard to the accuracy of defining the genuine epitopes 
(Connelley et al. – in preparation). By using pMHC I tetramers to analyse the 
frequency of epitope-specific responses in this current work it has been possible to 
extend the studies of the Tp2-specific responses to a larger number of animals, to in 
vitro cell lines generated under a variety of conditions and also to direct ex vivo 
quantification – thereby refining our understanding of the relative dominance of the 3 
epitopes and the factors that may influence this.  
CD8 T cell responses against the Tp249-59 epitope showed consistent dominance 
in all 5 BoLA-A10 homozygous animals examined. However, the epitope specificity 
profile of responses in the A10-heterozygous animals differed in two respects from 
that of the homozygous animals. First, only 4 of the 6 heterozygous animals had a 
detectable Tp2 antigen-specific CD8 T cell response, and in one of these the specific 
T cells were at very low frequencies. Second, in those heterozygous animals that had 
a detectable response, the specific CD8 T cells were focused solely on the Tp298-106 
epitope, with no detectable CD8 T cells specific for the Tp249-59 and Tp250-59 epitopes. 
These observations indicate that the presence of the MHC class I allele 2*01201 
alone does not predict the Tp2 epitope specificity of the CD8 T cell response in 
A10+ animals and that the presence of other expressed MHC alleles in heterozygous 
animals strongly influences the epitope specificity of the response to this antigen. 
The factors that might have affected these findings, including the potential influence 
of in vitro manipulation of the CD8 T cell cultures and use of different stimulator 
cells for antigen presentation, were explored in a further series of experiments.  
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The 6 A10-heterozygous animals examined consisted of 3 pairs that had 
identical class I MHC haplotypes. The initial failure to detect Tp2-specific CD8 T 
cells in one animal of each pair suggested that the parasite-infected cells used as 
stimulators to generate the T cell cultures from these animals might be defective in 
their ability to stimulate Tp2-specific CD8 T cells in vitro. In other systems, intrinsic 
differences of antigen presenting cells, such as factors related to antigen digestion, 
transport and peptide trimming, have been reported to influence immunodominance 
of CD8 T cell responses in other systems [Tenzer et al., 2009]. However in the 
current study, CD8 T cell cultures derived from each animal by stimulation with 
either autologous or MHC identical infected cells exhibited similar specificities, 
indicating that the difference between the animals was not due to a defect in the 
stimulator cells. 
Well-established culture methods were applied [Goddeeris and Morrison, 1988] 
for in vitro expansion of memory CD8 T cells from the immune cattle. Although 
such methods have provided valuable data, results from studies of other models using 
similar methodology [Koning et al., 2014, Belyakov et al., 2001] have indicated that 
changes in the clonotypic composition of CD8 T cells can occur after repeated in 
vitro stimulation, especially for T cell populations with high clonotypic diversity. 
Although the basis of the changes were not determined, it was proposed that in vitro 
manipulation could cause selective expansion of T cell clonotypes with high avidity, 
which if pronounced could result in the alteration of epitope specificity of the 
cultured CD8 T cell population [Price et al., 2005]. 
In the current study, this was investigated by examining the specificity of 
cultures generated following a single in vitro stimulation of purified CD8 T cells 
with irradiated cells. The epitope specificities of these primary cultured CD8 T cell 
lines derived from both A10-homozygous and heterozygous animals generally 
showed the same profiles of epitope dominance hierarchy as the cultures obtained 
following 3 in vitro stimulations, although the percentages of epitope-specific CD8 T 
cells were generally lower in the former, reflecting more limited expansion of the 
epitope-specific CD8 T cells from the memory T cell pools. An interesting 
observation was the apparent different kinetics of expansion of the CD8 T cells 
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specific for the Tp250-59 and Tp249-59 epitopes during primary culture of CD8 T cells 
from one of the A10-homozygous animals (animal 403957, Figure 3.4C). The 
response to Tp250-59 was initially dominant and was followed by a drop of percentage 
of these cells on day 13 of cell culture when the Tp249-59 epitope became dominant. 
Variation in a number of parameters, including precursor frequency of the specific T 
cells, epitope abundance on the infected cells used for stimulation and the affinities 
of the TCRs of the responding T cells for the peptide-MHC I complex, could account 
for these different expansion rates of epitope-specific CD8 T cells. In spite of these 
observations, the Tp249-59 epitope dominance in A10-homozygous cattle and the 
Tp298-106 epitope-dominance in A10-heterozygous cattle were confirmed in the 
primary CD8 T cell cultures.  
Although responses to the Tp249-59 epitope predominated in all five A10 
homozygous cattle, the percentages of Tp250-59-specific CD8 T cells were higher in 
two of the animals (592 and 1011) compared to the other three cattle. Previous 
studies of CD8 T cell clones from these two cattle had shown that over 70% of CD8 
T cell clones recognised the Tp249-59 peptide [MacHugh et al., 2009]. At that time, 
the existence of two distinct epitopes within the Tp249-59 sequence had not been 
recognised. The CD8 T cell lines from these animals examined in the current study 
had been subjected to an additional 2-3 in vitro passages. It is therefore possible that 
this resulted enrichment of the Tp250-59-specific populations in these cultures, 
although in the absence of comparative data from earlier passages, this remains 
speculative.  
The complete absence of Tp2-specific CD8 T cell responses in some animals 
might be due to the response being masked by a dominant response restricted by the 
non-A10 MHC haplotype. Moreover, the absence of detectable responses to the 
Tp250-59 and Tp249-59 epitopes could potentially be due to more efficient presentation 
of these epitopes by A10-homozygous infected cells compared to heterozygous cells. 
It has been reported that diversified MHC class I genotypes in heterozygous 
individuals could increase the competition between different alleles for surface 
expression and result in altered epitope presentation for CD8 T cell activation and 
proliferation [Tourdot and Gould, 2002]. These possibilities were investigated by 
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examining the responses elicited by stimulating CD8 T cells from the A10-
heterozygous animals with A10-homozygous stimulator cells. However, CD8 T cells 
specific for Tp249-59 and Tp250-59 were still not detected in these cultures; nor did 
stimulation with A10-homozygous cells reveal Tp298-106-epitope-specific CD8 T cell 
responses in animals that originally did not have any detectable Tp2-specific 
response. A 1.5-3 fold increase in the proportions of Tp298-106-specific CD8 T cells 
was observed in the cultures from the three Tp2-positive A10-heterozygous animals, 
compared to cultures generated from the same animals with autologous A10-
heterozygous stimulator cells. This finding suggested that these animals may have 
generated CD8 T cell responses restricted by products of the non-A10 MHC I 
haplotype, which would not have been present in CD8 T cell cultures generated with 
A10-homozygous stimulator cells. This point will need to be clarified in further 
experiments. 
Further evidence that the Tp2 epitope specificities detected in CD8 T cell lines 
are representative of the responses of these BoLA-A10 cattle was obtained by 
examining the in vivo response in 4 of the cattle following parasite challenge. 
Tetramer staining again demonstrated a dominant response to the Tp249-59 epitope in 
A10-homozygous cattle and the Tp298-106 epitope in A10-heterozygous cattle. For 
homozygous cattle, the percentage of Tp249-59-specific CD8 T cells was much lower 
in one of the A10-homozygous animal (403992 - 0.5%) than the other animal 
(302186 - 7.5%). This difference might relate to earlier clearance of the challenge 
infection in this animal and hence a less pronounced expansion of the specific 
memory CD8 T cells. Nevertheless, these results suggest that, in terms of epitope 
dominance hierarchy, the composition of in vitro CD8 T cell lines are representative 
of in vivo antigen-specific CD8 T cell responses against T. parva.  
Staining of T cells with fluorochrome-conjugated pMHC I tetramers is the most 
direct means of identifying epitope-specific CD8 T cells and has been used 
extensively to quantify CD8 T cell responses. In comparison with other methods, 
which in general rely on detection of T cell function such as cytokine secretion or 
cytotoxicity, tetramers are more sensitive for enumerating T cells responding to 
relatively dominant antigens.  However, their main disadvantage is lack of sensitivity 
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in detecting T cells present at low frequency. This is because of the limitations of 
flow cytometry in distinguishing small numbers of genuinely positive signals from 
non-specific background staining. Various approaches have been taken to improve 
accurate detection of low-frequency antigen-specific CD8 T cells by tetramers 
[Wooldridge et al., 2009, Chattopadhyay et al., 2008]. Magnetic-beads-based 
enrichment of tetramer-positive cells prior to performing flow cytometry has been 
used to quantify rare positive cells from naïve T cell populations [Obar et al., 2008, 
Moon et al., 2007]. An attempt was made to use a two-step approach in the current 
study to detect cells specific for all 3 Tp2 epitopes in the three A10-heterozygous 
cattle that did not show any detectable Tp2-specific CD8 T cell responses. Cell 
sorting was initially used to collect rare positive events and the resultant cells 
subjected to antigenic stimulation in culture. In one of the 3 animals, 10% Tp298-106 
tetramer-positive cells were detected in the CD8 T cell culture established by sorting 
positive events present at 0.1% using the respective tetramer. This would indicate 
that the original CD8 T cell population contained approximately 0.01% epitope-
specific T cells. This is in line with the reported lowest level of antigen-specific CD8 
T cells detectable by tetramer staining [Singh et al., 2013, Comin-Anduix et al., 
2006]. The absence of detectable tetramer-positive cells in cultures of the other 
sorted populations indicates that there was either no response or aminimal response 
to the epitopes in these animals. 
The data presented in this chapter clearly demonstrate that the dominance 
hierarchies of the 3 Tp2 CD8 T cell epitopes differs between A10-homozygous and 
A10-heterozygous animals. The ex vivo results demonstrated that this was not due to 
an artefact of the in vitro culture systems and indicated that the specificities of the 
CD8 T cell cultures reflected the in vivo CD8 T cell responses. While all A10-
homozygous animals generated CD8 T cell responses to all 3 Tp2 epitopes, the 
responses in A10-heterozygous animals were variable and when present only 
recognised one of the 3 Tp2 epitopes. When compared with previous observations in 
an A10/A18 heterozygous cattle, where CD8 T cell responses to the Tp249-59 epitope 
were detected using ELISPOT assay [Graham et al., 2008], results in the current 
study suggests that discrepancies of MHC I genotypes and detection approaches may 
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induce the different profiles of Tp2 antigen specificities in A10-heterozygous cattle. 
Further investigation is required to explore the reasons underlying the absence of any 
responses to Tp249-59 and Tp250-59 epitopes in the A10-heterozygous animals. Two 
possibilities are proposed. First, the MHC-heterozygosity may in some way alter the 
processing of these epitopes thus altering their density on the surface of the infected 
cells. Second, expression of other MHC I alleles may result in negative selection of 
the TCRs specific for Tp249-59 and Tp250-59 thus reducing the repertoire of T cells 
capable of responding to these epitopes. 
The fact that the three epitopes are derived from the same antigen and presented 
by the same MHC I allele provides a model system to investigate the potential 
influence of T cell repertoires to epitope specificity of CD8 T cell responses. 
Therefore, following work were conducted to initially analyse clonotype 
compositions of Tp2 epitope-specific CD8 T cells from both A10-homozygous and –
heterozygous cattle.  
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Chapter 4: TRB repertoire analyses for Tp2 
epitope-specific CD8 T cell responses  
4.1 Introduction 
Antigen specificity of CD8 T cells is determined by the T cell receptor (TCR), a 
cell surface heterodimer composed of α and β chains. During T cell development, 
TCR diversity is generated through recombination of variable (V), diversity (D) and 
joining (J) gene segments for the β chain and V and J gene segments for the α chain. 
Nucleotide additions and deletions at the junctions between V(D)J produce the 
complementarity determining region 3 (CDR3). Together with CDR1 and CDR2 
regions, encoded within the variable gene of each chain, they form the six loops of 
the αβTCR that interact with peptide-MHC I (pMHC I) complexes presented on the 
surface of antigen presenting cells (APCs) or infected cells [Garboczi et al., 1996, 
Market and Papavasiliou, 2003, Stewart-Jones et al., 2003]. Somatic recombination, 
which occurs in developing T cells within the thymus, draws on multiple germline-
encoded V, D and J gene segments. Different combinations of these gene segments, 
together with junctional diversity, have been estimated in humans to have the 
potential to generate between 1015 and 1020 unique αβTCRs [Lieber, 1991, Davis and 
Bjorkman, 1988]. However, many combinations are non-functional or are deleted 
during development because of their ability to recognise self-peptide-MHC. A direct 
estimate showed that naïve human peripheral blood contains at least ~107 αβTCRs at 
any given time [Arstila et al., 1999]. The size of the αβTCR repertoire for naïve 
mouse T splenocytes was also estimated to be ~106 unique αβTCRs [Casrouge et al., 
2000].  
The highly diverse TCR repertoire is believed to be of benefit by enabling the 
adaptive immune system to recognize a large variety of pathogen-derived peptides 
[Nikolich-Zugich et al., 2004]. In general, the T cell response specific for a given 
peptide-MHC includes T cells with different TCR rearrangements utilising different 
gene segments. The benefits, if any, of this diversity in generating effective 
pathogen-specific immune protection are still unclear. One proposal is that 
generation of heterogeneous CD8 T cell clonotypes with multiple choices of 
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structural and functional avidity for immunodominant epitope recognition 
collectively enhances the efficacy of the immune response andminimises the 
likelihood of mutational escape from immune control [Belz et al., 2001, Charini et al., 
2001]. Evidence for such an effect was reported in CD8 T cell responses against an 
immunodominant Herpes Simplex Virus (HSV) glycoprotein B-derived peptide 
(495-502; SSIEFARL). Animal survival observed in H-2Kbm8 mice was associated 
with a diverse epitope-specific CD8 T cell repertoire, while mice with a less diverse 
Kb-specific repertoire showed death after infection [Messaoudi et al., 2002]. In this 
case, the protection provided by diverse TCR repertoire was illustrated to be 
associated with a greater range of high avidity TCRs, which were demonstrated to be 
more effective than low avidity TCRs against pathogen infection [Derby et al., 2001]. 
For pathogens with rapid evolving rate, such as primate immunodeficiency viruses, 
TCR diversity has been suggested to potentially recognize an increased spectrum of 
epitope mutants allowing more effective control of mutated viruses [Douek et al., 
2002, Price et al., 2004].  
Despite the advantages of TCR diversity, TCR β-chain (TRB) analyses of 
epitope-specific CD8 T cells in several virus disease models have shown substantial 
variation in repertoire usage. For example, CD8 T cells specific for a subdominant 
epitope in Epstein-Barr virus (EBV) nuclear antigen 4 (EBNA4 399-408) showed 
highly restricted Vβ usage, while CD8 T cells specific for a dominant epitope in the 
same antigen (EBNA4 416-424) had a broad repertoire usage [Campos-Lima et al., 
1997]. The TCR diversity was proposed to influence the immunodominance 
hierarchy of CD8 T cell responses. A correlation of TCR diversity with magnitude of 
the CD8 T cell response has also been reported in individuals with HIV infection 
[Balamurugan et al., 2010]. However, such a correlation was not significant for other 
virus disease models [La Gruta et al., 2008, Koning et al., 2013].  
Epitope dominance hierarchy has potential implications for vaccine development. 
The results of the previous chapter demonstrated dominance hierarchies of three 
defined T. parva epitopes from the same parasite protein (Tp2) presented by the 
same MHC class I allele (BoLA 2*01201), which differed between A10-
homozygous and -heterozygous cattle. This chapter aims to explore potential 
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mechanistic explanations for this phenomenon, by examining the TCR repertoires of 
the responding CD8 T cells. 
Previously, TRB repertoires of Tp2 epitope-specific CD8 T cells were analysed 
using a method combining CD8 T cell cloning and Vβ subfamily-specific PCR and 
sequencing [Connelley et al., 2011, Connelley et al., 2008]. However, the generation 
of T cell clones is extremely time-consuming. Therefore, the current study set out to 
use a template-switch anchored RT-PCR, for direct analysis of purified epitope-
specific T cell populations.  By using a forward primer designed according to the 
anchor sequence added to the 5‟-terminus of full-length mRNA during reverse-
transcription and a reverse primer specific for the constant region of bovine TRB 
genes, the rearrangement of bovine TRB can be amplified without bias in 
composition [Quigley et al., 2011, Douek et al., 2002]. The generation of pMHC I 
tetramers incorporating the defined Tp2 epitopes facilitated purification of epitope-
specific CD8 T cells from both in vitro and ex vivo T cell populations. Direct 
analysis of T cells harvested ex vivo has the advantage of avoiding potential bias as a 
result of outgrowth of some clonotypes during in vitro expansion [Dietrich et al., 
1997, Davis et al., 2011]. 
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4.2 Materials and methods 
4.2.1 Enrichment of epitope-specific CD8 T cells 
Tetramer staining combined with magnetic beads based cell sorting (MACS) 
were used for enrichment of epitope-specific CD8 T cells from PBMC isolated from 
immune cattle at the peak of the active CD8 T cell response following parasite 
challenge. Briefly, 1×108 PBMC were stained with PE-labelled pMHC I tetramer for 
30min at 4°C in MACS buffer (PBS containing 0.5% BSA and 2mM EDTA). Cells 
were then washed and labelled with anti-PE antibody coated microbeads (Miltenyi 
Biotec) for 30min at 4°C, washed and passed through a magnetized LS column 
(Miltenyi Biotec). Columns were then washed and removed from the magnet, and 
bound cells were eluted with standard cell culture medium. Cells were then stained 
with an antibody cocktail reactive with all lineages except CD8 T cells (as described 
in section 3.2.6) for identification of tetramer positive CD8 T cells. Sorted cells were 
examined using a FACSCalibur cell analyser and if necessary to obtain sufficient 
purity (>98%), tetramer positive CD8 T cells were sorted using a FACSAria III.  
4.2.2 Template switch anchored RT-PCR  
Details of TRB repertoire analysis using the template switch anchored RT-PCR 
were described in section 2.3.1. Briefly, mRNA was isolated from purified epitope-
specific CD8 T cells and used for cDNA synthesis. To obtain full-length cDNA, a 
template-switch reverse transcription method was used employing the two intrinsic 
properties of Moloney murine leukemia virus (MMLV) reverse transcriptase – 
reverse transcription and template switching [Zhu et al., 2001]. Because the template 
switching activity ofmMLV reverse transcriptase only happens when the enzyme 
reaches the end of RNA, full-length cDNA can be enriched and prematurely 
terminated cDNA are eliminated. An anchor sequence is added to the 5‟-end of 
mRNA during the process of reverse transcription. Primers specific for this anchor 
sequence and the constant region of the bovine TRB gene were used for PCR 
amplification of TRB transcripts. PCR products were purified and subcloned for 
Sanger sequencing. 
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4.2.3 PCR amplification of TRB transcripts with defined Vβ 
and Jβ gene segments 
Specific primers were designed to amplify one particular VDJ rearrangement 
incorporating the Vβ28 and Jβ3.2 gene segments. Forward and reverse primers used 
were VB28F 5‟-CGCCAAGATCCGGGATTTG-3‟ and JB3.2R 5‟-
CAGCACAGTCAGCTTGGAAC-3‟. The PCR protocol used was performed as 
described previously [Connelley et al., 2008]. Briefly, total RNA was extracted from 
target samples using Tri-reagent (Sigma-Aldrich, Poole, Dorset, UK) and cDNA 
subsequently synthesised using the Reverse Transcription System (Promega, 
Madison, WI, USA) with priming by the Oligo (dT)15 primer, according to the 
manufacturers' instructions. A single-round PCR was conducted in reactions 
composed of 1 µ cDNA template, 10 pmol each of the forward and reverse primers, 
0.5 units of Biotaq (Bioline, London, UK) and 2μl SM-0005 10× buffer (ABgene, 
Epsom, Surrey, UK) per 20μl reaction. Cycling conditions were 5min at 94 °C, 5 
cycles of 1min at 94 °C, 1min at 60 °C, 1min at 72 °C), 25 cycles of 30 s at 94 °C, 
1min at 60 °C, 1min at 72 °C and a final extension period of 5min at 72 °C. PCR 
products were analysed in 1.5% agarose gels and visualised using the G:Box system 
(Syngene, UK) after staining with GelRed Nucleic Acid Gel Stain (Biotium, Inc. 
Hayward, CA).    
4.2.4 Analysis of sequence data 
Sequences of TRB transcripts obtained from epitope-specific CD8 T cells 
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4.3 Results 
4.3.1 Development of the template-switch anchored RT-PCR 
for TRB repertoire analysis 
Initial attempts to use a published protocol [Quigley et al., 2011] for obtaining 
TRB transcripts from sorted epitope-specific CD8 T cells from A10 immune cattle 
were unsuccessful. Successful amplification of TRB transcripts from unsorted 
cultured CD8 T cells using the same process suggested that either (1) cell staining 
and sorting was causing a deterioration of yield and/or quality of mRNA or (2) 
inadequate numbers of sorted cells were collected for downstream work. A variety of 
modifications to the protocols for mRNA isolation and cDNA synthesis from sorted 
cells were attempted without success. 
To circumvent this technical problem and obtain sufficient numbers of epitope-
specific CD8 T cells with high purity and retain high quality mRNA, tetramer 
positive cells from primary CD8 T cell cultures (day 9 for A10-homozygous and day 
11 for A10-heterozygous) were first sorted into 10-20 wells of a 96-well plate at 102-
103 cells per well and stimulated with autologous parasitized cells in the presence of 
rIL2 to amplify the cell numbers, as shown in Figure 4.1. After 7 days in culture the 
expanded cells (with a starting number of 1000 - 20,000 sorted pMHC I tetramer 
positive cells) were collected and checked for epitope specificity and purity, and 
cultures containing ≥98% positive cells were used directly for TRB repertoire 
analysis. Cultures with less than 98% purity were re-sorted to enhance cell purity - 
PCR amplification from these sorted cells was successful (suggesting that if the 
starting population was sufficiently enriched to subject the cells to only aminimal 
sorting time, the quality and quantity of mRNA was adequate for subsequent cDNA 
synthesis). The resultant cells were then stored into RNAlater for mRNA isolation 
and TRB repertoire analysis according to the method described in section 2.3.1. 
Sequence data were generated by subcloning the RACE-PCR amplicons and 
Sanger sequencing. For each purified epitope-specific CD8 T cell population, more 
than 50 recombined in-frame sequences with defined V, J and CDR3 regions were 
obtained, as shown in Table 4-1. 
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Epitope-specific CD8 T cells from primary cultured CD8 T cell lines were sorted and cultured for 7 
days with the presence of stimulators (irradiated autologous TpM) and rIL2 (100U/ml). Epitope 
specificity and purity (≥98%) were determined prior to mRNA isolation. Using the established 
template-switch anchored RT-PCR, TRB transcripts of epitope-specific CD8 T cells were amplified 









Full-length mRNA isolation 
and cDNA synthesis 
 
Full-length mRNA isolation 
and cDNA synthesis 
Tetramer staining for epitope 
specificity and purity check 
 
Tetramer staining for epitope 
specificity and purity check 
RACE-PCR for TRB amplification 
 




Tetramer staining of primary 
cultured CD8 T cells for cell sorting 
 
Tetramer staining of primary 






In vitro expansion of epitope-
specific CD8 T cells 
 
In vitro expansion of epitope-
specific CD8 T cells 
Stimulator – autologous TpM 
cells (irradiated, 5×103 per well) 
Cytokine – rIL2, 100U/ml 
Figure 4.1 Illustration of preparing ep tope-specific CD8 T cells for TRB repertoire analysis.  
Up to 1×106 cells  
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Table 4-1 Total number of in-frame TRB sequences for epitope-specific CD8 T cells obtained 
from both A10-homozygous and A10-heterozygous cattle 
MHC I 
haplotype Animal Tp249-59 Tp250-59 Tp298-106 
A10/A10 302186 73 87 73 
A10/A10 403992 83 84 59 
A10/A10 403957 52 63 81 
A10/A12 102121   74 
A10/N5 102170   86 
A10/A11 402082   85 
The numbers of sequencing reads with in-frame TRB chain sequences are shown for 9 Tp2 epitope-
specific CD8 T cell populations derived from 3 A10-homozygous cattle and for 3 Tp2 epitope-specific 
CD8 T cell populations derived from 3 A10-heterozygous cattle. 
 
4.3.2 TRB clonotype compositions for Tp2 epitope-specific 
CD8 T cells from A10-homozygous cattle 
The epitope dominance hierarchy of CD8 T cell responses specific for the three 
defined Tp2 epitopes - Tp249-59, Tp250-59 and Tp298-106 - has been verified for A10-
homozygous cattle, showing a highly dominant response to the Tp249-59 epitope and 
smaller responses to the Tp250-59 and Tp298-106 epitopes (see section 3.3.1). T cell 
receptor β chain repertoires for CD8 T cells specific for the three epitopes were 
initially analysed for the three A10-homozygous cattle. The TRB clonotype 
composition for each of the purified epitope-specific CD8 T cell populations are 
shown in Figure 4.2. The results identified a limited number of expanded TRB 
clonotypes in the CD8 T cells specific for both the dominant Tp249-59 epitope and the 
subdominant Tp250-59 and Tp298-106 epitopes. Clonal expansion of one or two 

























































A, D and G, Tp249-59 
epitope-specific TRB clonotype compositions for animal 302186, 403992 and 403957 respectively; B, E and H, Tp250-59 epitope-specific TRB clonotype compositions 
for animal 302186, 403992 and 403957 respectively; C, F and I, Tp298-106 epitope-specific TRB clonotype compositions for animal 302186, 403992 and 403957 
respectively. Each clonotype is represented by a unique colour. Vβ gene segments for identified clonotypes are shown. Clonotypes with the same Vβ gene but different 
CDR3β and/or Jβ genes are shown in different colours. Percentage of nucleotide sequence reads for each clonotype is illustrated.  
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The results of analyses of the sequences of all identified TRB clonotypes, 
including the V and J gene usage and the sequences of the CDR3s, are shown in 
Table 4-2. Some low-abundant clonotypes had the same Vβ and Jβ gene segments as 
a highly dominant clonotype, but had one or two amino acid differences within the 
translated CDR3β sequence. To investigate the possibility of sequencing errors, the 
sequences were examined to determine whether the substitutions were located within 
parts of the CDR3β sequence derived from germline V, D and J genes. Three amino 
acid substitutions (in red font) appeared within germline J segments of the CDR3β 
region. Therefore, these were considered to have arisen from PCR or sequencing 
errors, since germline TCR gene segments do not undergo somatic mutation [Bolotin 
et al., 2012]; and accordingly the sequences were corrected for subsequent analyses.  
Eight amino acid substitutions (in purple font and underlined) within junctions could 
have been generated by nucleotide additions or deletions during TCR rearrangement 
and although it is also possible that they were due to PCR errors; these were not 
corrected. Two examples of clonotypes incorporating the same Vβ and Jβ gene 
segments present in both the Tp249-59 and Tp250-59 epitope-specific CD8 T cells were 
observed (shown in green and brown font). For one of these pairs (brown), the CDR3 
sequences differed in both lengths and amino acid sequences and clearly represented 
different clonotypes. However, the other clonotype pair (shown in green font), both 
from animal 403957, had identical CDR3β sequences. This clonotype is dominant 
(44.2%, 23 of the 52 sequences reads) in Tp249-59 epitope-specific CD8 T cell 
population of this animal, and represented 7.9% of sequences (5 of the 63 sequence 
reads) obtained from the Tp250-59 epitope-specific CD8 T cells. The numbers of reads 
in the latter population seems too high to be due to contamination of tetramer-
negative cells in the sorted population. It is therefore possible that the Tp250-59 
tetramer cross-reacts to some degree with the Tp249-59 epitope-specific T cells 
expressing this particular TRB clonotype.  
The numbers of unique TRB clonotypes for each epitope-specific CD8 T cell 
population, following corrections referred to above, are shown in Figure 4.3. Very 
limited TRB clonotype diversity was observed within the 52-86 sequences obtained 
from T cells specific for each the of the three Tp2 epitopes in each individual animal, 
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although one Tp298-106-specific CD8 T cell population from animal 403957 showed 
more clonotypes than the other populations. The total numbers of clonotypes 
obtained from the three A10-homozygous cattle are 11 for the dominant Tp249-59 
epitope, 8 for the Tp250-59 epitope and 13 for the Tp298-106 epitope. Sharing of gene 
segments was observed between different epitope-specific clonotypes; however, 
different CDR3β sequences for these clonotypes suggest their unique specificity.  






Number Freq (%) Animal Vβ FR CDR3β FR Jβ 
Tp249-59 14 CAS SRYAGPETL YFG 2.4 25 34.2 302186 
16 CAS SLQPFYDY HFG 1.2 43 58.9 302186 
16 CAS SLQPFYVY HFG 1.2 4 5.5 302186 
16 CAS SLQPFYGY HFG 1.2 1 1.4 302186 
4.3 CSA TRGGREDY HFG 1.2 2 2.4 403992 
14 CAS SEWNTNGPL YFG 3.2 33 39.8 403992 
14 CAS SGWNTNGPL YFG 3.2 1 1.2 403992 
28 CAT AADLDDNPL YFG 3.3 46 55.4 403992 
28 CAT AADLDDDPL YFG 3.3 1 1.2 403992 
7.2 CAS SRDLVAETL YFG 2.4 23 44.2 403957 
7.2 CAS STVTAQIQ YFG 3.5 12 23.1 403957 
10.2 CAS SQAEVSGGAPWIPL YFG 3.3 1 1.9 403957 
12.1 CAS SYGGSGSYEQ YFG 3.7 16 30.8 403957 
Tp250-59 1.8 CAS SQDPETL YFG 2.4 25 28.7 302186 
2.7 CGA RGLGEV FFG 1.1 3 3.4 302186 
28 CAS AEYGGENTQPL YFG 3.2 58 66.7 302186 
28 CAS AEYGGKNTQPL YFG 3.2 1 1.1 302186 
1.3 CAS SPLGGYRSAVQL YFG 2.2 1 1.2 403992 
5 CAS VSPGGDY HFG 1.2 83 98.8 403992 
7.2 CAS SRDLVAETL YFG 2.4 5 7.9 403957 
12.1 CAQ HSSREQ YFG 3.7 58 92.1 403957 
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(Continued Table) 
Sequences of TRB repertoires specific for the three defined Tp2 epitopes in A10-homozygous cattle 
are shown in the standardised format: identified Vβ and Jβ gene segments, flanking sequences of 
CDR3β and CDR3β itself. Number and frequency of encoding nucleotide sequences for each 
clonotype are shown. Dominant clonotypes for each of the nine CD8 T cell populations are shaded. 
Amino acid variants within germline gene component of CDR3β region are in red font and variants 
within junctional region of CDR3β region are in purple font and underlined. Germline Jβ gene 
components of CDR3β are underlined. Germline Dβ gene components of CDR3β are in blue font. 
Sequences with the same Vβ and Jβ gene segments but different CDR3β sequences are in brown font. 
The one clonotype identified from both Tp249-59 and Tp250-59 epitope-specific CD8 T cell populations 









Number Freq (%) Animal Vβ FR CDR3β FR Jβ 
Tp298-106 13.5 CTS NLGGLDLGTQ YFG 2.3 72 98.6 302186 
13.5 CTS TFGGWALETL YFG 2.4 1 1.4 302186 
4.3 CSA GSGYEQ YFG 3.7 42 71.2 403992 
14 CAS SPGLGVQIQ YFG 3.5 12 20.3 403992 
15.2 CAS NAGQQGGTQPL YFG 3.2 5 8.5 403992 
1 CAS SVRGGDTQ YFG 2.3 1 1.2 403957 
1.7 CAS SQDYGATL YFG 2.4 1 1.2 403957 
12.1 CAT LILAREQ YFG 3.7 1 1.2 403957 
13.5 CTS SRGGRIDGEL HFG 3.1 3 3.7 403957 
13.5 CTS SPGGGRIDGEL HFG 3.1 1 1.2 403957 
13.5 CTS TLGGIVYEQ YFG 3.7 68 82.9 403957 
14 CAS SERFGGDGNNPL YFG 3.3 6 7.3 403957 
14 CAS SPQFGGGHPTQIQ YFG 3.5 1 1.2 403957 
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Two to five TRB clonotypes were identified from 8 Tp2 epitope-specific CD8 T cell populations (3 
populations in red bars for the Tp249-59 epitope, 3 populations in blue bars for the Tp250-59 and 2 
populations in green bars for the Tp298-106 epitope). For one CD8 T cell population specific for the 
Tp298-106 epitope, from animal 403957 (green bar), 8 clonotypes were confirmed. 
 
4.3.3 TRB repertoires of Tp298-106-specific CD8 T cells from 
A10 heterozygous cattle 
Specific CD8 T cells were detected for only one of the 3 Tp2 epitopes (Tp298-106) 
in four out of six A10-heterozygous animals, one animal (402145) showing a very 
low percentage of epitope-specific CD8 T cells. Tp298-106 epitope-specific CD8 T 
cells were purified from the three A10-heterozygous cattle that showed readily 
detectable responses and analyses of their TRB repertoire were undertaken, using the 
same approach as described above, to examine their clonal diversity. As shown in 
Figure 4.4, diversity profiles for TRB clonotypes similar to those observed in A10-
homozygous animals were observed, with a limited number of clonotypes detected in 
each animal and marked expansion of one dominant clonotype for each of the three 
purified CD8 T cell populations. 
Figure 4.3 Number of TRB clonotypes confirmed for Tp2 epitope-specific CD8 T cell 
populations from A10 homozygous cattle.  
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A striking feature of the results was that the dominant TRB clonotype in each of 
the 3 animals, which constituted 46-98% of sequences, used the same Vβ gene 
segment (Vβ13.5).  Sequences with Vβ4.3 gene were also shared by clonotypes from 
two of the animals (102121 and 402082). Sequences for all identified TRB 
clonotypes are shown in Table 4-3. For clonotypes from different animals that had 
the same Vβ gene, the Jβ gene segments and CDR3β sequences were different. 
Overall, the numbers of identified clonotypes are 5, 2 and 4 for animals 102121, 
102170 and 402082 respectively. Notably, the Vβ13.5 gene was also dominantly 
used by the Tp298-106 epitope-specific CD8 T cells from two of the A10-homozygous 
cattle (302186 and 403957). 
 
TRB clonotypes for each of the three Tp298-106 epitope-specific CD8 T cell populations obtained from 
A10-heterozygous cattle 102121, 102170 and 402082 are presented in A, B and C respectively. Each 
clonotype is represented by a unique colour. Vβ gene segments for identified clonotypes are shown. 
Clonotypes with the same Vβ gene usage but different CDR3β and/or Jβ genes are shown in different 










Figure 4.4 TRB clonotype distributions for Tp2 epitope-specific CD8 T cell populations 
obtained from A10 heterozygous cattle.  
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 Table 4-3 Sequences of TRB repertoires for Tp298-106 epitope-specific CD8 T cells from A10 
heterozygous cattle 
Sequences of TRB repertoires specific for the Tp298-106 epitope in A10 heterozygous cattle are shown 
in the standardised format: identified Vβ and Jβ gene segments, flanking sequences of CDR3β and 
CDR3β itself. Number and frequency of encoding nucleotide sequences for each clonotype are shown. 
Dominant clonotypes for each of the three CD8 T cell populations are shaded. Nucleotide sequences 
of listed clonotypes can be found in Appendix B. 
 
In summary, analyses of samples of the TRB repertoires of Tp2 epitope-specific 
CD8 T cells in both A10-homozygous and -heterozygous cattle detected a similar 
profile of restricted number of TRB clonotypes specific for all three defined Tp2 
epitopes - Tp249-59, Tp250-59 and Tp298-106. Each response was dominated by one or 
two highly abundant clonotypes. With one exception, which may relate to tetramer 
cross-reactivity, the TRB repertoires of T cells specific for each of the 3 Tp2 epitopes 
had distinct sequences and in most cases used different Vβ genes. However, the same 
Vβ gene segment was used by dominant clonotypes in Tp298-106-specific CD8 T cells 
in 5 of the 6 A10 animals that responded to this epitope. 
Further analyses of the CDR3β sequences of T cells specific for each epitope 
were undertaken to investigate whether the TRB repertoires of the responding T cell 
in different animals exhibited any common features. 
Epitope 
Sequence 
Number Freq (%) Animal Vβ FR CDR3 FR Jβ 
Tp298-106 1.5 CAS SEYPRGGHSNPL YFG 3.3 2 2.7 102121 
4.3 CSA GSWESETL YFG 2.4 1 1.4 102121 
7 CAS SSGFGGDDTQ YFG 3.4 13 17.6 102121 
13.5 CTS SLGGPYSETL YFG 2.4 57 77.0 102121 
20.1 CAW TSGGWNNPL YFG 3.3 1 1.4 102121 
13.5 CTS SLSGETL YFG 2.4 2 2.3 102170 
13.5 CTS NLGGITDTQ YFG 3.4 84 97.7 102170 
4.3 CSA PGTEGYEQ YFG 3.7 24 28.2 402082 
4.6 CSA GGDSYEQ YFG 3.7 12 14.1 402082 
13.5 CTS SLDSLRGY HFG 1.2 10 11.8 402082 
13.5 CTS SQDPHSGGNTQPL YFG 3.2 39 45.9 402082 
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4.3.4 Detailed sequence analysis identified a conserved 
CDR3β motif in Tp298-106 epitope-specific CD8 T cells 
Structural studies of TCR-pMHC I complexes have shown that the CDR3 
regions of TCR make direct contact with peptide presented by MHC I molecules 
[Stewart-Jones et al., 2003, Garcia et al., 1999]. The data presented in Table 4-2 and 
Table 4-3 demonstrate that the CDR3β sequences of TRB clonotypes specific for the 
same Tp2 epitope vary in length and residue usages, without any obvious 
conservation of sequence. However, further analysis of the sequences of dominant 
clonotypes (sequences are summarized in Table 4-4) identified an “LGG” motif, 
which was present in the CDR3β sequences of dominant clonotypes identified in 
Tp298-106 epitope-specific responses of two A10-homozygous cattle (302186 and 
403957) and two A10-heterozygous cattle (102121 and 102170), as shown in Figure 
4.5. Additionally, these clonotypes utilize the same Vβ13.5 gene segment. The 
CDR3β sequences of CD8 T cells specific for Tp249-59 and Tp250-59 did not show 
such a feature.  
Further analysis confirmed that the two glycines (GG) in the motif were encoded 
by a germline Dβ gene segment (sequence segment in blue font in Table 4-4), 
whereas the leucine (L) residue was encoded by a codon generated by non-germline 
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Both nucleotide and amino acid sequences for dominant TRB clonotypes for the three Tp2 epitopes are shown in the standardised format: identified Vβ and Jβ gene 
segments, flanking sequences of CDR3β and CDR3β itself. Number and frequency of encoding nucleotide sequences for each clonotype are shown. Germline Jβ gene 
components in CDR3β are underlined and germline Dβ gene components are in blue font. 
 
Epitope  Sequence Number Freq (%) Animal 
Vβ FR CDR3β FR Jβ    
Tp249-59 16 TGTGCCAGC C  A  S 
AGCCTACAGCCTTTCTATGACTAT 
S  L  Q  P  F  Y  D  Y    
CACTTCGGC 
H  F  G 1.2 43 58.9 302186 
28 TGTGCCACG C  A  T 
GCTGCAGATCTCGACGACAACCCTCTG  
A  A  D  L  D  D  N  P  L 
TATTTTGGA 
Y  F  G 3.3 46 55.4 403992 
7.2 TGCGCCAGC C  A  S 
AGTAGAGATCTAGTCGCAGAGACGCTG 
S  R  D  L  V  A  E  T  L 
TACTTCGGC 
Y  F  G 2.4 23 44.2 403957 
Tp250-59 28 TGTGCCAGC C  A  S 
GCTGAATATGGGGGGGAGAACACCCAGCCCCTG 
A  E  Y  G  G  E  N  T  Q  P  L 
TACTTTGGA 
Y  F  G 3.2 58 66.7 302186 
5 TGTGCCAGC C  A  S 
GTCTCGCCTGGTGGGGACTAT 
V  S  P  G  G  D  Y 
CACTTCGGC 
H  F  G 1.2 83 98.8 403992 
12.1 TGCGCCCAG C  A  Q 
CATTCTTCGCGGGAGCAG 
H  S  S  R  E  Q 
TATTTCGGC 
Y  F  G 3.7 58 92.1 403957 
Tp298-106 13.5 
TGTACCAGC 
C  T  S 
AATTTGGGGGGCCTGGACCTGGGCACTCAG 
N  L  G  G  L  D  L  G  T  Q 
TACTTCGGC 
Y  F  G 2.3 72 98.6 302186 
4.3 TGCAGTGCT C  S  A 
GGTTCGGGCTATGAGCAG 
G  S  G  Y  E  Q 
TATTTCGGc 
Y  F  G 3.7 42 71.2 403992 
13.5 TGTACCAGC C  T  S 
ACATTGGGGGGGATCGTCTATGAGCAG 
T  L  G  G  I  V  Y  E  Q 
TATTTCGGC 
Y  F  G 3.7 68 82.9 403957 
13.5 TGTACCAGC C  T  S 
AGTTTGGGGGGTCCGTACTCAGAGACGCTG 
S  L  G  G  P  Y  S  E  T  L 
TACTTCGGG 
Y  F  G 2.4 57 77.0 102121 
13.5 TGTACCAGC C  T  S 
AACCTGGGGGGCATCACAGACACGCAG  
N  L  G  G  I  T  D  T  Q 
TACTTCGGC 
Y  F  G 3.4 84 97.7 102170 
13.5 TGTACCAGC C  T  S 
AGTCAGGACCCGCATTCGGGAGGGAACACCCAGCCCCTG 
S  Q  D  P  H  S  G  G  N  T  Q  P  L  
TACTTTGGA 
Y  F  G 3.2 39 45.9 402082 
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Colours represent physicochemical properties: polar (G, S, T, Y and C), green; neutral (Q and N), 
purple; basic (K, R and H), blue; acidic (D and E), red; hydrophobic (A, V, L, I, P, W, F and M), 
black. Residue size is proportional to frequency appeared in all aligned sequences. Graph was 
generated using a web-based application WebLogo3 (http://weblogo.threeplusone.com/). 
 
4.3.5 Sharing of an identical TRB clonotype by the Tp249-59–
specific response in different A10-homozygous animals 
A previous study of TRB sequences of Tp2-specific CD8 T cells in two A10-
homozygous cattle [Connelley et al., 2011] reported a conserved TRB rearrangement 
(Vβ28-CASAEYGGENTQPLYF-Jβ3.2) in the response to the Tp249-59 peptide in 
both animals. At that time, pMHC I tetramers were not available  - in this study this 
TRB chain was identified within the Tp250-59 epitope-specific T cell populations of 
one of the A10-homozygous animals - 302186 (Table 4-2, the bold and italic 
sequence). 
To verify the epitope specificity of CD8 T-cells expressing this TRB chain and 
to examine if it was shared in all Tp250-59-specific responses, a PCR to specifically 
amplify Vβ28-Jβ3.2 rearranged TRB chains was designed. Amplification of cDNA 
from Tp249-59 and Tp250-59 epitope-specific CD8 T cells isolated from 302186 using 
this PCR produced a band of the correct size from the Tp250-59-specific CD8 T cells 
Residue positions in CDR3β 
 







Figure 4.5 Preferential usage of a “LGG” motif by CDR3β sequences of dominant clonotypes 
specific for the Tp298-106 epitope from animals 302186, 403957, 102121 and 102170.  
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but not Tp249-59-specific CD8 T cells (Figure 4.6). Sequencing of the PCR product 
confirmed the Vβ28-CASAEYGGENTQPLYF-Jβ3.2 rearrangement. 
Using the same method, the same TRB rearrangement Vβ28-
CASAEYGGENTQPLYF-Jβ3.2 was also identified within Tp250-59 epitope-specific 
CD8 T cells from the other two homozygous cattle, 403992 and 403957 (Table 4-5). 
The clonotype from animal 403992 showed one nucleotide variant in the CDR3β 
region, which did not cause an amino acid coding change.  
Together these findings demonstrated the existence of a shared or „public‟ TRB 
chain present in the Tp250-59 epitope-specific CD8 T cell response of all 5 A10-








Both Tp249-59 (A) and Tp250-59 (B) epitope-specific CD8 T cells were sorted using FACS with >98% 
purity from CD8 T cell enriched cell line of A10-homozygous cattle (data shown from animal 
302186). Unstained cell populations are shown in blue dots. Tp249-59 and Tp250-59 epitope-specific 
tetramer stained cells are shown in red and purple dots respectively. PCR amplification using Vβ28 
and Jβ3.2 gene specific primers (see section 4.2.3) showed expected product from Tp250-59 epitope-
specific CD8 T cells but not from Tp249-59 epitope-specific CD8 T cells (C). 
 
 
Figure 4.6 The Vβ28- CASAEYGGENTQPLYF-Jβ3.2 rearrangement was verified in Tp250-59 
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Table 4-5 The TRB rearrangement Vβ28- CASAEYGGENTQPLYF-Jβ3.2 was identified from 
two A10-homozygous cattle 403992 and 403957 
Both nucleotide and amino acid sequences for the identified TRB rearrangement Vβ28- 
CASAEYGGENTQPLYF-Jβ3.2 are shown in the standardised format: identified Vβ and Jβ gene 
segments, flanking sequences of CDR3β and CDR3β itself. Epitope specificity for the identified 
clonotype and the animals from which the clonotypes were identified are shown. 
 
4.3.6 Epitope-specific TRB clonotypes in cultured CD8 T cells 
are representative of in vivo responding populations 
The TRB repertoire data described above was derived from CD8 T cells that had 
been expanded in vitro by stimulation with irradiated parasitized cells. To investigate 
whether the clonotypic composition of these cell populations reflects the actual 
populations responding to parasite challenge in vivo, a preliminary experiment was 
undertaken to compare the TRB sequences of epitope-specific CD8 T cells obtained 
ex vivo from one of A10-homozygous immune animals (302186) with those obtained 
from in vitro cultures from the same animal. CD8 T cells were examined at the peak 
time point of the Tp249-59-specific CD8 T cell response (determined by tetramer 
staining - see section 3.3.6) after parasite challenge of the immune animal. Based on 
the previous observation that flow cytometric sorting of enriched tetramer sorted 
populations enabled the SMART-PCR to be used successfully, epitope-specific CD8 
T cells were initially enriched by MACS cell purification of tetramer-stained cells. 
As shown in Figure 4.7, this increased the frequency of epitope-specific CD8 T cells 
(in red quadrats) from 1.46% to 65%. Flow cytometric sorting was then used to 






Vβ FR CDR3 FR Jβ 
Tp250-59 
28 TGTGCCAGC C  A  S 
GCCGAATATGGGGGGGAGAACACCCAGCCCCTG 
A  E  Y  G  G  E  N  T  Q  P  L 
TACTTTGGA 
Y  F  G 3.2 403992 
28 TGTGCCAGC C  A  S 
GCTGAATATGGGGGGGAGAACACCCAGCCCCTG 
A  E  Y  G  G  E  N  T  Q  P  L 
TACTTTGGA 
Y  F  G 3.2 403957 
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PBMC from T. parva challenged 
animal were stained with Tp249-59 tetramer and subjected to MACS sorting as described in section 
4.2.1. Abundance of tetramer positive CD8 T cells increased from 1.46% in PBMC to 65% after 
enrichment. Percentage of epitope-specific CD8 T cells in the whole PBMC was determined through 
both tetramer and antibody staining as in section 3.3.6. 
 
 Sequences of TRB transcripts obtained from the ex vivo purified (≥98% purity) 
Tp249-59 epitope-specific CD8 T cells for animal 302186 are shown in Table 4-6. 
Three clonotypes observed in vitro were also observed from ex vivo purified epitope-
specific CD8 T cells. The dominant clonotype (shaded) with 59% of sequencing 
reads within the in vitro data was also the most abundant clonotype (85% of 
sequencing reads) in ex vivo purified responding CD8 T cells. However, another 
highly abundant clonotype with the Vβ14-CASSRYAGPETLYF-Jβ2.4 
rearrangement (34%, in italic font) in in vitro data was represented only at a low 
level (2.4%) within ex vivo population. Three clonotypes which were not present in 
in vitro data were identified from ex vivo purified epitope-specific CD8 T cells. 
These results indicated that the dominant TRB clonotypes identified in the in vitro 
cultured CD8 T cells are also present in the in vivo responding population, although 
their percentage representation in the two CD8 T cell populations differed. Further 
Figure 4.7 MACS enrichment of tetramer positive CD8 T cells.  
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depth of sequencing is required to more comprehensively compare the in vitro and in 
vivo repertoires (see further discussion below). 
Table 4-6 TRB repertoires specific for the Tp249-59 epitope from both in vitro memory and ex 
vivo responding CD8 T cells 
Sequences of TRB repertoires specific for the Tp249-59 epitope obtained from both in vitro cultured 
(derived from immune cattle 302186) and ex vivo purified (from parasite challenged cattle 302186) 
CD8 T cells are shown in the standardised format: identified Vβ and Jβ gene segments, flanking 
sequences of CDR3β and CDR3β itself. Number and frequency of encoding nucleotide sequences for 
each clonotype are shown. The dominant clonotype is shaded. The clonotype in italic font shows 
significant decrease of abundance in the ex vivo data. Nucleotide sequences of listed clonotypes can be 











Sequence In vitro Ex vivo 
Vβ FR CDR3 FR Jβ Number  Freq(%) Number Freq(%) 
Tp249-59 
4.6 CSA EGLGSL YFG 3.3 0 0 1 2.4 
13.2 CAS SYGTGYEQ YFG 3.7 0 0 1 2.4 
14 CAS SEGNSNYDY HFG 1.2 0 0 2 4.9 
14 CAS SRYAGPETL YFG 2.4 25 34.2 1 2.4 
16 CAS SLQPFYDY HFG 1.2 43 58.9 35 85.4 
16 CAS SLQPFYVY HFG 1.2 4 5.5 0 0 
16 CAS SLQPFYGY HFG 1.2 1 1.4 1 2.4 
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4.4 Discussion 
Work presented in the current chapter described the assessment of TRB 
repertoires for the three defined Tp2 epitopes and the potential relevance of 
repertoire usage to the epitope dominance hierarchy and the capacity of CD8 T cell 
responses to recognize allelic variants of epitopes. Meanwhile, the identified TRB 
clonotypes were analysed to determine whether there are similarities between 
animals in the TRB clonotypes of CD8 T cells recognizing the same epitopes. 
During TCR recombination, germline gene segments rearrangement and non-
germline nucleotide additions/deletions at gene junctions result in a diverse 
repertoire of αβTCR [Nikolich-Zugich et al., 2004]. The sequence of the junctional 
region provides a unique marker for each rearrangement and this region also encodes 
the CDR3 regions of the TCR polypeptide chains. In the case of TCRβ chain, the 
protein loop encoded by the CDR3 region interacts closely with the MHC-bound 
peptide and hence is important in determining antigenic specificity [Turner et al., 
2006]. TRB sequencing has been used as an approach of analysing clonotypic 
composition of CD8 T cell responses [Koning et al., 2013, La Gruta et al., 2008, 
Kedzierska et al., 2006]. For a defined epitope, CD8 T cells can utilise a range of 
different TCRβ chains incorporating different gene segments and with different 
CDR3 sequences. The TRB clonotypes of a particular epitope usually vary between 
different animals, which are referred to as private repertoires [Kim et al., 2005]. 
However, TRB rearrangements that are conserved between animals have also been 
observed for CD8 T cell responses to some epitopes and are named as public 
repertoires [Venturi et al., 2008a, Venturi et al., 2006, Kedzierska et al., 2004]. These 
public TRBs can serve as useful markers to monitor the respective epitope specific 
CD8 T responses. 
Previous studies analysed TRB sequences of CD8 T cells from two A10-
homozygous cattle reactive with the Tp249-59 epitope [Connelley et al., 2011]. 
However, the Tp250-59 epitope was not defined at that time and the TRB sequences 
were obtained from a panel of epitope-specific CD8 T cell clones derived from CD8 
T cell cultures subjected to 3 in vitro stimulations. The approach used for TRB 
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analysis, involving CD8 T cell cloning and Vβ subfamily-specific PCR and 
sequencing, is time-consuming and limits the number of epitope-specific CD8 T cell 
populations that can be analysed [Connelley et al., 2008]. A template-switch 
anchored RT-PCR, coupled with pMHC I tetramer staining and MACS/FACS 
purification techniques, allows direct TRB repertoire analysis of uncloned epitope-
specific CD8 T cells [Quigley et al., 2011]. Moreover, attempts were made to obtain 
epitope-specific CD8 T cells from primary CD8 T cell cultures, in order tominimise 
the potential alteration of clonotype compositions due to prolonged in vitro culture 
[Koning et al., 2014, Belyakov et al., 2001]. Additionally, attempts were also made 
to isolate epitope-specific CD8 T cells directly ex vivo from one parasite challenged 
immune animal. 
A common feature of TRB clonotypes for the examined epitope-specific CD8 T 
cell populations, derived from both in vitro cultured CD8 T cells and PBMCs 
isolated ex vivo, was the presence of one or two expanded clonotypes that accounted 
for a large proportion of the sequences obtained. The detection of only two 
clonotypes in 63-86 sequencing reads obtained for 5 of the Tp2 epitope-specific CD8 
T cell populations (Tp249-59-specific CD8 T cells from 302186, Tp250-59-specific CD8 
T cells from 403992 and 403957, Tp298-106-specific CD8 T cells from 302186 and 
102170) are extreme examples of this. Many CD8 T-cell responses are characterised 
by a clonotypic structure in which there are a limited number of dominant clonotypes 
and a large number of very low frequency clonotypes [Chen et al., 2001, Naumov et 
al., 1998]. A comprehensive analysis of the full TRB repertoire would therefore 
require a substantially greater depth of sequencing than was attempted in this study, 
where the primary aim was to characterise the more abundant clonotypes. 
As with any TRB analysis conducted on in vitro CD8 T-cells, it is possible that 
certain clonotypes are preferentially expanded during the period in culture, leading to 
a clonotypic profile that is not representative of the in vivo population. To address 
this, an experiment comparing the TRB repertoires for both in vitro cultured CD8 T 
cells and ex vivo CD8 T cells isolated during the active response to parasite challenge 
from the same animal (302186) was performed. Of the 4 clonotypes identified in 
vitro and 6 clonotypes identified in the ex vivo population, 3 were common to both. 
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In both populations the same TRB clonotype (Vβ16-CASSLQPFYDYHF-Jβ1.2) was 
dominant (85% in vivo and 59% in vitro) and the second dominant clonotype (Vβ14-
CASSRYAGPETLYF-Jβ2.4) in the in vitro memory population was also evident in 
the in vivo responding CD8 T cells, although at a lower frequency (2.4% in vivo and 
34% in vitro). Notably, the clonotypes that appeared to be unique to either the in 
vitro or ex vivo populations were present at low frequency, suggesting the failure to 
find them in the other population may have been an issue of resolution that could be 
resolved by sequencing more TRB chains. These results are consistent with previous 
findings [MacHugh et al., 2009], where remarkably similar clonotypic profiles were 
demonstrated for in vitro and ex vivo T. parva-specific CD8 T cell responses using 
the TRB heteroduplex technique. 
The large component of these dominant TRB clonotypes in epitope-specific 
CD8 T cells indicates their major contribution to the fine antigenic specificity of 
CD8 T cell responses against T. parva. In a murine influenza virus model, TCRβ 
chain clonotypes were demonstrated to determine the avidity of CD8 T cells to viral 
epitopes [Moffat et al., 2010]. Selective expansion of high-avidity CD8 T cells, 
which has been reported in both human and mouse anti-virus responses [Cukalac et 
al., 2014a, Price et al., 2005], could be responsible for the clonal expansion of few 
dominant clonotypes observed in the current study. 
Previous studies of CD8 T cell responses against the Tp249-59 epitope, using 
synthetic peptides with amino acid substitutions, have shown that different TRB 
clonotypes can vary in their ability to recognise peptides with substitutions at some 
positions [Connelley et al., 2011]. Hence, CD8 T cell responses with a very narrow 
TRB repertoire may be less likely to cross-react with epitope variants containing one 
or two amino acid substitutions. The polymorphism of Tp2 antigen of T. parva has 
been demonstrated, showing a total of 23 allelic variants for the Tp249-59 epitope 
from 82 examined parasite isolates [Pelle et al., 2011]. Future investigation to define 
the cross-reactivity of identified TRB clonotypes to allelic variants of Tp2 epitopes 
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Sequence analysis of epitope-specific TRB clonotypes identified from different 
animals observed i) the preferential usage of Vβ13.5 gene and a semi-conserved 
CDR3β motif by the Tp298-106 epitope-specific CD8 T cells in 2 A10-homozygous 
and 3 A10-heterozygous cattle, ii) a conserved TRB clonotype with Vβ28-
CASAEYGGENTQPLYF-Jβ3.2 rearrangement from Tp250-59 epitope-specific CD8 
T cells in all examined A10-homozygous cattle. Reasons for the preferential usage of 
Vβ13.5 gene by the Tp298-106 epitope are unclear. However, extensive studies in 
human and mouse models suggested that both MHC I-restricted thymic selection and 
structural complementarity of TCR to its cognate peptide-MHC I complex can 
induce the biased usage of particular TCR V genes [Turner et al., 2006]. The 
conserved TRB clonotype usage by different animals has been reported in many 
virus disease models and proposed as a result of recombinatorial biases and 
convergent recombination during TCR rearrangement [Li et al., 2012, Venturi et al., 
2008b]. Functionality of the conserved Vβ28-CASAEYGGENTQPLYF-Jβ3.2 
clonotype is yet to be defined. However, the dominant status of this clonotype within 
the Tp250-59 epitope-specific CD8 T cells in animal 302186 indicated its rapid 
responding capacity against parasite infection. This is consistent with the previous 
observations in two A10-homozygous cattle, where a significant increase of 
proportions of the conserved clonotype within Tp2 antigen-specific CD8 T cells was 
observed after parasite challenge [Connelley et al., 2011].  
Overall, profiles of TRB clonotypes for the three defined Tp2 epitopes were 
analysed in both A10-homozygous and -heterozygous cattle, providing a general 
view of clonotypic dominance in epitope-specific CD8 T cell populations. A 
conserved TRB rearrangement specific for the Tp250-59 epitope was verified, which 
serves as a marker of antigen-specific CD8 T cell responses, and most importantly, 
allows tracking of antigen-specific CD8 T cell responses in vivo. With the defined 
Vβ and Jβ gene segments, a more comprehensive repertoire diversity would be 
achieved employing high through-put sequencing approaches. 
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Chapter 5: Identification of Tp250-59-specific T- 
cells through high throughput sequencing 
analysis to detect a ‘public’ TCR 
5.1 Introduction 
In previous chapters, the observation of Tp2 epitope dominance variation 
between BoLA-A10-homozygous and heterozygous cattle suggests that bovine 
immunodominant CD8 T cell responses against T. parva can‟t be predicted solely 
based on the presence of MHC I restriction elements. T cell receptor β chain (TRB) 
repertoires for the three defined Tp2 epitopes were analysed for both BoLA-A10-
homozygous and heterozygous cattle in the last chapter to investigate their potential 
contribution to the formation of the immunodominance hierarchy. From the obtained 
epitope-specific TRB clonotypes, a conserved Tp250-59 epitope-specific TRB 
rearrangement was verified to be shared by multiple BoLA-A10-homozygous 
individuals with unrelated genetic background. This conserved TRB sequence 
provides a unique „barcode‟ for this epitope-specific CD8 T cell response, which can 
be exploited to further study the effect of the TRB repertoire on the 
immunodominance of epitopes of cattle CD8 T cell responses against T. parva. 
Altered hierarchy of antigen-specific CD8 T cell responses in MHC class I 
diversified individuals have been reported previously in mice and human virus 
disease models [Betts et al., 2000, Belz et al., 2000]. In an influenza virus mouse 
model, the CD8 T cell response against some epitopes was reduced by up to 95% in 
F1 progeny compared to their inbred parents [Day et al., 2011]. In the case of human 
immunodominant CD8 T cell responses against human immunodeficiency virus 
(HIV), more complex situations have been observed. Epitope dominance varies 
greatly between individuals having defined MHC class I restriction elements, with 
CD8 T cell responses against some epitopes only present in a subset of individuals 
[Betts et al., 2000].  Potential factors that could influence both antigen processing 
and CD8 T cell activation were examined to understand the mechanistic basis of this 
phenomenon [Day et al., 2011, Flesch et al., 2010]. However, a definitive conclusion 
wasn‟t achieved due to the complexity of the parameters that influence 
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immunodominance [Yewdell, 2006]. In spite of this, antigen-specific TCR repertoire 
changes during ontogeny were proposed as a potential reason, if not the complete 
explanation, for the diminished epitope specificity in MHC I heterozygotes. 
Similarly, in the murine influenza virus model, loss of a prominent epitope-specific 
TRB repertoire in H2k×b F1 mice was reported to be responsible for the decreased 
epitope-specific CD8 T cell responses when compared with their inbred parents 
[Belz et al., 2000]. In a human Epstein-Barr virus (EBV) model, deletion of a 
dominant TCR specific for an HLA-B8 restricted EBV-derived epitope 
FLRGRAYGL was observed in heterozygous individuals with a cross-reacting 
alloantigen HLA-B*4402 [Burrows et al., 1995, Argaet et al., 1994]. Although 
individuals with HLA-B*4402 expression used diversified TCRs to recognize the 
epitope, this observation clearly demonstrates that presence of additional MHCI 
alleles can alter the epitope-specific TCR repertoire. 
As presented in Chapter 3, Tp2 epitope dominance variation was observed for 
cattle with the MHC class I restriction allele 2*01201 (designated to the BoLA-A10 
haplotype). For BoLA-A10-homozygous cattle, CD8 T cells showed dominant 
responses to the Tp249-59 epitope, with subdominant responses to the Tp250-59 and 
Tp298-106 epitopes. For BoLA-A10-heterozygous cattle, the Tp298-106 epitope became 
dominant in some but not all animals; and CD8 T cell responses to the other two 
epitopes were not detectable in any of the heterozygous cattle. Reasons for Tp2 
epitope dominance change in BoLA-A10-heterozygous cattle are unclear. The results 
presented in Chapter 3 clearly indicate that the presence of other MHC class I alleles 
has negative effects on CD8 T cell responses against Tp249-59 and Tp250-59 epitopes. 
Evidence for the presentation of the Tp249-59 epitope by parasite-infected BoLA-A10-
heterozygous cells is available from previous studies, where T. parva specific CD8 T 
cells generated through autologous stimulation showed specific CD8 T cell response 
to the Tp249-59 epitope for one BoLA-A10/A18 heterozygous animal [Graham et al., 
2008]. Therefore, it was decided to examine if the absence of detectable Tp249-59 and 
Tp250-59-specific responses in the six A10-heterozygous cattle used in this study was 
due to TCR repertoire alteration, leading to the deletion of T cells specific for these 
epitopes. Due to the diversity of the TCR repertoire and the generally „private‟ nature 
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of epitope-specific T cells responses (where individuals in an outbred population will 
express unique TCRs in responses against defined epitopes) [Kedzierska et al., 2008], 
application of TCR analysis to address such questions can be difficult. However, the 
presence of the conserved TRBV28+ TRB rearrangement in the Tp250-59 epitope-
specific responses provides a representative TRB sequence that could be used to 
investigate if Tp250-59 epitope-specific CD8 T cells are deleted in BoLA-A10 
heterozygous animals. 
Using an indirect approach, the diversity of an individual human‟s TRB 
repertoire was estimated to be ~106 for naïve T cells and 1-2×105 for memory T cells 
[Arstila et al., 1999]. Later approaches using high-throughput sequencing technology 
observed the same TRB diversity for naïve T cells but surprisingly a 10 to 20-fold 
larger TRB diversity for memory T cells than previous reports [Robins et al., 2009]. 
Although the bovine TRB repertoire diversity is yet to be determined, the available 
data indicates the presences in the genome of aminimum of 86 functional TRBV, 3 
TRBD and 17 TRBJ genes. The potential VDJ permutations that can be used for 
functional TRB recombination were also estimated to be about 3 times of that for 
human [Connelley et al., 2009]. Detection of a defined TRB rearrangement in highly 
complex populations (e.g. quiescent PBMC) requires analysis that has the capacity to 
provide a high resolution TRB repertoire profile. Due to their inherent limitations of 
low throughput and low resolution, traditional methods of examining TRB 
repertoires such as Sanger sequencing and spectratyping are not suited to perform 
such analysis [Calis and Rosenberg, 2014, Six et al., 2013]. However, high-
throughput sequencing (HTS) technologies are rapidly becoming powerful tools for 
TCR repertoire profiling [Six et al., 2013, Baum et al., 2012], and it was decided to 
attempt detection of the public TRBV28+ Tp250-59-specific CD8 T cell TRB chain 
directly ex vivo from CD8 T cell isolated from PBMC using this approach.   
To validate this approach, an initial experiment was conducted to detect the 
public TRBV28+ Tp250-59-specific TRB chain from memory CD8 T cells of T. parva-
immunised BoLA-A10-homozygous animal in which the public TRB chain had been 
detected during in vitro analyses. Once established the approach would then be used 
for subsequent detection of potential epitope-specific CD8 T cell clonotypes from the 
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naïve repertoire of BoLA-A10-homozyogus and heterozygous cattle, in order to 
determine if TRB repertoire alteration could contribute to the observed variation in 
the  epitope dominance of CD8 T cell responses in the T. parva system. 
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5.2 Materials and methods   
5.2.1 Sample preparation for Illumina sequencing 
The detailed procedure for sample preparation is described in section 2.3.3. 
Briefly, CD8 T cells were purified from isolated PBMC from parasite immunized 
A10-homozygous cattle, according to the method described in section 2.2.2. Purified 
CD8 T cells were then checked for purity and CD4 T cell contamination using flow 
cytometry. Further purification, by flow cytometric sorting to eliminate CD4 T cells 
was performed if necessary. cDNA of purified CD8 T cells was prepared using the 
Promega® Reverse Transcription System as described in section 2.3.3.3. Forward and 
reverse primers to permit specific amplification of TRBV28+-TRBJ2.2/3.2+ TRB 
chains (Table 5-1) were designed. Oligonucleotide adapters and indexes were added 
to the 5‟ end of gene-specific primers for sequencing and sample identification. Two 
reverse primers (only differing in the sample index sequence) were used to permit 
multiple-sample indexing. The obtained PCR amplicons were purified using AMpure 
Beads (Beckman Coulter, High Wycombe, UK) according to section 2.3.3.5 and the 
purity was checked using Agilent 2200 TapStation (Agilent Technologies) according 
to the manufacturer‟s instructions.  The purified amplicons were then sent for 
sequencing on the Illumina® HiSeq2500 platform. Paired-end reads of 250bp in 
length for each direction were generated.  








Gene-specific forward (VB28F1) and reverse (JBR1 and JBR2) primers are shown. The regions in 
lowercase are specific for Vβ28 and Jβ2.2/3.2 segments. Regions in uppercase are adapters added to 
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5.2.2 Sequence data analysis 
Sequence data obtained from the Illumina platform were analyzed according to 
published algorithms [Bolotin et al., 2012, Warren et al., 2011], modified to fit with 
the objective of this study. A flow chart in Figure 5.1 illustrates the major steps for 
data analysis. Two approaches were used for estimating the diversity of Vβ28-Jβ3.2 
TRB rearrangements. 
(i). Extract sequences with valid Vβ and Jβ gene segments. Since Vβ and Jβ gene 
segments have been defined during amplicon preparation, raw sequence reads with 
valid Vβ and Jβ nucleotide sequences were selected for further analysis. During this 
process, sequences with low-quality nucleotides (<Q30 quality score – probability of 
a 1 in 1000 incorrect base call) were removed. 
(ii). Identify CDR3β. Sequences with valid Vβ and Jβ gene segments were then 
aligned for localizing Vβ and Jβ genes on each reads. CDR3β regions were defined 
through identification of the three nucleotides encoding the conserved amino acid 
Cys (C) located towards the 3‟ end of the V gene segment and the three nucleotides 
encoding the conserved amino acid Phe (F) in 5‟ end of the J gene segment.  
(iii). Extract CDR3β sequences containing the Jβ3.2 gene segment. The specific 
reverse primer designed to amplify this gene rearrangement is within a 30bp region 
of Jβ3.2, from the 3‟ end to the conserved Phe-Gly-X-Gly (F-G-X-G) motif, which is 
conserved between Jβ2.2 and Jβ3.2 germline sequences. Transcripts containing Jβ2.2 
were identified based on differences in sequences 5‟ to this conserved motif. This 
enabled the remaining CDR3β sequences containing Jβ3.2 and Vβ28 gene segments 
to be identified and grouped into unique CDR3β sequences.  
(iv). Error rate calculation. In order to estimate the proportion of CDR3β that were 
potentially generated from artefacts (i.e. PCR or sequencing errors), sequencing 
reads were aligned with the defined Vβ gene segment to identify erroneous 
nucleotides. Error rate was calculated according to the following formula. Given the 
average length of CDR3β sequences, a cutoff for erroneous sequences was calculated 
as (error rate×CDR3β length (kbp) ×100) %. According to the cutoff, a respective 
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proportion of low-abundant sequences were removed tominimize all potential 
erroneous CDR3β sequences. 
 
(v). Clonotype identification. First, sequences representing “core clonotypes” 
were identified by grouping identical CDR3β nucleotide sequences. Second, 
correction of PCR and sequencing errors was performed through merging low-
abundant “core clonotypes” with more abundant “core clonotypes” that differs by no 
more than three nucleotide mismatches within the germline V, D and J segments of 
CDR3. For the three nucleotide mismatches, ≤2 mismatches are allowed within the V 
gene segment (excluding the last two identified nucleotides), ≤2 mismatches are 
allowed within the J gene segment (excluding the first two identified nucleotides), ≤1 
mismatches are allowed within the D gene segment (excluding the first two and the 
last two identified nucleotides). By doing this, diversity of junction sequences of 
VDJ will not be influenced. This correction is feasible as TCRs do not undergo 
somatic hypermutation and therefore mismatches within germline V, D and J 
segments of CDR3 can only arise from PCR or sequencing errors. Dβ genes are 
usually difficult to define due to nucleotide additions and deletions during somatic 
rearrangement. In the current study, error correction was conducted for two sample 
clonotypes with identifiable germline Dβ gene segment within CDR3β region. PCR 
or sequencing error rate was estimated according to these samples. 
(vi). To determine the presence and frequencies of clonotypes with the defined 
CDR3β sequence, the filtered data were searched for the conserved epitope-specific 




Error rate (errors/kbp) = Total number of erroneous nucleotides in Vβ Total number of aligned sequences × length of Vβ (kbp) 
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Raw sequencing reads were 
initially trimmed according to quality score (Q30) and Vβ and Jβ gene alignment. From the resultant 
high-quality sequencing reads, sequences with Vβ28-Jβ3.2 rearrangement were used for subsequent 
error correction according to two approaches described in section 5.2.2. An estimation of Vβ28-Jβ3.2 




Figure 5.1 Flow chart for steps of sequencing data analysis.  
Raw sequencing reads 
 
Raw sequencing reads High quality (≥Q30) sequences with valid Vβ and Jβ gene 
ssegments 
 
High quality (≥Q30) sequences with valid Vβ and Jβ gene 
ssegments 




Error rate calculation 
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5.3 Results 
5.3.1 Amplicon preparation for Illumina sequencing 
As described in the previous chapter, a conserved (or public) TRB sequence with 
a Vβ28-CASAEYGGENTQPLYF-Jβ3.2 rearrangement is shared by the Tp250-59 
epitope-specific CD8 T cells from 5 BoLA-A10-homozygous cattle. Using this as a  
„barcode‟ for Tp250-59 -specific CD8 T cells may allow HTS analysis of the TRB 
repertoire to be used for the detection of epitope-specific CD8 T cell clonotypes 
within highly diverse repertoires, such as observed in samples derived directly ex 
vivo. To maximize the chances of achieving sufficient sequencing depth to detect this 
TRB chain, PCR amplification using primers specific for the defined Vβ28 and Jβ3.2 
genes were designed. As i) Vβ28 is a single member subgroup, and the bovine 
genome contains aminimum of ~90 functional TRBV genes and ii) the primers were 
specific for only 2 (Jβ 2.2 and 3.2) of the 17 functional bovine TRBJ genes 
[Connelley et al., 2009], it was estimated that compared to the pan-TRB 
amplification protocol described in previous chapters, similar sequencing levels 
using this PCR would enable an ~700 fold higher resolution of the repertoire of 
Vβ28-Jβ2.2/3.2 TRB rearrangement. 
CD8 T cells purified from PBMC of a previously T. parva immunized BoLA-
A10-homozygous animal (403957) were initially used to validate the methodology. 
Purity and CD4 T cell contamination of isolated CD8 T cells were checked. As 
shown in Figure 5.2A, purity of the CD8 T cells was above 97%. No significant CD4 
T cell contamination was observed (data not shown). From two aliquots of purified 
CD8 T cells (1×107 cells per aliquot), TRB amplicons with the defined Vβ28 and 
Jβ2.2/3.2 gene segments were prepared using the gene-specific primers. High-fidelity 
DNA polymerase was used to limit PCR errors during amplification. PCR cycles 
were checked to obtain adequate amplicons for sequencing. As shown in Figure 5.2B, 
30 PCR cycles were sufficient to generate a visible PCR product (length around 
450bp). Purity of the product post-purification with AMpure beads was confirmed by 
agarose gel electrophoresis (Figure 5.2C). Paired-end reads with a length of 250bp 
for each direction were generated on an Illumina HiSeq2500 platform and forward 
and reverse reads were paired to get contiguous sequences, as shown in Figure 5.2D. 
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The quality parameters of generated sequences for both samples are shown in Figure 
5.3. Quality scores for nucleotides upto the 250bp position was ≥Q30, a benchmark 
quality score for Illumina sequencing. Lower qualities were observed for nucleotides 
between 250-500bp. For data analysis, sequences with low-quality nucleotides were 





















A, CD8 T cells were purified from PBMC of T. parva-immunized BoLA-A10 homozygous animal 
403957. Two aliquots of 1×107 CD8 T cells were used for amplicon preparation. B, PCR cycles were 
checked to choose the optimal condition for obtaining adequate amplicons for sequencing. C, PCR 
amplicons were purified using AMpure beads according to methods described in section 2.3.3.5 and 
the purity of the resultant PCR products were checked using Agilent 2200 TapStation. D, PCR 
amplicons were sent for sequencing on the Illumina® platform. Paired-end reads were generated for 
CDR3β clonotype analysis. 
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across all nucleotide bases are shown for the raw data of both samples. For the two samples, 
nucleotides upto 250 bp position were ≥Q30. Quality scores for nucleotide bases marked by blue lines 
showed variation. Sequences with low quality scores were removed and the remaining high-quality 
sequences were used for subsequent analysis.     
 
5.3.2 Clonal diversity of defined Vβ-Jβ gene rearrangements 
5.3.2.1 Extraction of sequences with in-frame CDR3β 
As shown in Table 5-2, for both samples, 91% of raw sequences had the defined 
Vβ and Jβ gene segments, providing 2.8 million sequences for sample 1 and 3.5 
million for sample 2. CDR3β sequences were extracted by identification of the three 
nucleotides encoding the conserved amino acid Cys (C) located towards the 3‟ end of 
the V gene segment and the three nucleotides encoding the conserved amino acid Phe 
(F) in 5‟ end of the J gene segment. For samples 1 and 2, CDR3β sequences were 
obtained for ~2.6 million and ~3 million reads respectively, of which ~2 and ~2.4 
million sequences were identified as being with Vβ28-Jβ3.2 rearrangements. 
Approximately 1×105 and 1.32×105 unique CDR3β amino acid sequences were 
encoded by the nucleotide sequences in samples 1 and 2 respectively. CDR3β length 
distributions for the identified unique amino acid sequences are shown in Figure 5.4. 
The general feature for CDR3β length distribution appears to be a bell shape, with 
Figure 5.3 Quality of nucleotide sequences generated from Illumina sequencing.   
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sequences having 14-18 amino acid residues within CDR3β region are the dominant 
components and less sequences for CDR3β shorter than 14 amino acids or longer 
than 18 amino acids. This type of CDR3β length distribution, also known as 
Gaussian distribution, has been widely observed in both human and mouse studies 
[Miqueu et al., 2007]. More amino acid sequences were identified from sample 2 
than from sample 1. CDR3β length distribution analysis in Figure 5.4 shows that the 
majority of these extra sequences in sample 2 had 15-18 amino acid residues within 
the CDR3β region. 
Table 5-2 Summary of Illumina sequencing data of CDR3β transcripts with Vβ28-Jβ3.2/2.2 
rearrangements from CD8 T cells derived from the PBMC of a previously T. parva immunized 
A10-homozygous animal (403957). 
a) For paired-end Illumina sequencing, half of the reads began from either 3‟-end or 5‟-end of the TRB 
sequence. 
b) Total number of high-quality (≥Q30 quality score) nucleotide sequences. Percentages in parentheses 
are proportions of raw data used for analysis. 
c) Sequencing reads with the defined Vβ28 and Jβ2.2/3.2 gene segments.  
d) Identification of CDR3β region is according to the conserved amino acid Cys (C) located towards 









1  2  
6,287,572/2 a)  7,579,198/2  










Reads with valid Vβ 
and Jβ genes  c) 2,934,553 (93%) 201,826 3,560,823 (94%) 287,097 
CDR3β extraction d) 2,614,697 (83%) 144,211 2,981,400 (79%) 200,050 
Reads with Vβ28 and 
Jβ3.2 2,051,452 (65%) 100,349 2,404,207 (63%) 132,170 
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CDR3β lengths ranging from 11 to 24 amino acids were observed for both samples, with CDR3β 
lengths of 14-18 residues dominant. 
 
5.3.2.2 Correction of errors in TRB sequencing 
Due to the non-germline, hyper-variable CDR3β region, sequencing errors in 
HTS of antigen-specific repertoires is problematic and can lead to dramatic over-
estimation of repertoire diversity. Although quantifying repertoire diversity was not a 
critical aim of the study it was considered necessary to obtain an estimation of the 
sequencing error rate to avoid mis-interpretation of the data – 2 alternative 
methodologies were employed. 
The abundance of each identified Vβ28-Jβ3.2 amino acid sequence was 
examined. Figure 5.5 shows abundance distribution of sequences encoded by 1-30 
sequencing reads. In both samples ~80% of the identified amino acid sequences 
(~80,000 and ~100,000 in samples 1 and 2 respectively) were represented by only a 
single read. This distribution of read frequency suggests that many of the apparently 
unique CDR3β amino acid sequences may have arisen as artifacts due to late PCR or 
sequencing errors. As shown in Figure 5.6, nucleotide sequences that encode these 
CDR3β amino acid sequences were calculated as 3.97% and 4.51% of the total 
sequencing reads with Vβ28-Jβ3.2 rearrangements in sample 1 and 2 respectively.  



















The encoding nucleotide sequences for the ~80% unique CDR3β amino acid sequences that were 
sequenced once in sample 1 and 2 are 3.97% and 4.51% of the total Vβ28-Jβ3.2 sequencing reads 
respectively. 
The first error correction method used was based on an estimation of the error 
rate in the sequencing reads, similar to that described in [Warren et al., 2011]. Using 
the germline Vβ28 sequence, it was possible to determine that the error rate was 
0.8766 bp/Kbp and 0.8876 bp/Kbp for sample 1 and 2 respectively (Table 5-3). As 
Figure 5.6 Percentages of nucleotide sequences encoding the unique CDR3β amino acid 
sequences with 1 read.  
Figure 5.5 Abundance distribution of unique CDR3β amino acid sequences with 1-30 
sequencing reads.  
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the average length of the CDR3β region was ~50bp, an estimated 4.4% of the 
sequence reads are likely to contain a nucleotide error within the CDR3β. This 
calculated cutoff is very close to the percentages (3.97% and 4.51% in Figure 5.6) of 
single nucleotide sequences encoding unique CDR3β amino acid sequences in both 
datasets. Removing the 3.97% and 4.51% of single read sequences resulted in a 
diversity of ~2-3×104 unique CDR3β amino acid sequences.  
Table 5-3 Error rates for sequencing data of sample 1 and 2. 
Error rates of sequence data for the two samples and the cutoff for low-abundant sequencing reads are 
calculated according to section 5.2.2. Error rate = total number of erroneous nucleotides in Vβ/ (total 
number of analyzed sequences × Vβ length). Cutoff = (error rate × CDR3β length × 100) %. 
 
A more detailed error correction process (as described in section 5.2.2) has been 
described for HTS datasets of human and murine TCR [Bolotin et al., 2012].  This 
was applied to a representative subset of sequence data. In this process low-abundant 
reads with no more than a total of three mismatches in germline V, D and J gene 
components of the CDR3β region (in these regions mismatches between reads can 
only arise from PCR or sequencing errors) were mapped to a major „core clonotype‟ 
sharing the same non-germline CDR3β sequence. By avoiding manipulation of the 
non-germline gene junctions, this correction step maintains the genuine CDR3β 
sequence diversity. A summary of this error correction is shown in Table 5-4 and the 
complete analysis is detailed in Appendix C. Notably some of the apparently 
erroneous sequences were represented by up to 25 reads, suggesting that some of the 
errors may have been introduced early during PCR (and thus subsequently amplified). 
For the example shown in Table 5-4, a total of 88 low-abundant clonotypes, 
encoding 49 unique CDR3β amino acid sequences, were corrected and mapped to the 















Sample 1 579,885 2,614,697 0.253 0.8766 0.05 4.38% 
Sample 2 669,531 2,981,400 0.253 0.8876 0.05 4.44% 
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can dramatically inflate the apparent CDR3β clonal diversity of samples analyzed by 
HTS.   
During error correction, three types of low-abundant clonotypes (<25 
sequencing reads in the above example) were observed; 1) clonotypes which differ 
only in germline V, D and/or J components that can thus be safely considered as 
erroneous and merged to dominant clonotypes - such as those shown in Table 5-4, 2) 
clonotypes with residue variants at gene junctions and 3) clonotypes that were 
removed due to the presence of more than three errors in the amplified V, D and J 
genes. Examples for the latter two types of clonotypes are shown in Table 5-5. 
Frequencies for the three types of low-abundant clonotypes for the sample analyzed 
were calculated as 70.9%, 22.3% and 6.8% respectively. The second type of 
clonotypes could be generated from non-germline nucleotide additions/deletions 
during the VDJ rearrangement. Therefore, these clonotypes could represent the real 
diversity of Vβ28-Jβ3.2 rearrangement. The proportion of clonotypes with less than 
25 sequencing reads were found to encode up to 98% of the whole identified unique 
CDR3β amino acid sequences. Therefore, the realistic estimation of Vβ28-Jβ3.2 
repertoire diversity is around 24% (2% + 98%×22.3%) of the sequences defined 
before error correction, which equals 2.4×104 for sample 1 and 3.2×104 for sample 2. 
However, the precise clonal diversity for Vβ28-Jβ3.2 rearrangement can only be 
verified after a comprehensive error correction for all identified sequencing reads. At 
the time the study was conducted, the lack of an efficient bioinformatics package for 
conducting error correction for bovine TCR data made it unfeasible to complete such 
an analysis. 
Nevertheless, application of the two approaches to error correction (using a 
calculated cutoff and using an error correction algorithm based on sharing of non-
germline CDR3β nucleotide sequence) provided very similar results – estimating that 
the realistic range of unique Vβ28/Jβ3.2+ TRBs identified in each of the populations 
was 2-3×104.   
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CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ  Jβ Dβ 
3343 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
25 CASDPSGGANAQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACGCCCAGCCCCTGTACTTT 28 3.2 3 
21 CASDPAGGANTQPLYF TGTGCCAGCGACCCTGCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
17 CASDPSGGANTQPLYF TGTGCCAGCGACCCGTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
10 CASDPSGGANPQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACCCCCAGCCCCTGTACTTT 28 3.2 3 
6 CASDPTGGANTQPLYF TGTGCCAGCGACCCTACGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
5 CASDPSGGASTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAGCACCCAGCCCCTGTACTTT 28 3.2 3 
5 CASDPSGGAITQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGATCACCCAGCCCCTGTACTTT 28 3.2 3 
5 CASDPSGGANTQPLDF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGGACTTT 28 3.2 3 
2 CVSDPSGGANTQPLYF TGTGTCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSVGANTQPLYF TGTGCCAGCGACCCTTCGGTGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSGGANTQPLDF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGGACTTT 28 3.2 3 
2 CASDPAGGANAQPLYF TGTGCCAGCGACCCTGCGGGGGGAGCGAACGCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQLLSF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCTCCTGTCCTTT 28 3.2 3 
1 CASDPSVGATTQPLSF TGTGCCAGCGACCCTTCGGTGGGAGCGACCACCCAGCCCCTGTCCTTT 28 3.2 3 
The dominant “core clonotype”, which determines the nucleotide sequence of the final clonotype, is shown in bold. Vβ (orange), Dβ (blue) and Jβ (green) gene 
components and corrected errors (red) within CDR3β nucleotide sequence are shown. A limited number of low-abundant clonotypes are shown. The complete table 
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CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ Jβ Dβ 
3343 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
9 CASDRSGGANTQPLYF TGTGCCAGCGACCGTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
3 CASDPSGVANTQPLYF TGTGCCAGCGACCCTTCGGGGGTAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSGAANTQPLYF TGTGCCAGCGACCCTTCGGGGGCAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDHSGGANTQPLYF TGTGCCAGCGACCATTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSGGADTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGGACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDLSGGANTQPLYF TGTGCCAGCGACCTGTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPAVGANAQPLYF TGTGCCAGCGACCCTGCGGTGGGAGCGAACGCCCAGCCGCTGTACTTT 28 3.2 3 
The dominant “core clonotype”, which determines the nucleotide sequence of the final clonotype, is shown in bold. V segments (orange), D segments (blue), J 
segments (green) and errors (red) within CDR3 nucleotide sequence are shown. Variations in sequences from the “core clonotypes” at gene junctions are shown in 
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5.3.3 Assessment of coverage of the Vβ28-Jβ3.2 repertoire in 
the analyzed samples 
To enable an evaluation of how comprehensively the Vβ28-Jβ3.2 repertoire in 
PBMC was being analysed using the HTS approach, the results from two aliquots of 
CD8 T cells derived from the same individual (403957) and having the same number 
of cells (1×107) were compared to identify how much commonality there was in the 
identified TRB repertoires. These two aliquots of CD8 T cells were isolated from the 
same batch of blood sample, processed at the same time, prepared using identical 
procedures for mRNA isolation, cDNA synthesis, PCR amplification and purification, 
and the same quantity of purified PCR product was sent for sequencing. 
As can be seen in Table 5-2, more sequencing reads were obtained from sample 
2 and there was a commensurate greater number of unique amino acid sequences 
encoded by the Vβ28-Jβ3.2 rearrangements in sample 2 compared to sample 1 
(132,170 vs. 100,349) in the uncorrected datasets. Notably, only 16,194 CDR3β 
amino acid sequences were found in both datasets (Figure 5.7A); this is ~16% and 
12% of the amino acid sequences identified in samples 1 and 2 respectively. These 
values are based on the uncorrected sequence data and so may under-estimate the 
true degree of sequence overlap between the 2 samples. Sequence overlap was then 
analyzed for the two samples after removing the 3.97% and 4.51% of single read 
sequences. As shown in Figure 5.7B, from 2-3×104 CDR3β amino acid sequences, 
only 6,426 sequences were shared by the two datasets, which is 30% and 22.5% of 
























A, from identified unique CDR3β amino acid sequences with Vβ28-Jβ3.2 rearrangements, 16,194 
sequences were found in both samples, 16.1% of amino acid sequences for sample 1 and 12.2% of 
amino acid sequences for sample 2. B, after the cut-off of the 3.97% and 4.51% of single read 
sequences, 2-3×104 unique CDR3β amino acid sequences were obtained for samples 1 and 2. Within 
these sequences, 6,426 amino acid sequences were found in both samples, 30% of amino acid 
sequences for sample 1 and 22.5% of amino acid sequences for sample 2. 
 
 
Figure 5.7 Proportion of Vβ28-Jβ3.2 amino acid sequences shared between samples 1 and 2.  
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5.3.4 Identification of potential epitope-specific TRB 
rearrangements 
Results from the previous chapter have demonstrated the presence of the 
conserved TRB sequence Vβ28-CASAEYGGENTQPLYF-Jβ3.2 in the Tp250-59 
epitope-specific CD8 T cells from animal 403957 (6% of in vitro generated CD8 T 
cell line, Figure 3.1). However, the exact sequence of the conserved Vβ28-
CASAEYGGENTQPLYF-Jβ3.2 rearrangement was not found within the diverse 
Vβ28-Jβ3.2 rearrangements obtained in either sample 1 or 2. Instead, sequences that 
encode 1 amino acid substitution from the conserved TRB sequence were observed. 
As shown in Table 5-6, errors (in red font) within germline V, D and J gene 
components of CDR3β were corrected using the method as above and six unique 
CDR3β amino acid sequences (1 high- and 5 low-abundant sequencing reads) were 
identified. The one residue (in purple font and underlined) differing between these 
sequences and the expected TRB sequence (Vβ28-CASAEYGGENTQPLYF-Jβ3.2) 
was located at the non-germline Dβ-Jβ gene junction. Of the six unique CDR3β 
amino acid sequences, only one sequence was identified from both samples, but 
encoded by significantly different number of sequencing reads (1267 reads from 
sample 1 and 1 read from sample 2). Four sequences only appeared in sample 1 and 
one sequence only appeared in sample 2. These results also suggest that sequencing 
reads obtained from each of the two samples are likely not sufficient to cover all 
potential Vβ28-Jβ3.2 rearrangements. 
Interestingly, the Vβ28-CASAEYGGKNTQPLYF-Jβ3.2 clonotype has been 
identified in the Tp250-59 epitope-specific CD8 T cells obtained from cattle 302186 in 
the previous chapter (Table 4-3), suggesting that this TRB (and possibly others that 
have an amino acid substitution in this position) is also expressed by Tp250-59-
specific CD8 T cells. 
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Table 5-6 Sequencing reads with one amino acid variant comparing with the defined TRB clonotypes Vβ28-CASAEYGGENTQPLYF-Jβ3.2. 
Nucleotide and amino acid sequences for the Vβ28-Jβ3.2 rearrangements with one residue variation compared to the conserved Vβ28-CASAEYGGENTQPLYF-Jβ3.2 
rearrangement are shown. Number of sequencing reads for each amino acid sequence is shown for both samples. Germline V, D and J gene components of CDR3β are 
shown in orange, blue and green fond respectively. Nucleotide mismatches in germline gene components are in red. Amino acid variants in non-germline Dβ-Jβ 
junctions are in purple and underlined. Unique amino acid sequences are shaded.  
Number of sequencing reads CDR3, amino acid 
sequence CDR3, nucleotide sequence Vβ Jβ Dβ Sample 1 Sample 2 
Conserved  CASAEYGGENTQPLYF TGTGCCAGCGCTGAATATGGGGGGGAGAACACCCAGCCCCTGTACTTT 28 3.2 2 
1245 1 CASAEYGGTNTQPLYF TGTGCCAGCGCTGAATACGGGGGGACGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2  CASAEYGGTNTQPLYF TGTGCCAGCGCTGAATACGGTGGGACGAACACCCAGCCCCTGTACTTT 28 3.2 3 
10  CASAEYGGTNTQPLYF TGTGCCAGCGCTGAATACGGCGGGACGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2  CASAEYGGTNTQPLYF TGTGCCAGCGCTGAATACGGCGGGACGAACACCCAGCCGCTGTACTTT 28 3.2 3 
2  CASAEYGGTNTQPLYF TGTGCCAGCGCCGAATACGGCGGGACGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1  CASAEYGGTNTQPLYF TGTGCCAGCGCTGAATACGGCGGGACGAACACGCAGCCCCTGTACTTT 28 3.2 3 
2  CASAEYGGTNTQPLYF TGTGCCAGCGCTGAATACGGCGGGACGAACACCCAGCCCCTTTACTTT 28 3.2 3 
2  CASAEYGGTNTQPLYF TGTGCCAGCGCTGAATACGGCGGGACGAACACCCAGCCCCTATACTTT 28 3.2 3 
1  CASAEYGGANTQPLYF TGTGCCAGCGCTGAATACGGGGGGGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
5  CASAEYGGANTQPLYF TGTGCCAGCGCTGAATACGGCGGGGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1  CASAEYGGANTQPLYF TGTGCCAGCGCTGAATACGGGGGGGCAAACACCCAGCCCCTGTACTTT 28 3.2 3 
1  CASAEYGGVNTQPLYF TGTGCCAGCGCTGAATACGGGGGAGTGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1  CASAEYGGVNTQPLYF TGTGCCAGCGCTGAGTACGGGGGTGTGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1  CASAEYGGKNTQPLYF TGTGCCAGCGCTGAATACGGAGGGAAGAATACCCAGCCCCTGTACTTT 28 3.2 3 
1  CASAEYGGMNTQPLYF TGTGCCAGCGCTGAGTACGGGGGTATGAACACCCAGCCCCTGTACTTT 28 3.2 3 
 4 CASAEYGGGNTQPLYF TGTGCCAGCGCTGAGTATGGAGGGGGGAACACCCAGCCCCTGTACTTT 28 3.2 3 
 
  132 
Doctor of Philosophy – The University of Edinburgh – 2015 
5.4 Discussion 
In order to investigate the potential influence of CD8 T cell repertoires to Tp2 
epitope dominance variation between A10-homozygous and -heterozygous cattle, 
work in this chapter aimed to establish a system enabling the detection of epitope-
specific CD8 T cells directly ex vivo. In the previous chapter, TCRβ repertoires of 
epitope-specific CD8 T cells were analysed and a conserved TCRβ clonotype with 
Vβ28-CASAEYGGENTQPLYF-Jβ3.2 rearrangement was identified to be shared by 
the Tp250-59 epitope-specific CD8 T cells from 5 A10-homozygous cattle. In the 
current work, this specific TRB clonotype was used as a „barcode‟ to serve as a 
proxy for the detection of Tp250-59-specific CD8 T cells.  
The application of high throughput sequencing (HTS) technology for analysing 
immune repertoires such as TCR provides a high resolution picture of repertoire 
usages for a complex CD8 T cell population [Calis and Rosenberg, 2014, Six et al., 
2013]. Initial experiments were conducted to provide „a proof of concept‟ that HTS 
could be used to identify the „public‟ TCRβ chain directly ex vivo. To achieve this, 
purified CD8 T-cells from the PBMC of a T. parva-immunised A10-homozygous 
animal, from which the „public‟ TCRβ chain had been identified from in vitro 
cultured CD8 T cells previously, were analysed. From the resultant sequencing data, 
the public TRB clonotype was not detected. As the current study was to validate the 
utilization of HTS for detecting epitope-specific TRB clonotype, the result suggests 
that further optimisation of the methodology is required before continuing the 
analyses of naïve CD8 T cell repertoires in A10-homozygous and –heterozygous 
cattle.  
High quality sequencing reads were obtained, indicating the success of the 
sequencing approach at the technical level. However, TCR repertoire analysis using 
HTS is generally challenging due to 1) the highly diverse repertoires being analysed 
[Arstila et al., 1999] and 2) the presence of hypervariable, non-germline sequences 
incorporated during the process of somatic recombination [Schatz and Ji, 2011] 
which means that differentiation of error and genuine sequence variation is difficult. 
Although error correction was not a priority of this study, a realistic estimation of the 
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diversity of Vβ28-Jβ3.2 rearrangements would allow the evaluation of repertoire 
coverage in the analysed samples, since identification of the public TRB 
rearrangement Vβ28-AEYGGENTQPLYF-Jβ3.2 requires a sufficient sequencing 
depth for the Vβ28-Jβ3.2 repertoires.  
Error correction for TRB sequences is widely recognized as difficult due to base 
pair changes in the non-germline coding region potentially being a result of error or 
genuine sequence variants between clonotypes. Erroneous clonotypes could hugely 
inflate the clonotypic diversity in analysed samples. Studies using human and mouse 
models have shown that many of the aberrant clonotypes are present at low 
frequency, suggesting that errors are introduced either later in PCR or during 
sequencing [Shugay et al., 2014, Bolotin et al., 2012, Nguyen et al., 2011]. Various 
approaches have been employed for error correction. One method was to remove 
sequences with low abundant reads based on a calculated error rate [Warren et al., 
2011]. A 4.4% cutoff was applied in the current study based on an error rate of 0.88 
erroneous nucleotides per 1000bp sequencing reads (Table 5-3). Removing a 
corresponding proportion of low-abundant sequencing reads resulted in 80% 
reduction of Vβ28-Jβ3.2 amino acid sequence diversity. However, this approach 
could be problematic due to removing of genuine clonotype variants, and result in an 
underestimation of real repertoire coverage by the sequencing data. A more 
sophisticated approach [Bolotin et al., 2012] was then used to remove only 
PCR/sequencing artefacts by targeting germline V, D and J sequences for error 
correction. However, an efficient bioinformatics package [Bolotin et al., 2013] is 
required for this method, which is currently not available for bovine TCR (although 
these are being developed - private communication to Dr. Connelley). To provide an 
indication of how such correction would affect the data generated in this study, 
manual correction was performed on a representative clonotype (Table 5-4 and Table 
5-5). Based on the analysis of this one sample, a similar level of Vβ28-Jβ2.3 
repertoire diversity (2.5-3.2 × 105) was estimated as the previous approach applying 
a crude cutoff.  
To generate sequencing data, 1×107 CD8 T cells were used, which is equivalent 
to the numbers of CD8 T cells used for establishing the T. parva-specific CD8 T cell 
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cultures from which the public TRB sequence was identified. Therefore, the 
assumption was that the samples used were sufficiently large to permit the 
identification of the public Vβ28-Jβ3.2 TRB rearrangement. Previous studies have 
identified ~90 functional Vβ and 17 Jβ germline genes [Connelley et al., 2009]. 
Assuming that the use of these gene segments is evenly distributed during TRB 
rearrangement (which is unlikely to be the genuine in vivo situation but allows an 
approximate calculation to be made), it is possible to estimate that within 1×107 CD8 
T cells, 1.3×104 (1×107 × 1/90 × 2/17) cells will express TRB chains with a Vβ28-
Jβ2.2/3.2 rearrangement. The sequencing depth achieved in samples 1 and 2 (2×106 
and 2.4×106 high-quality sequences respectively) therefore provided more than 100-
fold sequencing coverage of the estimated repertoire. In fact, the number of Vβ28-
Jβ3.2 TRB amino acid sequences obtained (ranging from 1-1.3×105 before and 2-
3×104 after error correction) was greater than that estimated. However, comparison 
of TRB repertoires of the two samples (derived from the same animal and processed 
at the same time) revealed limited overlap of the Vβ28-Jβ3.2 TRB amino acid 
sequences as shown in Figure 5.7. A similar level of TRB amino acid sequence 
sharing has been reported in human models, although TRB sequences were derived 
from different individuals in the study [Warren et al., 2011]. This limited proportion 
of shared Vβ28-Jβ3.2 amino acid sequences indicates that the data obtained in the 
current study may not be sufficient to exhaustively sequence all of the Vβ28-Jβ3.2 
repertoire in the analysed memory CD8 T cell populations and this, rather than 
insufficient biological sampling may account for the failure to identify the targeted 
public TCR. 
A review of the current literature suggests that use of HTS to track antigen-
specific CD8 T cell clonotypes in unsorted memory populations has not been 
attempted previously. In a study of human CD8 T cell repertoires against HCMV, 
antigen-specific clonotypes were tracked in memory populations [Klarenbeek et al., 
2012]. However, sequencing data obtained in that study were from pMHC I tetramer 
sorted CD8 T cells and furthermore in HCMV antigen-specific CD8 T cell 
clonotypes are known to continuously expand over a period of time. Studies 
conducted in this project, instead, attempted to track a single epitope-specific TRB 
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sequence in the whole memory population. As this TRB may be present at low 
frequency during a quiescent memory stage, the ability to effectively and 
comprehensively cover the full TRB repertoire in sequenced samples may be of 
critical importance. The results presented in this chapter suggest that problems still 
exist in the application of HTS to detect antigen-specific T cell clonotypes in 
unsorted memory or naïve CD8 T cell populations. 
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Chapter 6:   Transduction of bovine CD8 T cells 
for the expression of epitope-specific TCR  
6.1 Introduction 
Studies carried out in humans and mice have clearly demonstrated that naive 
CD8 T cell populations go through three stages of development in vivo during 
responses to infection or vaccination, namely expansion, contraction and 
differentiation, leading to the establishment of a memory CD8 T cell population 
[Kaech et al., 2002].  The frequency of CD8 T cells specific for individual epitopes 
in naïve T cell populations is extremely low. For example, it was estimated that a 
mouse possesses between 10 and 1000 naïve CD8 T cells capable of responding to a 
specific antigen [Blattman et al., 2002, Bousso et al., 1998, Casrouge et al., 2000]. 
This small population is activated after encountering antigen presenting cells (APCs), 
usually dendritic cells (DCs), and then undergo robust proliferation and 
differentiation to become effector T cells. A proportion of the activated CD8 T cells 
acquire cytolytic activity and are known as cytotoxic T lymphocytes (CTLs). Thus, 
fully activated CD8 T cells can kill infected cells or release cytokines to inhibit 
pathogen replication and survival [Heath and Carbone, 2001b, Harty et al., 2000]. 
The majority (90 - 95%) of effector cells die following the pathogen clearance and 
surviving cells differentiate into memory cells, a heterogeneous population 
characterized by the ability to react rapidly against subsequent challenge with the 
same pathogen [Miller et al., 2008, Callan et al., 2000]. There is evidence that the 
functional capacity and homeostasis of memory CD8 T cell populations strongly 
influence the level of immune protection [Seder et al., 2008, Farber et al., 2014].  
For efficient activation of a naïve antigen-specific CD8 T cell, three necessary 
signals (commonly referred to as Signals 1, 2, 3) are required [Kaech and Cui, 2012]. 
Appropriate antigen stimulation via the T cell receptor (TCR) following recognition 
of antigenic peptide presented on MHC I molecules provides the initial activation 
signal (signal 1). The overall strength of this signal can be influenced by both the 
amount of available antigen and TCR affinity for the peptide-MHC, and determines 
the function and differentiation of antigen-specific CD8 T cells [Zehn et al., 2012]. 
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However, without additional co-stimulation, recognition of antigen alone can result 
in anergy or deletion of the responding naïve CD8 T cells [Mescher et al., 2006]. 
Therefore, activation signal (signal 2) involving the engagement of co-stimulatory 
molecules such as CD28 and CD40 ligand on CD8 T cells with CD80 and CD40 on 
APCs is essential for productive CD8 T cell activation [Acuto and Michel, 2003]. 
Pro-inflammatory cytokines such as IL-12 and type I interferon (IFNα and β), 
representing signal 3, also appear to be critical, especially for the formation of 
memory CD8 T cell populations [Harty and Badovinac, 2008]. The particular 
cytokines that provide signal 3 depend on the individual pathogen and the pattern 
recognition receptor (PRR) signalling pathways it activates in APCs [Thompson et 
al., 2006, Haring et al., 2006]. In addition to these signals, there is increasing 
evidence for the requirement of CD4 T cells during the generation of optimal CD8 T 
cell effector or memory responses against pathogenic infections [Bevan, 2004]. The 
precise function and mechanisms of CD4 T cell involvement are still unclear. There 
is strong evidence that CD4 T cells are essential for survival and maintenance of 
effector and memory CD8 T cells following activation [Novy et al., 2007, Janssen et 
al., 2005, Sun et al., 2004]. Other findings suggest that CD4 T cell help is required 
for programming the induction of CD8 T cell responses [Crispe, 2014, Smith et al., 
2004].  
The protective function of bovine CD8 T cell responses against T. parva 
infection has been demonstrated by adoptive transfer of CD8 T cell-enriched 
populations between immune and naïve twin calves [McKeever et al., 1994, 
Morrison et al., 1987]. However, a study of responses to primary infection of calves 
with a lethal dose of T. parva sporozoites demonstrated that, although infection 
provoked a potent CD8 T cell response, the responding cells did not show parasite-
specific cytolytic activity and did not appear to exert any control of the infection 
[Houston et al., 2008]. It was proposed that there was a defect in the functional 
differentiation of the responding T cells. Experiments in which defined T. parva 
antigens recognized by bovine CD8 T cells were used to immunize cattle by prime-
boost protocols using plasmid DNA and poxvirus vectors, have also indicated that 
the functional capacity of the CD8 T cell response may be important [Graham et al., 
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2006]. Immunisation resulted in antigen-specific CD8 T cell responses in most of the 
animals; however, in most animals the CD8 T cells did not show cytotoxic activity 
[Graham et al., 2006]. Again, it was suggested that naïve antigen-specific CD8 T 
cells may not have undergone appropriate functional differentiation. Although great 
advances have been made for understanding the role of CD8 T cell mediated immune 
responses in immunity against T. parva [Morrison, 2009], limited information is 
available on the factors that influence the effective induction of a protective CD8 T 
cell responses. In vitro experiments, involving mixing of different combinations of 
purified CD4 and CD8 T cell populations from T. parva-immune and naïve MHC-
identical animals, suggested that immune CD4 T cells are required for efficient recall 
of a parasite-specific CD8 T cell response [Taracha et al., 1997]. Further 
investigation would be informative for a better understanding of the role of CD4 T 
cells in the generation and recall of memory CD8 T cell responses against T. parva. 
A major obstacle to tracking the development of antigen-specific CD8 T cell 
responses in naïve animals is the extremely low frequency of antigen-specific cells in 
circulating CD8 T cell populations [Blattman et al., 2002, Bembridge et al., 1995]. In 
mice, generation of transgenic lines of animals expressing T cell receptors of defined 
epitope specificity has been used to overcome this obstacle. Studies of these TCR 
transgenic mice have provided valuable insights into induction of T cell responses in 
different disease models [Chen and Zavala, 2013, Li et al., 2010, Bumann, 2003]. 
However, this transgenic approach is not currently feasible for studies in large 
outbred species such as cattle. MHC I tetramer staining combined with magnetic 
beads-based cell enrichment has been used to purify naïve antigen-specific CD8 T 
cells from mouse models [Obar et al., 2008]. However, only very small numbers of 
cells can be obtained and even low levels of unspecific staining can result in low cell 
purity when staining cell populations containing rare positive cells. An alternative 
approach involving generation of TCR-transduced CD8 T cells in vitro has been used 
in mice and humans [Morgan et al., 2006, Kessels et al., 2001]. Adequate number of 
antigen-specific T cells can be generated from naïve CD8 T cells transduced in vitro 
with a TCR of defined antigen specificity; moreover, adoptive transfer of these CD8 
T cells into laboratory animals has facilitated studies of effective memory CD8 T cell 
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response development [Kearney et al., 1994, Stemberger et al., 2007, Harty and 
Badovinac, 2008]. The current study aimed to establish some of the tools and 
reagents to enable this approach to be pursued to investigate responses of naïve 
antigen-specific CD8 T cells in cattle.  
The first requirement to undertake TCR gene transfer is to identify paired 
functional TCR α and β chains expressed by T cells of the desired antigen specificity. 
To date, studies of TCR gene expression by T. parva-specific CD8 T cells have 
mainly focused on the TCRβ chain repertoires and little is known about TCRα chain 
usage. Rearrangement of the TCRα chain occurs after TCRβ chain rearrangement 
during cell development in the thymus; thus, two developing T cells with the same 
TCRβ chain rearrangement may have different rearranged TCRα chains. Moreover, 
unlike TCRβ chain, mature T cells frequently express two recombined TCRα chains 
[Gascoigne and Alam, 1999, Han et al., 2014]. This is due to the absence of genomic 
allelic exclusion and therefore generation of rearrangements of TCRα chains from 
both TCR haplotypes [Gascoigne and Alam, 1999]. When two apparently functional 
rearrangements occur, only one of the TCRα chains is believed to engage in antigen 
recognition, although both TCRα chains can be expressed on the cell surface [Ni et 
al., 2014, Heath and Miller, 1993]. For TCR gene transfer, the second requirement is 
an efficient transgene delivery system. A lentiviral vector was used for its ability to 
efficiently transduce non-dividing T cells, although activation signals are still 
required for efficient transduction [Unutmaz et al., 1999].  
From a panel of Tp2 epitope-specific CD8 T cell clones, paired TCR α chain 
expressions for a defined TCR β chain were analysed. Epitope specificity for one of 
the identified TCRαβ pairs was confirmed to have functional activity, which provides 
a fundamental material for future generation of bovine naïve antigen-specific CD8 T 
cells. Experiments conducted in this chapter also attempted to validate the efficiency 
of lentiviral transduction of bovine CD8 T cells. Preliminary data of successful 
transgene expression on activated bovine CD8 T cells provides promising evidence 
for future utilization of lentivirus constructs to transduce bovine T cells.  
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6.2 Materials and methods 
6.2.1 Generation of lentiviral constructs  
Details of the methods used to obtain lentiviral-bovine TCR constructs are 
provided in section 2.3.4. Briefly, full-length cDNAs of paired TCR α and β chain 
transcripts were amplified from CD8 T cell clones of defined epitope specificity, and 
then combined by linking with a T2A „self-cleaving‟ sequence in order to express 
two single chains driven by one promoter. The combined sequence was cloned into a 
lentiviral vector pSxW.tCD34. Plasmids with the generated lentiviral-bovine TCR 
constructs were obtained for preparing pseudotyped lentivirus particles. 
6.2.2 Preparation of pseudotyped lentivirus particles 
Details of pseudotyped lentivirus generation are provided in section 2.2.12. 
Briefly, 293 T cells were transfected with the generated lentiviral-TCR vectors along 
with the packaging vectors pCMVΔ8.91 and pMD2.G, using CaCl2 transfection 
method. Viral particles collected from supernatant of cell cultures were concentrated 
by ultracentrifugation and stored at -80°C. 
6.2.3 Virus titer 
The viral titer here refers to the concentration of transducing units. Virus titer 
was determined by transduction of the TCR- human leukemia Jurkat reporter cell line 
JRT3-T3.5 using serially diluted viral suspensions. To start with, 200μl of freshly 
prepared or stored virus stock were mixed with 1800μl of standard cell culture media. 
This virus suspension was diluted further to the desired concentration and 1ml added 
to 1×106 seeded Jurkat cells in 1 well of a 24-well plate, as described in section 
2.2.13. The percentage of cells expressing the transgene was determined by 
immunofluorescence staining of a human CD34 tag gene expression and flow 
cytometry 72 hours post transduction. Since the vector number is generally higher 
than one at >30% of transduction, the titer was determined from the dilution that 
generated <30% of transgene-expressing cells according to the formula indicated 
below [Swainson et al., 2008, Kustikova et al., 2003]. 
 
 
  141 
Doctor of Philosophy – The University of Edinburgh – 2015 
Titer (transduction units/ml) = (% transgene
+ cells/100) × number of cells per well 
total volume of virus (ml) 
 
6.2.4 Luciferase assay 
The reporter cell line JRT3-T3.5 used here has been transfected with a luciferase 
reporter construct under the transcriptional control of nuclear factor of activated T 
cells (NFAT), a transcription factor that is induced upon TCR signaling [Karttunen 
and Shastri, 1991]. For activation, 105 Jurkat cells transduced with lentivirus were 
stimulated for 16 hours with 1.5-2 × 104 peptide loaded antigen presenting cells (592 
TA, see section 3.2.5 for peptide loading). The supernatant was then collected for 
luciferase detection using BioLux® Gaussia Luciferase Assay Kit (New England 
Biolab) according to the manufacturer‟s instructions. The maximal activity of the 
luciferase reporter construct was determined by stimulation of the Jurkat reporter 
cells with 5ng/ml PMA and 1 μM ionomycin for 4 hours. Non-stimulated reporter 
cells were set up as negative control. The luciferase activity of stimulated transduced 
Jurkat cells was expressed in relative luminescence activity, calculated according to 
the formula RLU (%) = (Release from tests -minimum release) x 100/ (Maximum 
release -minimum release) [Aarnoudse et al., 2002]. 
6.2.5 Pre-activation of bovine CD8 T cells 
To facilitate lentiviral transduction, anti-CD3 and anti-CD28 monoclonal 
antibodies, which provide strong activation and proliferation signals through the T 
cell receptor complex, were used to activate bovine CD8 T cells. One day before cell 
stimulation, the anti-bovine CD3 antibody (MM1A) was added to the wells of a 96-
well flat-bottom plate (not-treated, Costar) at a final concentration of 1μg/ml in PBS 
and incubated at 4°C overnight. 
On the day of stimulation, unbound antibody was removed from the wells and 
purified anti-bovine CD28 antibody (low endotoxin, AbD Serotec) and recombinant 
rIL2 were added along with 5×104 T cells/well. The volume was adjusted to 200μl 
per well, giving a final concentration of 5μg/ml anti-CD28 and 100U/ml of rIL2. The 
plates were incubated at 37°C in 5% CO2 for 24 hours. To confirm cell activation of 
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the CD8 T cells, preliminary experiments were carried out to measure activation at 
20 hours after stimulation, using cell cycle analysis. Cell cycle staining was 
performed using Hoechst 33285 dye (Sigma). Briefly, 10µl of Hoechst 33285 dye (at 
a concentration of 1mM) were added to cells maintained in the culture medium and 
incubated for 30min at 37°C. The cells were analysed by flow cytometry as soon as 
possible without washing out the stain. FlowJo software was used for cell cycle 
analysis. 
6.2.6 Lentiviral transduction of bovine CD8 T cells 
Details of lentiviral transduction of bovine CD8 T cells are presented in section 
2.2.14. Briefly, primary bovine CD8 T cells were purified from PBMC by MACS 
sorting and then pre-stimulated with anti-bovine CD3/CD28 antibodies for 24 hours 
in the presence of rIL2, to achieve activation. For virus transduction, the viral 
particles were added to the pre-activated bovine CD8 T cells at a multiplicity of 
infection (MOI) of 1~10. Polybrene was added to a final concentration of 6μg/ml to 
increase the efficiency of transduction.  
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6.3 Results 
6.3.1 Identification of paired TCR α and β chains expressed 
by CD8 T cell clones 
In the previous chapter, analyses of the TCR repertoires of epitope-specific CD8 
T cells focused on the expressed TCRβ chains. Hence, information on the α chains 
expressed along with the β chains in individual T cells was not available. To 
determine the paired TCRα chain usages in CD8 T cells specific for the defined 
Tp250-59 epitope, CD8 T cell clones specific for this epitope were generated 
(according to section 2.2.6). The experiments focused on a TCRβ clonotype (Vβ28-
CASAEYGGENTQPLYF-Jβ3.2), for which studies described in the previous chapter 
showed was conserved in the CD8 T cell responses of three A10-homozyous cattle. 
This clonotype had also been reported in two additional A10-homozygous cattle in a 
previous study [Connelley et al., 2011]. The TCRα chain usage of the Tp250-59 
epitope-specific CD8 T cell clones expressing this conserved TCRβ chain was 
investigated in four of the A10 homozygous cattle. A PCR employing primers 
specific for Vβ28 and Jβ3.2 gene segments (as described in section 4.2.3) was first 
used to identify T cell clones expressing these gene segments. As shown in Figure 
6.1, clones yielding positive PCR results were identified in all 4 animals. PCR 
products from positively amplified clones were then sequenced to confirm the 
presence of the specific Vβ28-CASAEYGGENTQPLYF-Jβ3.2 TCRβ chain 
rearrangement. Sequencing results determined that a total of 37 CD8 T cell clones 
were generated with the defined TCRβ chain expression, as listed in Table 6-1. Of 
these 37 CD8 T cell clones, 21 were used for TCRα chain amplification. The 
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cDNAs of generated Tp250-59 epitope-specific CD8 T cell clones were used for PCR identification of 
clones with the defined TRB expression.  
 
Table 6-1 Number of Tp250-59 epitope-specific CD8 T cell clones with the defined TRB 
rearrangement from each A10 homozygous cattle 
Animal Total number of CD8 T cell clones 
Number of clones 
with the defined TRB 
Number of clones used 
for TCRα amplification 
302186 46 9 5 
403992 17 4 3 
403957 20 4 3 
1011 - 20 10 
Number of CD8 T cell clones with the defined TCR β chain expression and total number of CD8 T 
cell clones from which the defined clones were selected are shown for the respective A10 
homozygous cattle. CD8 T cell clones were generated from the 3 A10-homozygous cattle (302186, 
403992, 403957) used in this study. Previously generated CD8 T cell clones from animal 1011 were 
also used. -, number unavailable. Number of clones used for TCRα expression analysis is also shown 
for each animal. 
 
Using PCRs employing a panel of forward primers that amplify groups of 
known bovine Vα gene subfamilies and a reverse primer specific for the bovine Cα 
gene as described in section 2.3.4.1, TCRα chain transcripts were amplified from 21 
of the Tp250-59 epitope-specific CD8 T cell clones. Single-band PCR products were 
obtained from these clones, for one or more of the Vα gene-specific primers. 
Summaries of TCRα chain analysis for these clones are shown in Table 6-2. PCR 
Figure 6.1 Selection of Tp250-59 epitope-specific CD8 T cell clones with Vβ28-
CASAEYGGENTQPLYF-Jβ3.2 rearrangement.  
Cultured Tp250-59 epitope-
specific CD8 T cell clones 
 
Cultured Tp250-59 epitope-
specific CD8 T cell clones 
RNA isolation and 
cDNA synthesis 
 
RNA isolation and 
cDNA synthesis 
PCR identified CD8 T cell clones 
with expected TRB expression 
 
PCR identified CD8 T cell clones 
with xp cted TRB expression 
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products from 12 of the 21 CD8 T cell clones were sequenced to identify in-frame 
TCRα chain sequences. For 11 clones, one in-frame TCRα chain was identified for 
each clone, while for one clone from animal 302186, two in-frame TCRα chains 
were identified.  
Table 6-2 Summary of TCRα chain analysis for CD8 T cell clones from A10-homozygous cattle. 
Animal 
 Number of clones 
PCR products for Vα primers Sequenced 
clones 
In-frame TCRα chains 
One primer Multiple primers One  Two  
302186  5 1  1 
403992  3 2 2  
403957  3 1 1  
1011 10  8 8  
Numbers of the Tp250-59 epitope-specific CD8 T cell clones used for TCRα chain amplification and 
sequencing are shown for each of the four A10-homozygous cattle. Numbers of clones with one or 
two identified in-frame TCRα chains are also shown for each individual. 
Sequencing of the PCR products of those clones that yielded more than two PCR 
products indicated that this was due to cross-reactivity of the PCR primers. Figure 
6.2 shows representative PCR amplification results for 4 CD8 T cell clones from 4 
animals. Three clear single PCR bands were amplified from CD8 T cell clone 
2186.31 with primers designed to be specific for Vα8.4, Vα9 and Vα13 gene 
subgroup respectively (Figure 6.2A). The same result was obtained for all 5 clones 
derived from the same animal. The Sequence data from this clone showed two in-
frame TCRα rearrangements, with Vα8.4 and Vα13 gene segments. The sequence 
amplified using the Vα9-specific primer was identical to that obtained using the 
Vα13-specific primer, both having the same Vα13-Jα20 rearrangement (Table 6-3). 
PCR products amplified using Vα9 and Vα13 specific primers were also obtained for 
the 3 CD8 T cell clones from animal 403957, as shown for clone 3957.11 in Figure 
6.2B. Sequencing results of the two PCR products from clone 3957.11 showed the 
same Vα13-Jα49 rearrangement (Table 6-3). These results demonstrate that under the 
PCR conditions used there is cross-reactivity of Vα9-specific primer with Vα13.  
PCR products amplified with multiple Vα gene-specific primers were also 
observed for 3 CD8 T cell clones from animal 403992. Two patterns of PCR 
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amplification were observed, as shown for clone 3992.12 and 3992.8 in Figure 6.2C 
and Figure 6.2D respectively. Sequencing of PCR products from clone 3992.12 
showed only one in-frame TCRα chain rearrangement Vα12-Jα34 (Table 6-3); PCR 
products amplified using Vα8.1 and Vα20 subgroup-specific primers are out-of-
frame. For the clone 3992.8, PCR products amplified using Vα4 and Vα26 subgroup-
specific primers showed the same in-frame TCRα rearrangement Vα26-Jα22, 
suggesting the cross-reactivity of Vα4-specific primer with Vα26 under the PCR 
conditions. PCR products amplified using Vα8.1 and Vα29 subgroup-specific 
primers are out-of-frame. Therefore, for the two CD8 T cell clones from animal 
403992, one in-frame TCRα chains was identified for each clone.  
For animal 1011, TCRα transcripts were amplified from 10 CD8 T cell clones 
and all of them had only one PCR product, amplified using the Vα26 subgroup-
specific primer as shown for clone 1011.35 in Figure 6.2E. PCR products of 8 clones 
were sequenced and shown to have the same in-frame TCRα rearrangement Vα26-
Jα8.2. 
In total, two in-frame TCRα chains were identified from 1 clone of animal 
302186; two in-frame TCRα chains were identified from 2 clones of animal 403992; 
one in-frame TCRα chain was identified from 1 clone of animal 403957 and one in-
frame TCRα chain was identified from 8 clones of animal 1011. Sequences of all the 
identified TCRα rearrangements are shown in Table 6-3. CD8 T cell clones from 
each individual showed unique TCRα chain usage, although they all have the same 
TCRβ chain. The observation that two different TCRα chains were used by two CD8 
T cell clones (3992.12 and 3992.8) from the same individual (403992) suggests they 
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Single-band PCR products for multiple Vα-specific primers were seen from some CD8 T cell clones 
including 2186.31 (A), 3957.11 (B), 3992.12 (C) and 3992.8 (D). From CD8 T cell clone 1011.35 (D), 
only one PCR product was observed and amplified using Vα26-specific primer.    
 
Figure 6.2 Illustration of TCRα expression analysis for Tp250-59 epitope-specific CD8 T cell 
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Table 6-3 Sequences of identified TCRα rearrangements for Tp250-59 epitope-specific CD8 T cell 
clones from different A10-homozygous individuals 
Both nucleotide and amino acid sequences for CDR3α, Vα and Jα gene usages are shown for defined 
Tp250-59 epitope-specific CD8 T cell clones from four A10-homozygous individuals. Clone identity is 
expressed as animal label followed by the clone label generated for the respective animal. Germline Jα 
gene segments within CDR3α region are underlined.  
 
6.3.2 Verification of the Tp250-59 epitope specificity for 
identified αβTCR heterodimers 
Having identified TCRα chains that are co-expressed with the Vβ28-
CASAEYGGENTQPLYF-Jβ3.2 TCRβ chain in the Tp250-59 epitope-specific CD8 T 
cell clones, the epitope specificity of the different TCR α and β chain pairs for the 
Tp250-59 epitope was investigated. Two constructs were initially generated using the 
same TCR β chain (TCRβ28) with the two TCRα chains, TCRα8 and TCRα13, 
identified from the same CD8 T cell clone 2186.31. The initial aim was to determine 
which of the two α chains conveyed epitope specificity. 
6.3.2.1 Generation of lentiviral-bovine TCR vectors 
A vesicular stomatitis virus glycoprotein (VSV-g)-pseudotyped HIV-based 
second-generation lentivirus expression system was employed for in vitro expression 
of the bovine TCR heterodimers. Before constructing lentiviral-TCR vectors, full-
length cDNAs of both defined TCR α and β chains were obtained through PCR 
amplification, cloning and sequencing as described in section 2.3.4.2. The cDNA and 
amino acid sequences of the selected cDNAs are shown in Appendix C. Figure 6.3 
shows a map of the lentiviral-TCR constructs. To obtain equivalent levels of TCR α-
Clone Vα FR CDR3 FR Jα 
2186.31 
8-f TGTGCTCTC C  A  L 
CTCCGTTCAGGCTGGCAACTG 
L  R  S  G  W  Q  L 
ACCTTTGGA 
T  F  G 22 
13-b TGTGCAGCA C  A  A 
AGTGACCGATCTAACTACAAGCTC 
S  D  R  S  N  Y  K  L 
ACCTTTGGA 
T  F  G 20 
3992.8 26-ae TGCATCCTG C  I  L 
ATGGAGAGTTCAGGCTGGCAACTG 
M  E  S  S  G  W  Q  L 
ACCTTTGGA 
T  F  G 22 
3992.12 12-f TGTGCAGTT C  A  V 
GACAGGGACAAACTC 
D  R  D  K  L 
ATCTTTGGG 
I  F  G 34 
3957.11 13-b TGTGCAGCA C  A  A 
AGTGCCAGCTACGGCCAGAAC 
S  A  S  Y  G  Q  N 
TATTTTGGG 
Y  F  G 49 
1011.35 26-i TGCATCCTG C  I  L 
ATGGCGGGTTATCAGAAACTC 
M  A  G  Y  Q  K  L 
ACATTTGGA 
T  F  G 8.2 
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chain and β-chain expression, an oligonucleotide encoding a self-cleaving peptide 
(T2A) was introduced to link the two full-length TCR cDNA transcripts; this also 
enabled gene expression to be controlled by the same promoter [Yang et al., 2008, de 
Felipe et al., 1999]. The lentiviral vector also incorporates a truncated human CD34 
gene (tCD34) downstream to the cloning site and linked with the TCR transgene 
cassette using another oligonucleotide encoding the P2A self-cleaving peptide 
derived from Porcine Teschovirus-1. The tCD34 gene was introduced as a reporter 
gene for detecting target gene expression and it also acts as a control for the activity 
of the target gene promoter. The tCD34 gene has been found as a naturally occurring 
splice variant of human CD34, with part of the cytoplasmic domain for signal 
transduction being deleted [Fackler et al., 1995]. Having no interference with 
physiological functions of target cells, the gene has been used as a maker for 







An HIV-based second-generation lentivirus 
vector was used to express bovine TCR α and β genes. The vector uses a SFFV promoter for driving 
gene expression and a tCD34 tag for transgene detection. Full-length transcripts of selected TCR α 
and β chains were obtained through PCR analysis as described in section 2.3.4.2. A single sequence 
includes a TCR α and a TCR β chain combined by a self-cleaving T2A peptide was designed and 
cloned into the lentiviral vector. Two lentiviral constructs were generated with two TCR α chains 
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Figure 6.3 Lentiviral constructs of bovine TCR.  
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6.3.2.2 Epitope specificity of bovine TCR transgenes 
Virus titre and transgene expression of bovine TCR were determined using the 
TCR- human leukemia Jurkat T cell line JRT3-T3.5 [Weiss and Stobo, 1984]. As 
shown in Figure 6.4, CD34 expression was detected for the lentiviral-TCR 
transgenes incorporating either of the TCR α chains, suggesting successful 
expression of the bovine TCR gene inserts. Virus titre was determined for both 
constructs as described in section 6.2.3. As shown in Figure 6.4C, virus titre for the 
TCR α13β28 construct was one log higher than that for the TCR α8β28 construct. 
Detection of cell surface expression of the epitope specific TCR transgene was 
initially examined by staining of the transduced Jurkat cells with 2*01201-Tp250-59 
tetramer. The cells were also stained with 2*01201-Tp249-59 and 2*01201-Tp298-106 
tetramers as controls. As shown in Figure 6.5, there was no detectable staining with 
any the tetramers of cells expressing either of the TCR transgenes. Despite the 
absence of tetramer staining, evidence of functional activity of the expressed TCR 
transgenes was investigated. Luciferase production was measured for the transduced 
Jurkat cells following stimulation with antigen presenting cells (APC, 592TA) loaded 
with peptide for the Tp250-59 epitope. As shown in Figure 6.6, cells expressing either 
TCR transgenes did not show significant increased luminescence activity upon 
stimulation with the Tp250-59 epitope, compared with APC alone or APC pulsed with 
the control Tp298-106 epitope. Stimulation with T. parva-infected A10-homozygous 
cells (592TpM) also did not result in an increase in luciferase activity. 
 In summary, although the CD8 T cell clones, from which the two TCRα chain 
were obtained, showed Tp250-59 epitope specificity and gave strong staining with the 
2*01201-Tp250-59 tetramer (data not shown), expression in Jurkat cells of transgenes 
incorporating the two TCR α and β chain combinations detected in the T cell clones 
did not result in detectable expression of a functional TCR, based either on tetramer 
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A and B, transduction of 
JRT-T3.5 cell line with serial diluted viral particles was performed according to section 6.2.3. 
Percentages of transgene expression cells were analysed using flow cytometry. Un-transduced cells 
are represented by grey dots and transduced cells are represented by black dots. C, virus titers for both 
lentiviral constructs were calculated from a dilution generating less than 30% of transgene-expressing 




Lentiviral construct Virus titer (TU/ml) 
TCR α8β28 2×105 
TCR α13β28 2×106 
Figure 6.4 Lentiviral transduction of Jurkat cells and virus titering.  
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Tetramer staining was performed according to section 2.2.9. Light grey histograms represent un-







Luciferase activity of TCR α8β28 and TCR 
α13β28 transduced JRT3-T3.5 cells were detected to evaluate the functional activity and confirm the 
epitope specificity of bovine TCR transgenes. Data were obtained from duplicate wells of one test for 
each condition and presented as average with standard deviation. Both TCR transgenes didn‟t show 
luciferase activity to the Tp250-59 epitope. 
 
Figure 6.6 Functional activity of TCR transgenes.  
Figure 6.5 Tetramer staining of transduced Jurkat cells to determine epitope specificity of 
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To investigate whether the failure to detect expression was a consequence of the 
particular TCRα chains selected, further experiments were undertaken to isolate and 
express full-length TCRα cDNA from other CD8 T cell clones. CD8 T cell clone 
1011.35 was initially chosen as a source of TCRα chain for generating the transgene 
construct. This T cell clone yielded a PCR product from only one of the TCRα 
primer pairs tested, suggesting expression of a single α chain. Full-length cDNA of 
the identified TCRα chain from clone 1011.35 was amplified, cloned and sequenced 
according to the description in section 2.3.4.2. The obtained TCRα26 (Vα26- 
CILMAGYQKLTF-Jα8.2) sequence was then constructed into a lentiviral-TCR 
α26β28 vector as described in the previous section. As shown in Figure 6.7, the TCR 
α26β28 transgene was successfully expressed following transduction of Jurkat cells. 
Approximately 85% of the transduced cells expressed CD34, of which about 60% 
showed specific staining with the 2*01201-Tp250-59 tetramer; no staining was 
detectable with Tp298-106 and Tp249-59 epitope-specific tetramers. Moreover, Tp250-59 
epitope stimulation of TCR α26β28 transgene expressing cells resulted in significant 
up-regulation of luciferase production comparing to stimulation with the control 
epitope Tp298-106 (P<0.05) or with APC alone (P<0.01). These results clearly 
demonstrated successful expression of bovine TCRα26β28 in Jurkat cells and 
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A, the TCRα26β28 transgene expression in transduced (black dots) Jurkat report cell line JRT3-T3.5. 
Un-transduced cells are shown as grey dots. Virus titer was determined as 2×105 TU/ml. B, tetramer 
staining of transduced Jurkat cells (dark grey histograms) showed the Tp250-59 epitope specificity. 
Light grey histograms represent un-transduced cells. C, luciferase activity of TCRα26β28 transduced 
Jurkat cells showed significant increase under the Tp250-59 epitope stimulation, comparing with empty 
APC (P<0.01) and the control Tp298-106 epitope (P<0.05). Data were obtained from duplicate wells of 
one test for each condition and presented as average with standard deviation. 
Figure 6.7 The TCRα26β28 transgene expression and its Tp250-59 epitope specificity.  
C – Functional activity of TCR α26β28 transgene 
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6.3.3 Lentiviral transduction of bovine CD8 T cells for 
epitope-specific TCR expression 
Verification that the bovine TCRα26β28 clonotype can be expressed in Jurkat 
cells and retains functional specificity for the immunogenic epitope Tp250-59 provided 
the basis to investigate in vitro transduction of bovine naïve CD8 T cells. However, 
the efficiency of lentiviral transgene system in bovine immune cells is still unknown. 
It is well established that lentiviral transduction is ineffective in resting cells. Hence, 
a protocol for pre-activating CD8 T cells was investigated before proceeding with 
lentivirus transduction.   
6.3.3.1 Activation of bovine CD8 T cells for lentiviral transduction 
Activation of bovine CD8 T cells purified (by MACS purification) from PBMC 
of both T. parva immunized and naive healthy cattle was carried out using anti-CD3 
(1µg/ml) and anti-CD28 (5µg/ml) monoclonal antibodies as described in section 
6.2.5. After 20 hours stimulation, cell cycles of un-stimulated and stimulated cells 
were analysed through DNA staining with Hoechst 33285 dye. According to the 
DNA content, cell cycle (approximately 24 hours) for a typical eukaryotic cell  can 
be divided into four discrete phases: M (mitosis, 4N), G1 (gap 1, cells in resting or 
preparing for DNA synthesis, 2N), S (synthesis, DNA replication, 2N-4N), and G2 
(gap 2, protein synthesis for mitosis, 4N) [Callard and Hodgkin, 2007]. As shown in 
Figure 6.8, in the absence of stimulation the cells only showedminimum level of cell 
activation, with more than 70% cells staying in G0/G1 (2N) phase after 20 hours 
culture in standard cell culture media. A small percentage (2.5%) of cells entered 
G2/M phase (4N). By contrast, nearly 60% cells entered G2/M phase after 20 hours 
stimulation with the anti-CD3 and anti-CD28 and 3.6% cells stayed in G0/G1 phase. 
More of the stimulated CD8 cells (38%) were in S phase than the un-stimulated cells 
(26%). These results confirmed the activation of bovine CD8 T cells by stimulation 
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bovine CD8 T cells were cultured with or without TCR stimulation for 20 hours and then stained with 
Hoechst 33285 for cell cycle analysis. A, cell cycle analysis of CD8 T cells before stimulation, 76% 
cells in G0/G1 phase (2N, blue), 17.6% cells in S phase (green) and 6% cells in G2/M phase (4N, red). 
B, for un-stimulated cells, >70% of cells in G0/G1 phase, a small amount increase was seen for S 
phase cells (25.8%) and only 2.5% cells in G2/M phase. C, for stimulated cells, proportion increased 
for G2/M phase cells (58.7%) and only 3.6% cells remained in G0/G1 phase, nearly 40% cells in S 
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6.3.3.2 Lentiviral transduction of pre-activated bovine CD8 T cells 
A preliminary experiment was carried out to transduce bovine CD8 T cells with 
lentiviral particles incorporating the TCRα26β28 transgene, after 20-24 hours 
stimulation (section 2.2.14). Transgene expression was monitored by examining cell 
surface expression of the reporter gene product tCD34 at 48 and 72 hours after 
transduction. The level of transgene expression appeared to be higher at 48 hours 
than at 72 hours. Therefore, transgene expression was detected at 48 hours after 
transduction of bovine CD8 T cells. The expression of CD34 on the lentiviral 
transduced bovine CD8 T cells is shown in Figure 6.9.  Cells transduced with 
pseudotyped lentivirus constructed with bovine TCRα13β28 transgene showed CD34 
expression on 23% of the cells. However, only 2% of the CD8 T cells transduced 
with TCRα26β28 transgene were detected as CD34 positive. It has been shown that 
virus titre for the TCRα26β28 construct was one log lower than that for the 
TCRα13β28 construct, which determines that MOI for transduction couldn‟t reach to 
the same level for the two constructs. As shown in Figure 6.9, MOI for the 
TCRα13β28 construct was 10 for transduction, while it was 5 for the TCRα26β28 
construct. This lower MOI might be the reason for lower level of TCRα26β28 
transgene expression. 
Staining of the CD8 T cells with the 2*01201-Tp250-59 tetramer was also carried 
out to detect cells expressing a Tp250-59–specific TCR. As shown in Figure 6.10, 
tetramer-positive cells were not detected in CD8 T cells transduced with either of the 
TCR transgenes. The results obtained with the CD8 T cells transduced with 
TCRα13β28 are consistent with those obtained with transduced Jurkat cells, which 
showed CD34 expression, but failed to stain with tetramers. For the TCRα26β28 
transgene, failure to detect tetramer positive cells may be due to the low expression 
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Activated bovine CD8 T cells were transduced with transgenes TCRα13β28 (up panel) and 
TCRα26β28 (low panel). Transgene expression was detected using anti-CD34 antibody. Dot plots of 
FACS analysis are shown. Grey dots represent un-transduced cells and black dots represent 







Histogram of FACS analysis are shown. Light grey histograms represent unstained cells and dark grey 
histograms represent stained cells. Tetramer positive populations were not detected from bovine CD8 
T cells transduced with any of the two αβTCR transgenes. 
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6.4 Discussion 
Appropriate functional differentiation of naïve antigen-specific CD8 T cells is 
believed to be critical for bovine CD8 T cell responses against T. parva infection. 
However, limited information is available for factors involved in the induction of T. 
parva-specific CD8 T cell responses. One limitation for further investigation is to get 
access to naïve antigen-specific CD8 T cells, which are generally present at 
extremely low frequency in the naïve pool. Therefore, the current study was setup 
aiming to evaluate the feasibility of generating bovine naïve antigen-specific CD8 T 
cells in vitro.  
For this purpose, the experiments described in this chapter have identified 
several TCRα chains from CD8 T cell clones specific for the Tp250-59 epitope, which 
express a conserved TCRβ chain. The use of a TCR clonotype that is conserved 
between animals would potentially allow transfer of in vitro expanded antigen-
specific transduced CD8 T cells into animals. Three pairs of TCR α and β chains 
were constructed into lentivirus-TCR constructs for transgene expression on target 
cells (i.e. bovine naïve CD8 T cells). Using a TCR- human T lymphocyte reporter 
cell line, the epitope specificity for one of the αβTCR construct was confirmed by 
tetramer staining and demonstration of functional activity. The identification of this 
functional αβTCR provides an important material for transferring antigen-specificity 
into bovine naïve CD8 T cells. Preliminary experiments, using lentivirus-TCR 
constructs, showed successful transduction of bovine CD8 T cells for TCR transgene 
transcription, although the level of transduction obtained with the functional 
construct was very low to achieve functional activity, probably because of 
insufficient lentivirus titre. These results indicate that with future optimization, the 
lentiviral transgene expression system would be suitable for delivering the defined 
TCR transgenes into bovine naïve CD8 T cells.  
For the identification of TCRα chains paired with the defined TCRβ clonotype,  
a PCR approach using a panel of Vα subgroup specific primers, designed and 
provided by Dr. Tim Connelley [Connelley et al., 2014], was applied to a number of 
CD8 T cell clones derived from 4 A10-homozygous cattle. Previous studies have 
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demonstrated that bovine TCRα repertoire contains many subgroups with multiple 
members of genes that have arisen by gene duplication [Connelley et al., 2014, 
Reinink and Van Rhijn, 2009]. The design of primers that will reliably amplify all 
members of a duplicated subgroup and retain specificity for that subgroup is difficult. 
To achieve the former, it was necessary in some cases to accept cross-reactivity of 
primer sets with members of other groups. Therefore, the identity of the amplified 
TCRα chain V subgroups could be deduced with certainty from sequencing of the 
PCR products. This lack of subgroup specificity accounted for the detection of clones 
that yielded PCR products with more than two primer sets. Sequencing of PCR 
products obtained from individual T cell clones revealed cross-reactivity of the Vα9 
PCR primer with a member of Vα13 subgroup, the Vα26 PCR primer with Vα4. As 
observed in other species [Han et al., 2014, Padovan et al., 1993], examples of clones 
exhibited two TCRα chain rearrangements, both of which were full open reading 
frames (e.g. 2186.31), were found. Single TCRα rearrangements were identified for 
other examined clones and different individuals tend to have different TCRα chain 
usages. The observation of two CD8 T cell clones from the same animal (403992 and 
both can pair with the same TCRβ chain) having different TCR α chains indicates  
that the component of the Tp250-59-specific CD8 T cells expressing the Vβ28-
CASAEYGGENTQPLYF-Jβ3.2 β chain rearrangement in this animal arose from at 
least two independently generated clones in the naïve T cell repertoire.  
Expression of the same two recombined TCRα chains was observed for multiple 
clones from animal 302186. This would imply that these clones are highly likely to 
have arisen from the same rearranged CD8 T cell in the naïve T cell repertoire. Since 
only one TCRα rearrangement is likely to form the functional αβTCR heterodimer 
specific for the Tp250-59 epitope, experiments were undertaken to identify which 
TCRα chain conveyed the functional specificity and thus could be used for transgene 
expression. A third TCRα chain, which is expressed by CD8 T cell clones from 
animal 1011 and only yielded a PCR product with one of the Vα subgroup PCR 
primers, was chosen for the transduction experiments. For generating lentiviral-TCR 
constructs, full-length cDNA for TCR α and β chains were obtained and sequenced 
to confirm that no PCR errors were introduced into the constructs. 
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A TCR- transformed human T cell line, referred to as Jurkat cell line JRT3-T3.5, 
was initially used for transgene expression. The cell line expresses a luciferase 
reporter gene, under the transcriptional control of NFAT (nuclear factor of activated 
T cells)-responsive elements, which is activated upon stimulation via the TCR 
resulting in expression of the luciferase gene [Aarnoudse et al., 2002]. Both tetramer 
staining and luminescence activity of transduced reporter cells were used to 
determine the epitope specificity and functionality of the three αβTCR transgenes. 
The first two pairs of αβTCR heterodimer didn‟t elicit detectable responses to the 
defined Tp250-59 epitope, while the TCRα26β28 construct (from CD8 T cell clone 
1011.35) showed clear specificity for the Tp250-59 epitope from both tetramer staining 
and the functional assay. Nearly 60% of the TCRα26β28 transduced Jurkat cells 
were positively stained with the Tp250-59 tetramer (Figure 6.7B). Moreover, 
transduced cells showed specific activation in response to the Tp250-59 epitope, but 
not to the control epitope or APC alone (Figure 6.7C). Confirmation of epitope 
specificity and functional competence of the TCRα26β28 construct provided proof of 
concept for further experiments to transduce bovine CD8 T cells. 
The reasons are unclear for lack of functional expression of the other two α/β 
TCR constructs, which utilised two apparently functional α chains from the same 
CD8 T cell clone. However, lack of CD8 expression on the reporter cells and/or 
possibly low TCR affinity might result in the failure of detection, since both tetramer 
staining and activation of some T cells is dependent on CD8 [Laugel et al., 2007, 
Wooldridge et al., 2005]. In a study using tetramers incorporating modified MHC I 
heavy chains unable to interact with CD8, epitope-specific CD8 T cells with high 
functional avidity TCRs could be detected but not CD8 T cells with low avidity 
TCRs [Choi et al., 2003].  
Nevertheless, identification of one bovine αβTCR heterodimer with antigen 
specificity and functional responsiveness allowed initiation of preliminary 
experiments to transduce bovine CD8 T cells. The efficiency of TCR transgene 
expression using lentiviral transfer system was primarily examined in activated CD8 
T cells. Successful transduction of bovine CD8 T cells at the transcriptional level,  
based on expression of the CD34 reporter gene, was confirmed for the construct 
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TCRα13β28. However, expression of a functional TCR on the cell surface of the 
transduced CD8 T cells was not detectable by tetramer staining. This is consistent 
with the tetramer staining result of TCRα13β28 transduced Jurkat cells. For the 
TCRα26β28 construct with confirmed functional specificity to the Tp250-59 epitope, 
low level (2%) of transgene expression was detected on transduced CD8 T cells. 
Potential reason could be the lower virus titre (a log lower than the virus titre of 
TCRα13β28 construct), which resulted in lower MOI for CD8 T cell transduction. 
Functional TCR was also not detected from TCRα2628 transduced CD8 T cells by 
tetramer staining. Except for the low level of transgene expression, other factors 
including mis-pairing with endogenous TCR chains and competition with 
endogenous TCRs for surface expression could all interfere with the functional 
detection of expressed TCR transgene [Daniel-Meshulam et al., 2012, Okamoto et al., 
2009].. 
For future studies, optimisation of virus production conditions to increase virus 
titre would be necessary. It has been reported that various factors, including time of 
harvest after transfection, lentiviral vector stability, cell type and transfection 
methods and use of medium additives, can influence the yield of lentivirus obtained 
[Ansorge et al., 2010]. In terms of the efficiency of lentiviral transduction of CD8 T 
cells, various strategies have been proposed to improve TCR transgene stability and 
correct pairing, such as introducing a second disulphide bond into the constant 
regions of TCR α and β chains to enhance pairing, knocking down expression of the 
endogenous TCR chains to avoid pairing with the expressed transgenes and 
increasing CD3 expression [Daniel-Meshulam et al., 2012]. In a recently developed 
system, human hematopoietic progenitor cells (CD34+ cells) were used for 
transduction of antigen-specific TCRs and agonist peptides were used to inhibit 
endogenous TCR expression of transduced cells. This method showed high 
efficiency with nearly all generated naïve CD8 T cells expressing the single TCR 
transgene [Snauwaert et al., 2014]. Previous work from Niku et al has produced an 
anti-bovine CD34 antibody, which was later used to identify a CD34 expressing 
population with features of hematopoietic progenitor cells from bovine foetal and 
adult bone marrow [Niku et al., 2007, Pessa-Morikawa et al., 2012]. Building on 
 
  163 
Doctor of Philosophy – The University of Edinburgh – 2015 
these developments, future work exploring the usage of bovine T cell progenitors for 
TCR transgene expression would be of help to generate bovine naïve antigen-specific 
CD8 T cells in vitro. 
Overall, results in this chapter present the identification of a first reported bovine 
αβTCR heterodimer with functional specificity to the Tp2 antigen of T. parva. 
Although extensive work will be required for final generation of bovine naïve 
antigen-specific CD8 T cells, studies in this chapter provide the necessary material 
and evidence for applying lentiviral transduction approach to bovine T cells.  
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Chapter 7: General discussion 
Previous studies demonstrated that the T. parva antigen Tp2 induces highly 
dominant CD8 T cell responses in BoLA-A10 homozygous cattle immunised by 
infection and treatment against T. parva [MacHugh et al., 2009]. Three epitopes 
presented by the same MHC I allele, BoLA 2*01201, have been identified in this 
antigen. This project was set up to: (i) investigate the immunodominance hierarchy 
of these three Tp2 epitopes in A10+ cattle and to determine the predictability of the 
antigenic specificity of CD8 T cell responses in a larger number of animals; (ii) 
examine the clonal composition of the epitope-specific populations by employing 
TRB gene sequencing, to determine the diversity of the responses and whether the 
TRB chain rearrangements show any evidence of conservation; (iii) establish 
protocols for expressing functional TCRs in cultured cells by lentivirus transduction 
with cloned full-length TCR α and β chain cDNAs. Results obtained from these 
studies had the following significant outcomes. 
(1) A marked difference in the epitope dominance hierarchy detected in 
A10-homozygous and A10-heterozygous cattle. The Tp2 epitope specificity of 
CD8 T cell responses were examined in 11 cattle, including 5 A10-homozygous and 
6 A10-heterozygous animals, by generation of CD8 T cell lines and staining with 
class I MHC tetramers. The responses of the A10-homozygous animals were 
remarkably consistent, all 5 animals responding to all 3 epitopes with the Tp249-59 
epitope consistently the most dominant. By contrast, the 6 A10-heterozygous animals 
failed to respond to the Tp249-59 and Tp250-59 epitopes and 2 of the animals did not 
have detectable responses to any of the 3 defined Tp2 epitopes. Analyses of the in 
vivo responses in 2 homozygous and 2 heterozygous animals showed that epitope 
dominance hierarchy reflected that observed in vitro and demonstrated that CD8 T 
cells specific for the dominant epitopes represented 2-8% of the CD8 T cells at the 
peak of the response. Attempts to detect epitope-specific T cells in the two animals 
that did not have a detectable response to Tp2, by sorting of low frequency CD8 T 
cells with pMHC I tetramers, did not detect any positive cells. Based on these 
experiments, it was estimated that epitope-specific CD8 T cells (if present) are at a 
frequency of less than 1/105. These results clearly demonstrate that the co-expression 
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of other MHC I alleles along with those on the A10 haplotype profoundly alters the 
specificity of the response, such that the A10-heterozygous animals examined were 
unable to generate CD8 T cell responses against the Tp249-59 and Tp250-59 epitopes. 
(2) TRB repertoire analyses detected markedly expanded clonotypes within 
the specific responses and identified TRB gene rearrangements that were 
conserved or partially conserved between animals. Analyses of the sequences of 
TRB chains expressed by the epitope-specific CD8 T cells, following amplification 
by a template-switch anchored RT-PCR, demonstrated a broadly similar population 
structure for the different specificities, each population containing 1-3 highly 
expanded dominant TRB clonotypes along with variable numbers of low-abundant 
clonotypes. Of particular interest was the detection of semi-conserved TRB 
clonotypes in the Tp298-106-specific CD8 T cell populations of different animals and a 
completely conserved TRB clonotype, expressing the Vβ28-
CASAEYGGENTQPLYF-Jβ3.2 rearrangement, in the Tp250-59-specific populations 
from all 5 A10-homozygous cattle examined.   
(3) Establishment of a method to detect epitope-specific CD8 T cells ex vivo 
by high-throughput sequencing of TRB. The use of TRB clonotype analyses to 
detect epitope-specific T cells in different immune individuals is hampered due to the 
diversity and generally „private‟ TRB specificities within CD8 T cell repertoires. 
Using the identified „public‟ TRB sequence as a marker for Tp250-59-specific CD8 T 
cell populations, an attempt was made to use HTS analysis to examine the potential 
role of TCR repertoires in alterations of immunodominance hierarchies – a potential 
explanation for the failure of A10-heterozygous cattle to respond to this epitope 
Tp250-59. Although technically successful the results from a validation trial suggested 
that the methodology would not enable definitive conclusions to be made. 
(4) Reagents and methods established to generate cultured cells expressing 
functional epitope-specific TCRs. Several functional TCR α chains co-expressed 
with the conserved Vβ28-CASAEYGGENTQPLYF-Jβ3.2 β chain in CD8 T cell 
clones specific for the Tp250-59 epitope were identified and lentivirus constructs were 
generated with three of the α and β chain pairs to investigate expression. Lentivirus 
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transduction of Jurkat cells resulted in expression of all 3 gene pairs and one 
construct (TCRα26β28) was confirmed to express functional TCR on the cell surface, 
confirmed by responsiveness to the Tp250-59 epitope. This is the first report of 
successful expression of a functional bovine αβTCR by lentivirus transduction. 
Preliminary experiments of lentiviral transduction of bovine CD8 T cells 
demonstrated transgene expression by the transduced cells, confirming successful 
introduction of the genes into bovine CD8 T cells, but there was insufficient time to 
fully investigate surface expression of the functional proteins. 
Results of this project provided clear quantitative data on the epitope dominance 
hierarchy of the three defined Tp2 epitopes in T. parva–immunised Holstein cattle 
expressing the A10 MHC I haplotype. The findings represent progress towards 
understanding the immunodominant CD8 T cell responses against T. parva. Further 
investigation will be required to discover the mechanistic basis of the Tp2 epitope 
dominance hierarchy.  
One question raised from the observed difference in epitope dominance between 
A10-homozygous and -heterozygous cattle is whether it reflects a difference in 
antigen processing that alters presentation of the defined Tp2 epitopes in parasite 
infected A10-heterozygous cells. Proteasome activities, TAP and endoplasmic 
reticulum aminopeptidase (ERAP) have all been demonstrated to influence the 
generation of epitopes [Tenzer et al., 2009]. Future experiments to examine the 
ability of parasitized A10-heterozygous cells to generate and present Tp249-59 and 
Tp250-59 epitopes, and to determine the epitope abundance on cell surface, will be 
required to understand the effect of non-restriction MHC I haplotypes on epitope 
processing.   
The frequency of antigen-specific T cell precursors in the naïve TCR repertoire, 
the clonotype composition of the repertoire and the differentiation of responding 
CD8 T cells to establish memory populations, have all been reported to have 
profound influences on CD8 T cell responses against a number of viruses [La Gruta 
and Turner, 2014, Appay et al., 2008]. Analyses of the TCRβ chains expressed by 
samples of epitope-specific CD8 T cells in the current study revealed biased Vβ13.5 
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gene usage by T cells specific for the Tp298-106 epitope and a conserved TRB 
clonotype specific for the Tp249-59 epitope. However, to more fully understand the 
role of TCR repertoire in determining epitope dominance hierarchy and the 
difference between A10-homozygous and –heterozygous cattle, further experiments 
are required to address the following questions. 
(i) What are the frequencies of CD8 T cell precursors specific for the three 
defined Tp2 epitopes in the naïve pool of CD8 T cells in A10-homozygous and –
heterozygous animals and do the frequencies correlate with the epitope specificities 
of the responses induced by immunisation? There is evidence that the frequency of 
naïve T cell precursors can be a predictor of the magnitude of epitope-specific CD8 
T cell responses in several virus disease models [Tan et al., 2011, Kotturi et al., 
2008]. Techniques such as direct pMHC I tetramer enrichment [Obar et al., 2008] or 
indirect approach by comparing the expansion rate of endogenous and adoptively 
transferred titrated naïve epitope-specific CD8 T cells [Blattman et al., 2002] would 
allow the quantification of naïve CD8 T cell precursor for a given T. parva epitope. 
(ii) Does the diversity of TCR clonotypes within the repertoires of responding 
CD8 T cells influence the immunodominance hierarchy of the three defined Tp2 
epitopes? A direct correlation between TCR diversity and immunodominance status 
of viral derived epitopes has been reported in responses to human and mouse 
pathogens [Balamurugan et al., 2010, Messaoudi et al., 2002]. Current approaches 
involving fluorescence-activated cell sorting of cells stained with peptide-MHC I 
multimers (tetramer or dextramer) allow rapid purification of epitope-specific CD8 T 
cells present at low frequencies [Tario et al., 2015, Wooldridge et al., 2009]. The 
development of PCR and sequencing techniques, such as the template-switch 
anchored RT-PCR, single-cell PCR and next-generation sequencing, now facilitate 
greater depth analysis of TCR repertoires [Shugay et al., 2014, Han et al., 2014]. 
With the establishment of these methods, a complete view of antigen-specific CD8 T 
cell repertoires can be achieved. 
(iii) What factors are involved in the activation and differentiation of 
antigen-specific CD8 T cell precursors and how do they influence the epitope 
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dominance hierarchy? The importance of cross-priming, predominantly mediated by 
dendritic cells (DCs), for induction of primary CD8 T cell responses against viral 
infections is well recognised [Smed-Sorensen et al., 2012, Wilson et al., 2006, Heath 
and Carbone, 2001a]. A recent study of human CD8 T cell responses against HIV 
antigens demonstrated that cross-presentation of viral antigens by DCs and 
macrophages favoured CD8 T cell responses to immunodominant epitopes [Dinter et 
al., 2015]. Work is being carried out by other members of the Roslin group to 
establish an in vitro model to investigate the functional role of DC-mediated cross-
presentation to T. parva-specific CD8 T cells. Access to bovine naïve CD8 T cells 
would allow the requirements for the activation of T. parva antigen-specific CD8 T 
cell responses to be investigated using this cross-priming model.  
Overall, work in the current study showed clear evidences for epitope 
dominance variation among cattle expressing the restriction MHC I haplotype. The 
unique feature of this system, i.e. three epitopes derived from the same antigen and 
presented by the same MHC I allele, indicates the major influence of antigen-specific 
CD8 T cells on epitope dominance variation. The verification of a conserved TCRβ 
chain specific for the Tp250-59 epitope enables the detection of epitope-specific CD8 
T cells directly ex vivo from purified CD8 T cells, although the method still requires 
further validation. With the identified bovine αβTCR heterodimer specific for the 
Tp2 antigen of T. parva, future optimization of the lentivirus production and attempt 
to transduce bovine naïve CD8 T cells or haematopoietic progenitor cells would 
greatly facilitate the in vitro generation of bovine naïve antigen-specific CD8 T cells. 
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Appendices 
Appendix A. Solutions and medium 
Standard Culture Medium (SCM)  
RPMI 1640 medium + 25mM HEPES + L-glutamine (Life Technologies, UK)  
10% (heat inactivated) foetal bovine serum (Life Technologies, UK) 
100U/ml penicillin, 100Pg/ml streptomycin, 293Pg/ml L-glutamine (penicillin-
streptomycin-glutamine 100 x solution) (Life Technologies, UK) 
5 x 104M 2-mercaptoethanol 
 
RBC Lysis Buffer 
Trizma base 10.6g (0.175M) 
0.175M TRIS pH adjusted to 7.4 with concentrated HCl and made up to a volume of 
0.5L with Double-distilled water (DDW) 
Ammomium chloride 8.55g (0.16M) 
Made up to a volume of 1L with DDW. 
RBC lysis buffer consists of 1 part 0.175M TRIS pH7.4 and 9 parts 0.16M 
ammonium chloride. Filter sterilized using 0.45µmminisart single-use filter 




Phosphate Buffered Saline (PBS) 
Sodium chloride 170.0mM 
Potassium chloride 3.4mM 
Sodium phosphate, dibasic 9.2mM 
Potassium phosphate, monobasic 1.8mM 
pH6.8  
RPMI 1640 medium + 25mM HEPES + L-glutamine (Life Technologies, UK) 
2% (heat inactivated) foetal bovine serum (Life Technologies, UK) 
0.2% Sodium Azid  
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MACS Medium 
PBS + 0.5% bovine serum albumin (BSA) + 2mM EDTA 
 
DMEM Medium  
DMEM medium + 4.5g/L D-Glucose + L-glutamine (Life Technologies, UK) 
10% (heat inactivated) foetal bovine serum (Life Technologies, UK) 
100U/ml penicillin, 100Pg/ml streptomycin, 293Pg/ml L-glutamine (penicillin-
streptomycin-glutamine 100 x solution) (Life Technologies, UK) 
 
SOC Broth (Super Optimal broth with Catabolite repression) 
Tryptone 20.00g 
Yeast extract 5.00g 
Sodium chloride 0.50g 
Potassium chloride 0.19g 
Glucose 4.00g 
pH adjusted to 7.0 with 5M sodium hydroxide, made up to a volume of 1L with 
DDW and autoclaved 
 
Loading Buffer for Agarose Gel Electrophoresis 
 
Tris-acetate/EDTA electrophoresis buffer (TAE) 50× stock 
Trizma base 242g (2M) 
Glacial acetic acid 57.1ml (2M) 




Yeast extract 5.00g 
15% w/v Ficoll (Type 400) in DDW with bromophenol blue (0.25 v/v) and xylene 
cyanol (0.25%) dyes 
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Sodium chloride 10.00g 
pH adjusted to 7.0 with 5M sodium hydroxide, made up to a volume of 1L with 
DDW and autoclaved 
LB Agar plates 
LB broth added with Agar (15g/L) pH adjusted to 7.0 with 5M sodium hydroxide 
made up to a volume of 1L with DDW and autoclaved 
Upon use, LB agar was melted and ampicillin added to give a final concentration of 
100µg/ml. approximately 20mls of media was poured into sterile Petri dishes and 
allowed to set and dry. If LB/IPTG/X-Gal plates were required for blue/white colony 
selection, 20µl of 0.1M IPTG (Isopropyl β-D-1-thiogalactopyranoside) and 20µl of 
50mg/ml X-Gal (5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside) were applied to 
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Sequences of TRB repertoires specific for the 3 defined Tp2 epitopes derived from three A10-homozygous A) and three A10-heterozygous 
B) cattle are shown in the standardised format: identified Vβ and Jβ gene segments, flanking sequences of CDR3β and CDR3β itself. 
Number and frequency of encoding nucleotide sequences for each clonotype are shown. Dominant clonotypes for each of the nine CD8 T 
cell populations are shaded. Nucleotides and amino acid substitutions within germline gene component of CDR3β region are in red font 
and substitutions within junction regions of CDR3β are in purple font and underlined. Germline Jβ gene components of CDR3β are 
underlined. Germline Dβ gene components of CDR3β are in blue font. Sequences with the same Vβ and Jβ gene segments but different 
CDR3β sequences are in brown font. The one clonotype identified from both Tp249-59 and Tp250-59 epitope-specific CD8 T cell populations 






Appendix B. Sequences of TRB clonotypes identified from Tp2 epitope-specific CD8 T 
cell populations.  
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Sequence Number of 
sequence 
Frequency 
(%) Animal Vβ FR CDR3β FR Jβ 
Tp249-59 14 
TGTGCCAGC 
C  A  S 
AGTCGGTACGCAGGGCCAGAGACGCTG 
S  R  Y  A  G  P  E  T  L 
TACTTCGGC 
Y  F  G 2.4 25 34.2 302186 
16 TGTGCCAGC C  A  S 
AGCCTACAGCCTTTCTATGACTAT 
S  L  Q  P  F  Y  D  Y    
CACTTCGGC 
H  F  G 1.2 43 58.9 302186 
16  AGCCTACAGCCTTTCTATGTCTAT S  L  Q  P  F  Y  V  Y 
 1.2 4 5.5 302186 
16  AGCCTACAGCCTTTCTATGGCTAT S  L  Q  P  F  Y  G  Y 
 1.2 1 1.4 302186 
4.3 TGCAGTGCT C  S  A 
ACGAGAGGAGGACGGGAGGACTAT 
T  R  G  G  R  E  D  Y 
CACTTCGGCH  
F  G 1.2 2 2.4 403992 
14 TGTGCCAGC C  A  S 
AGTGAATGGAACACAAATGGGCCCCTG 
S  E  W  N  T  N  G  P  L 
TACTTTGGA 
Y  F  G 3.2 33 39.8 403992 
14  AGTGGATGGAACACAAATGGGCCCCTG S  G  W  N  T  N  G  P  L 
 3.2 1 1.2 403992 
28 TGTGCCACG C  A  T 
GCTGCAGATCTCGACGACAACCCTCTG  
A  A  D  L  D  D  N  P  L 
TATTTTGGA 
Y  F  G 3.3 46 55.4 403992 
28 TGTGCCACG C  A  T 
GCTGCAGATCTCGACGACGACCCTCTG 
A  A  D  L  D  D  D  P  L 
TATTTTGGA 
Y  F  G 3.3 1 1.2 403992 
7.2 TGCGCCAGC C  A  S 
AGTAGAGATCTAGTCGCAGAGACGCTG 
S  R  D  L  V  A  E  T  L 
TACTTCGGC 
Y  F  G 2.4 23 44.2 403957 
7.2 TGCGCCAGC C  A  S 
AGTACCGTGACAGCTCAGATCCAG 
S  T  V  T  A  Q  I  Q 
TACTTCGGG 
Y  F  G 3.5 12 23.1 403957 
10.2 TGTGCCAGC C  A  S 
AGCCAGGCTGAAGTCTCTGGGGGGGCACCTTGGATCCCTCTG 
S  Q  A  E  V  S  G  G  A  P  W  I  P  L 
TATTTTGGA 
Y  F  G 3.3 1 1.9 403957 
12.1 TGCGCCAGC C  A  S 
AGTTACGGGGGGAGCGGTTCCTATGAGCAG 
S  Y  G  G  S  G  S  Y  E  Q 
TATTTCGGC 
Y  F  G 3.7 16 30.8 403957 
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Sequence Number of 
sequence 
Frequency 
(%) Animal Vβ FR CDR3β FR Jβ 
Tp250-59 1.8 
TGTGCCAGC 
C  A  S 
AGCCAGGATCCAGAGACGCTG 
S  Q  D  P  E  T  L 
TACTTCGGG 
Y  F  G 2.4 25 28.7 302186 
2.7 TGTGGTGCT C  G  A 
AGAGGATTAGGGGAGGTT 
R  G  L  G  E  V 
TTCTTTGGA 
F  F  G 1.1 3 3.4 302186 
28 TGTGCCAGC C  A  S 
GCTGAATATGGGGGGGAGAACACCCAGCCCCTG 
A  E  Y  G  G  E  N  T  Q  P  L 
TACTTTGGA 
Y  F  G 3.2 58 66.7 302186 
28 TGTGCCAGC C  A  S 
GCTGAATATGGGGGGAAGAACACCCAGCCCCTG 
A  E  Y  G  G  K  N  T  Q  P  L 
TACTTTGGA 
Y  F  G 3.2 1 1.1 302186 
1.3 TGTGCCAGC C  A  S 
AGCCCGCTTGGGGGGTATCGAAGCGCCGTGCAGCTG 
S  P  L  G  G  Y  R  S  A  V  Q  L 
TACTTTGGA 
Y  F  G 2.2 1 1.2 403992 
5 TGTGCCAGC C  A  S 
GTCTCGCCTGGTGGGGACTAT 
V  S  P  G  G  D  Y 
CACTTCGGC 
H  F  G 1.2 83 98.8 403992 
7.2 TGCGCCAGC C  A  S 
AGTAGAGATCTAGTCGCAGAGACGCTG 
S  R  D  L  V  A  E  T  L 
TACTTCGGC 
Y  F  G 2.4 5 7.9 403957 
12.1 TGCGCCCAG C  A  Q 
CATTCTTCGCGGGAGCAG 
H  S  S  R  E  Q 
TATTTCGGC 
Y  F  G 3.7 58 92.1 403957 
Tp298-106 13.5 TGTACCAGC C  T  S 
AATTTGGGGGGCCTGGACCTGGGCACTCAG 
N  L  G  G  L  D  L  G  T  Q 
TACTTCGGC 
Y  F  G 2.3 72 98.6 302186 
13.5 TGTACCAGC C  T  S 
ACATTTGGGGGGTGGGCCCTCGAGACGCTG 
T  F  G  G  W  A  L  E  T  L 
TACTTCGGG 
Y  F  G 2.4 1 1.4 302186 
4.3 TGCAGTGCT C  S  A 
GGTTCGGGCTATGAGCAG 
G  S  G  Y  E  Q 
TATTTCGGc 
Y  F  G 3.7 42 71.2 403992 
14 TGTGCCAGC C  A  S 
AGTCCGGGACTGGGGGTTCAGATCCAG 
S  P  G  L  G  V  Q  I  Q 
TACTTCGGG 
Y  F  G 3.5 12 20.3 403992 
15.2 TGTGCCAGC C  A  S 
AATGCAGGGCAGCAGGGGGGCACCCAGCCCCTG 
N  A  G  Q  Q  G  G  T  Q  P  L 
TACTTTGGA 
Y  F  G 3.2 5 8.5 403992 
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Sequence Number of 
sequence 
Frequency 
(%) Animal Vβ FR CDR3β FR BJ 
Tp298-106 1 
TGTGCCAGC 
C  A  S 
AGTGTTCGGGGGGGAGACACGCAG 
S  V  R  G  G  D  T  Q 
TACTTCGGC 
Y  F  G 2.3 1 1.2 403957 
1.7 TGTGCCAGC C  A  S 
AGCCAAGATTATGGCGCGACGCTG 
S  Q  D  Y  G  A  T  L 
TACTTCGGG 
Y  F  G 2.4 1 1.2 403957 
12.1 TGCGCCACG C  A  T 
CTAATTCTTGCGCGGGAGCAG 
L  I  L  A  R  E  Q 
TATTTCGGC 
Y  F  G 3.7 1 1.2 403957 
13.5 TGTACCAGC C  T  S 
AGTCGGGGGGGGCGAATAGATGGGGAGCTG 
S  R  G  G  R  I  D  G  E  L 
CACTTCGGG 
H  F  G 3.1 3 3.7 403957 
13.5 TGTACCAGC C  T  S 
AGTCCGGGGGGGGGGCGAATAGATGGGGAGCTG 
S  P  G  G  G  R  I  D  G  E  L 
CACTTCGGG 
H  F  G 3.1 1 1.2 403957 
13.5 TGTACCAGC C  T  S 
ACATTGGGGGGGATCGTCTATGAGCAG 
T  L  G  G  I  V  Y  E  Q 
TATTTCGGC 
Y  F  G 3.7 68 82.9 403957 
14 TGTGCCAGC C  A  S 
AGTGAACGGTTCGGGGGGGATGGGAACAACCCTCTG 
S  E  R  F  G  G  D  G  N  N  P  L 
TATTTTGGA 
Y  F  G 3.3 6 7.3 403957 
14 TGTGCCAGC C  A  S 
AGTCCCCAGTTCGGGGGGGGGCATCCCACTCAGATCCAG 
S  P  Q  F  G  G  G  H  P  T  Q  I  Q 
TACTTCGGG 
Y  F  G 3.5 1 1.2 403957 
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B) Sequences of Tp298-106 epitope-specific TRB clonotypes from three A10-heterozygous cattle 
 
Epitope 
Sequence Number of 
sequence 
Frequency 
(%) Animal Vβ FR CDR3β FR BJ 
Tp298-106 1.5 
TGTGCCAGC 
C  A  S 
AGCGAATATCCTCGGGGGGGGCATAGCAACCCTCTG 
S  E  Y  P  R  G  G  H  S  N  P  L 
TATTTTGGA 
Y  F  G 3.3 2 2.7 102121 
4.3 TGCAGTGCT C  S  A 
GGATCATGGGAGTCAGAGACGCTG 
G  S  W  E  S  E  T  L 
TACTTCGGG 
Y  F  G 2.4 1 1.4 102121 
7 TGCGCCAGC C  A  S 
AGCTCGGGCTTCGGGGGTGATGACACGCAG 
S  S  G  F  G  G  D  D  T  Q 
TACTTCGGC 
Y  F  G 3.4 13 17.6 102121 
13.5 TGTACCAGC C  T  S 
AGTTTGGGGGGTCCGTACTCAGAGACGCTG 
S  L  G  G  P  Y  S  E  T  L 
TACTTCGGG 
Y  F  G 2.4 57 77.0 102121 
20.1 TGTGCCTGG C  A  W 
ACTTCGGGGGGATGGAACAACCCTCTG 
T  S  G  G  W  N  N  P  L 
TATTTTGGA 
Y  F  G 3.3 1 1.4 102121 
13.5 TGTACCAGC C  T  S 
AGTCTCAGCGGGGAGACGCTG 
S  L  S  G  E  T  L 
TACTTCGGG 
Y  F  G 2.4 2 2.3 102170 
13.5 TGTACCAGC C  T  S 
AACCTGGGGGGCATCACAGACACGCAG  
N  L  G  G  I  T  D  T  Q 
TACTTCGGC 
Y  F  G 3.4 84 97.7 102170 
4.3 TGCAGTGCT C  S  A 
CCCGGGACCGAGGGCTATGAGCAG 
P  G  T  E  G  Y  E  Q  
TATTTCGGC 
Y  F  G 3.7 24 28.2 402082 
4.6 TGCAGTGCC C  S  A 
GGGGGGGACAGCTATGAGCAG 
G  G  D  S  Y  E  Q  
TATTTCGGC 
Y  F  G 3.7 12 14.1 402082 
13.5 TGTACCAGC C  T  S 
AGTTTGGACAGCCTCCGGGGCTAT 
S  L  D  S  L  R  G  Y 
CACTTCGGC 
H  F  G 1.2 10 11.8 402082 
13.5 TGTACCAGC C  T  S 
AGTCAGGACCCGCATTCGGGAGGGAACACCCAGCCCCTG 
S  Q  D  P  H  S  G  G  N  T  Q  P  L  
TACTTTGGA 
Y  F  G 3.2 39 45.9 402082 
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CDR3β sequences defined through identification of the three nucleotides encoding the conserved amino acid Cys (C) located towards 
the 3‟ end of the V gene segment and the three nucleotides encoding the conserved amino acid Phe (F) in 5‟ end of the J gene segment were 
used for PCR and sequencing error correction, in order to define the real clonotype diversity. Low-abundant clonotypes with PCR and/or 
sequencing errors that can be safely corrected are shown in Table C-1; those clonotypes with nucleotide variants in gene junctions and 
clonotypes with more than 3 errors are shown in Table C-2. Number of sequencing reads, CDR3β amino acid sequences and CDR3β 
nucleotide sequences are shown in the first, second and third column. Vβ, Jβ and identifiable Dβ germline gene components of  CDR3β are 
shown in the last three columns. The dominant “core clonotype”, which determines the nucleotide sequence of the final clonotype, is 
shown in bold with identified Vβ (orange), Dβ (blue) and Jβ (green) gene components. Corrected errors (red font and bold) within CDR3β 





Appendix C. A typical example of PCR and sequencing error correction for clonotypes 
extracted from Illumina sequencing reads 
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CDR3β, amino acid 
sequences CDR3β, nucleotide sequences Vβ  Jβ Dβ 
3343 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
25 CASDPSGGANAQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACGCCCAGCCCCTGTACTTT 28 3.2 3 
21 CASDPAGGANTQPLYF TGTGCCAGCGACCCTGCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
17 CASDPSGGANTQPLYF TGTGCCAGCGACCCGTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
10 CASDPSGGANPQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACCCCCAGCCCCTGTACTTT 28 3.2 3 
6 CASDPTGGANTQPLYF TGTGCCAGCGACCCTACGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
5 CASDPSGGASTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAGCACCCAGCCCCTGTACTTT 28 3.2 3 
5 CASDPSGGAITQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGATCACCCAGCCCCTGTACTTT 28 3.2 3 
5 CASDPSGGANTQPLDF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGGACTTT 28 3.2 3 
4 CASDPSAGANTQPLYF TGTGCCAGCGACCCTTCGGCGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
4 CASDPSGGANTQPLYF TGTGCCAGCGACCCCTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CVSDPSGGANTQPLYF TGTGTCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCTGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSVGANTQPLYF TGTGCCAGCGACCCTTCGGTGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSGGANTQPLDF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGGACTTT 28 3.2 3 
2 CASDPLGGANTQPLYF TGTGCCAGCGACCCTTTGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
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2 CASDPSGGANTQPLCF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTGCTTT 28 3.2 3 





CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ  Jβ Dβ 
2 CASDPSGGANTQPRYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCGGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCGCTGTACTTT 28 3.2 3 
1 CASDPSGGAKTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAAAACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCACTGTACTTT 28 3.2 3 
1 CASDPSGGAKTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAAGACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAACCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPL*F TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTAGTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACTCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTEPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCGAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANT*PLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCTAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAATACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGATTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGACCACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPPGGASTQPLYF TGTGCCAGCGACCCTCCGGGGGGAGCGAGCACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQHLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCACCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTCTACTTT 28 3.2 3 
1 CDSDPSGGANTQPLYF TGTGACAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
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1 CASDPSGGANTQPPYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCCGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCGCTGTACTTT 28 3.2 3 




CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ  Jβ Dβ 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGTGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTTTACTTT 28 3.2 3 
1 CASDPSRGANTQPLYF TGTGCCAGCGACCCTTCGCGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANIQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACATCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTKPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCAAGCCCCTGTACTTT 28 3.2 3 
1 CSSDPSGGANTQPLYF TGTTCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCATCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 RASDPSGGANTQPLYF CGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCACTGTACTTT 28 3.2 3 
1 CASDPSEGANTQPLYF TGTGCCAGCGACCCTTCGGAGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSRGANTQPLYF TGTGCCAGCGACCCTTCGAGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCCGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAACCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPL*F TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTAGTTT 28 3.2 3 
1 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACGCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQPLFF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTTCTTT 28 3.2 3 
1 CASDPSGRANTQPLYF TGTGCCAGCGACCCTTCGGGGCGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
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1 CASDP*GGANTQPLYF TGTGCCAGCGACCCTTAGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 





CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ  Jβ Dβ 
1 WASDPSGGANTQPLYF TGGGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTHPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCACCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGAITQPLYF TGTGCCAGCGACCCCTCGGGGGGAGCGATCACCCAGCCCCTGTACTTT 28 3.2 3 
1 CSSDPSGGANTQPLYF TGTTCCAGCGACCCGTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPAGGANAQPLYF TGTGCCAGCGACCCTGCGGGGGGAGCGAACGCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSG*ANTQPLYF TGTGCCAGCGACCCTTCGGGGTGAGCGAACACCCAGCCCCTATACTTT 28 3.2 3 
1 CASDPSAGAITQPLYF TGTGCCAGCGACCCTTCGGCGGGAGCGATCACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSVGATTQPLYF TGTGCCAGCGACCCTTCGGTGGGAGCGACCACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANSQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACTCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGATAQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGACCGCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANTQLLSF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCTCCTGTCCTTT 28 3.2 3 
1 CASDPSGGANAQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAATGCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGAIPQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGATCCCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGANSQPLCF TGTGCCAGCGACCCTTCGGGGGGAGCGAACTCCCAGCCCCTGTGCTTT 28 3.2 3 
1 CASDPSGGATTQPLFF TGTGCCAGCGACCCTTCGGGGGGAGCGACCACCCAGCCCCTGTTCTTT 28 3.2 3 
1 CASDPSGGAIAQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGATCGCCCAGCCCCTGTACTTT 28 3.2 3 
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1 CASDPSGGANAEPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACGCCGAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGAITQPLSF TGTGCCAGCGACCCTTCGGGGGGAGCGATCACCCAGCCCCTGTCCTTT 28 3.2 3 






CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ  Jβ Dβ 
1 CASDPSGGASAQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAGCGCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSVGATTQPLSF TGTGCCAGCGACCCTTCGGTGGGAGCGACCACCCAGCCCCTGTCCTTT 28 3.2 3 
1 CASDPSEGANAQPLYF TGTGCCAGCGACCCTTCGGAGGGAGCGAATGCCCAGCCCCTGTACTTT 28 3.2 3 
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CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ Jβ Dβ 
3343 CASDPSGGANTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
9 CASDRSGGANTQPLYF TGTGCCAGCGACCGTTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
3 CASDPSGVANTQPLYF TGTGCCAGCGACCCTTCGGGGGTAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSGAANTQPLYF TGTGCCAGCGACCCTTCGGGGGCAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDHSGGANTQPLYF TGTGCCAGCGACCATTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
2 CASDPSGGADTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGGACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGAHTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGCACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGRANTQPLYF TGTGCCAGCGACCCTTCGGGGCGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGEANTQPLYF TGTGCCAGCGACCCTTCGGGGGAAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGAETQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGGAGACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGGACTQPLYF TGTGCCAGCGACCCTTCGGGGGGAGCGTGCACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDRSGGANAQPLYF TGTGCCAGCGACCGTTCGGGGGGAGCGAACGCCCAGCCCCTGTACTTT 28 3.2 3 
1 CTSDPSGGADTQPLYF TGTACCAGCGACCCTTCGGGGGGAGCGGACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSWGADTQPLYF TGTGCCAGCGACCCTTCGTGGGGAGCGGACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGRANAQPLYF TGTGCCAGCGACCCTTCGGGGCGAGCGAACGCCCAGCCCCTGTACTTT 28 3.2 3 
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1 CASDRSGGADPQPLYF TGTGCCAGCGACCGTTCGGGGGGAGCGGACCCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPAGGADTQPLYF TGTGCCAGCGACCCTGCGGGGGGAGCGGACACACAGCCCCTGTACTTT 28 3.2 3 




CDR3, amino acid 
sequences CDR3, nucleotide sequences Vβ Jβ Dβ 
1 CASDRSEGANA*PLYF TGTGCCAGCGACCGTTCGGAGGGAGCGAACGCCTAGCCCCTGTACTTT 28 3.2 3 
1 CASDRAGGAIAQPLYF TGTGCCAGCGACCGTGCGGGGGGAGCGATCGCCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDRAGGAVTQPLYF TGTGCCAGCGACCGTGCGGGGGGAGCGGTCACGCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPAGGAYAQPLYF TGTGCCAGCGACCCTGCGGGGGGAGCGTACGCACAGCCCCTGTACTTT 28 3.2 3 
1 CASDLSGGANTQPLYF TGTGCCAGCGACCTGTCGGGGGGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGRANTQPLYF TGTGCCAGCGACCCGTCGGGGCGAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPSGAANTQPLYF TGTGCCAGCGACCCGTCGGGGGCAGCGAACACCCAGCCCCTGTACTTT 28 3.2 3 
1 CASDPAVGANAQPLYF TGTGCCAGCGACCCTGCGGTGGGAGCGAACGCCCAGCCGCTGTACTTT 28 3.2 3 
1 CASDPSWGASAQPLYF TGTGCCAGCGACCCTTCGTGGGGAGCGAGCGCCCAGCCGCTGTACTTT 28 3.2 3 
1 CASDRAEAANTQPLYF TGTGCCAGCGACCGTGCGGAGGCAGCGAACACACAGCCCCTGTACTTT 28 3.2 3 
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Full-length cDNA of selected bovine TCR α and β chains were obtained from 
the Tp250-59 epitope-specific CD8 T cell clones, according to section 2.3.4. cDNAs of 
TCRβ28 (Vβ28-CASAEYGGENTQPL-Jβ3.2) and TCRα13 (Vα13-
CAASDRSNYKLTF-Jα20) were cloned and sequenced, and initially used to 
generate the TCRβ28-2A-TCRα13 construct. Sequence of the synthesized construct 
is shown in Figure D.1. In order to generate other constructs, full-length cDNA of 
TCRα8 (Vα8.4-CALLRSGWQLTF-Jα8.2) and TCRα26 (Vα26- 
CILMAGYQKLTF-Jα8.2) were obtained and synthesized, as shown in Figure D.2. 
Restriction sites (SmaI and BamHI) in the synthesized genes allow gene segments 
replacement to obtain new TCRβ-2A-TCRα constructs. All constructs generated 
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aggctgacagtgctgctgaacaagaccgccaagcacctgagcctgcacattgccaccaca 
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Restriction sites XbaI 
(tctaga) and XhoI (ctcgag) were added to the 5‟ and 3‟ ends of the construct for reconstitution of 
lentivirus-TCR vector. Kozak sequence (gccgccacc) at the 5‟ end of the construct is for the initiation 
of gene translation in cultured cells. TCR β and α gene segments are labelled. A self-cleaving 




Figure D.1 Sequence of the synthesized bovine TCRβ-2A-TCRα construct. 
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 With the restriction sites SmaI 
(cccggg) and BamHI (ggatcc), the synthesized genes are used to replace the TCRα13 in the initially 
synthesized TCRβ-2A-TCRα construct. The resultant constructs have the same TCRβ28 gene with 







Figure D.2 Sequences of synthesized TCRα8 and TCRα26 genes. 
BamHI 
 
  XXII 
Doctor of Philosophy – The University of Edinburgh – 2015 
References 
AARNOUDSE, C. A., et al. 2002. TCR reconstitution in Jurkat reporter cells 
facilitates the identification of novel tumor antigens by cDNA expression 
cloning. Int J Cancer, 99, 7-13. 
ABBOTT, R. J., et al. 2013. CD8+ T cell responses to lytic EBV infection: late 
antigen specificities as subdominant components of the total response. J 
Immunol, 191, 5398-409. 
ACUTO, O. & MICHEL, F. 2003. CD28-mediated co-stimulation: a quantitative 
support for TCR signalling. Nat Rev Immunol, 3, 939-51. 
AIFANTIS, I., et al. 1997. Essential role of the pre-T cell receptor in allelic 
exclusion of the T cell receptor beta locus. Immunity, 7, 601-7. 
AKRAM, A. & INMAN, R. D. 2012. Immunodominance: a pivotal principle in host 
response to viral infections. Clin Immunol, 143, 99-115. 
ALANIO, C., et al. 2010. Enumeration of human antigen-specific naive CD8+ T 
cells reveals conserved precursor frequencies. Blood, 115, 3718-25. 
ALEXANDER-MILLER, M. A., et al. 1996. Selective expansion of high- or low-
avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. 
Proc Natl Acad Sci U S A, 93, 4102-7. 
ALLAN, W., et al. 1990. Cellular events in the lymph node and lung of mice with 
influenza. Consequences of depleting CD4+ T cells. J Immunol, 144, 3980-6. 
ALTMAN, J. D., et al. 1996. Phenotypic analysis of antigen-specific T lymphocytes. 
Science, 274, 94-6. 
ANSORGE, S., et al. 2010. Recent progress in lentiviral vector mass production. 
Biochemical Engineering Journal, 48, 362-377. 
APPAY, V., et al. 2008. CD8+ T cell efficacy in vaccination and disease. Nat Med, 
14, 623-8. 
ARGAET, V. P., et al. 1994. Dominant selection of an invariant T cell antigen 
receptor in response to persistent infection by Epstein-Barr virus. J Exp Med, 
180, 2335-40. 
ARSTILA, T. P., et al. 1999. A direct estimate of the human alphabeta T cell 
receptor diversity. Science, 286, 958-61. 
BALAMURUGAN, A., et al. 2010. Rapid T cell receptor delineation reveals clonal 
expansion limitation of the magnitude of the HIV-1-specific CD8+ T cell 
response. J Immunol, 185, 5935-42. 
BALDWIN, C. L., et al. 1988. Bovine T cells, B cells, and null cells are transformed 
by the protozoan parasite Theileria parva. Infect Immun, 56, 462-7. 
BALDWIN, C. L., et al. 1987. Bovine helper T-cell clones specific for lymphocytes 
infected with Theileria parva (Muguga). Parasite Immunol, 9, 499-513. 
BALDWIN, C. L., et al. 1992. Theileria parva: CD4+ helper and cytotoxic T-cell 
clones react with a schizont-derived antigen associated with the surface of 
Theileria parva-infected lymphocytes. Exp Parasitol, 75, 19-30. 
BALLINGALL, K. T., et al. 2004. Bovine leukocyte antigen major 
histocompatibility complex class II DRB3*2703 and DRB3*1501 alleles are 
associated with variation in levels of protection against Theileria parva 
challenge following immunization with the sporozoite p67 antigen. Infect 
Immun, 72, 2738-41. 
 
  XXIII 
Doctor of Philosophy – The University of Edinburgh – 2015 
BARTON, G. M. & RUDENSKY, A. Y. 1999. Requirement for diverse, low-
abundance peptides in positive selection of T cells. Science, 283, 67-70. 
BASSING, C. H., et al. 2002. The mechanism and regulation of chromosomal V(D)J 
recombination. Cell, 109 Suppl, S45-55. 
BAUM, P. D., et al. 2012. Wrestling with the repertoire: the promise and perils of 
next generation sequencing for antigen receptors. Eur J Immunol, 42, 2834-9. 
BELYAKOV, I. M., et al. 2001. Activating CTL precursors to reveal CTL function 
without skewing the repertoire by in vitro expansion. Eur J Immunol, 31, 
3557-66. 
BELZ, G. T., et al. 2000. Contemporary analysis of MHC-related immunodominance 
hierarchies in the CD8+ T cell response to influenza A viruses. J Immunol, 
165, 2404-9. 
BELZ, G. T., et al. 2001. Diversity of epitope and cytokine profiles for primary and 
secondary influenza a virus-specific CD8+ T cell responses. J Immunol, 166, 
4627-33. 
BEMBRIDGE, G. P., et al. 1995. CD45RO expression on bovine T cells: relation to 
biological function. Immunology, 86, 537-44. 
BETTS, M. R., et al. 2000. Putative immunodominant human immunodeficiency 
virus-specific CD8(+) T-cell responses cannot be predicted by major 
histocompatibility complex class I haplotype. J Virol, 74, 9144-51. 
BEVAN, M. J. 2004. Helping the CD8(+) T-cell response. Nat Rev Immunol, 4, 595-
602. 
BIRNBAUM, M. E., et al. 2012. Diversity-oriented approaches for interrogating T-
cell receptor repertoire, ligand recognition, and function. Immunol Rev, 250, 
82-101. 
BISHOP, R., et al. 2003. Immunity to East Coast fever in cattle induced by a 
polypeptide fragment of the major surface coat protein of Theileria parva 
sporozoites. Vaccine, 21, 1205-12. 
BISHOP, R., et al. 2005. Analysis of the transcriptome of the protozoan Theileria 
parva using MPSS reveals that the majority of genes are transcriptionally 
active in the schizont stage. Nucleic Acids Res, 33, 5503-11. 
BLATTMAN, J. N., et al. 2002. Estimating the precursor frequency of naive antigen-
specific CD8 T cells. J Exp Med, 195, 657-64. 
BLUM, J. S., et al. 2013. Pathways of antigen processing. Annu Rev Immunol, 31, 
443-73. 
BOLOTIN, D. A., et al. 2012. Next generation sequencing for TCR repertoire 
profiling: platform-specific features and correction algorithms. Eur J 
Immunol, 42, 3073-83. 
BOLOTIN, D. A., et al. 2013. MiTCR: software for T-cell receptor sequencing data 
analysis. Nat Methods, 10, 813-4. 
BOUNEAUD, C., et al. 2000. Impact of negative selection on the T cell repertoire 
reactive to a self-peptide: a large fraction of T cell clones escapes clonal 
deletion. Immunity, 13, 829-40. 
BOUSSO, P., et al. 1998. Individual variations in the murine T cell response to a 
specific peptide reflect variability in naive repertoires. Immunity, 9, 169-78. 
BOYMAN, O., et al. 2009. Homeostatic proliferation and survival of naive and 
memory T cells. Eur J Immunol, 39, 2088-94. 
 
  XXIV 
Doctor of Philosophy – The University of Edinburgh – 2015 
BRADY, B. L., et al. 2010. Antigen receptor allelic exclusion: an update and 
reappraisal. J Immunol, 185, 3801-8. 
BRIDGEMAN, J. S., et al. 2012. Structural and biophysical determinants of 
alphabeta T-cell antigen recognition. Immunology, 135, 9-18. 
BROOKES, R., et al. 1995. Generation of diversity in the hierarchy of T-cell epitope 
responses following different routes of immunization with simian 
immunodeficiency virus protein. AIDS, 9, 1017-24. 
BROWN, C. G., et al. 1973. Letter: Infection and transformation of bovine lymphoid 
cells in vitro by infective particles of Theileria parva. Nature, 245, 101-3. 
BUMANN, D. 2003. T cell receptor-transgenic mouse models for studying cellular 
immune responses to Salmonella in vivo. FEMS Immunol Med Microbiol, 37, 
105-9. 
BURROWS, S. R., et al. 2006. Have we cut ourselves too short in mapping CTL 
epitopes? Trends Immunol, 27, 11-6. 
BURROWS, S. R., et al. 1995. T cell receptor repertoire for a viral epitope in 
humans is diversified by tolerance to a background major histocompatibility 
complex antigen. J Exp Med, 182, 1703-15. 
BUSCHER, G., et al. 1984. Titration in cattle of infectivity and immunogenicity of 
autologous cell lines infected with Theileria parva. Vet Parasitol, 15, 29-38. 
CALIS, J. J. & ROSENBERG, B. R. 2014. Characterizing immune repertoires by 
high throughput sequencing: strategies and applications. Trends Immunol, 35, 
581-590. 
CALLAN, M. F., et al. 2000. CD8(+) T-cell selection, function, and death in the 
primary immune response in vivo. J Clin Invest, 106, 1251-61. 
CALLARD, R. & HODGKIN, P. 2007. Modeling T- and B-cell growth and 
differentiation. Immunol Rev, 216, 119-29. 
CAMPOS-LIMA, P. O., et al. 1997. Epitope-dependent selection of highly restricted 
or diverse T cell receptor repertoires in response to persistent infection by 
Epstein-Barr virus. J Exp Med, 186, 83-9. 
CASROUGE, A., et al. 2000. Size estimate of the alpha beta TCR repertoire of naive 
mouse splenocytes. J Immunol, 164, 5782-7. 
CHARINI, W. A., et al. 2001. Clonally diverse CTL response to a dominant viral 
epitope recognizes potential epitope variants. J Immunol, 167, 4996-5003. 
CHATTOPADHYAY, P. K., et al. 2008. Techniques to improve the direct ex vivo 
detection of low frequency antigen-specific CD8+ T cells with peptide-major 
histocompatibility complex class I tetramers. Cytometry A, 73, 1001-9. 
CHEN, H., et al. 2012. TCR clonotypes modulate the protective effect of HLA class 
I molecules in HIV-1 infection. Nat Immunol, 13, 691-700. 
CHEN, W., et al. 2000. Dissecting the multifactorial causes of immunodominance in 
class I-restricted T cell responses to viruses. Immunity, 12, 83-93. 
CHEN, W., et al. 2002. Mice deficient in perforin, CD4+ T cells, or CD28-mediated 
signaling maintain the typical immunodominance hierarchies of CD8+ T-cell 
responses to influenza virus. J Virol, 76, 10332-7. 
CHEN, Y. C. & ZAVALA, F. 2013. Development and use of TCR transgenic mice 
for malaria immunology research. Methods Mol Biol, 923, 481-91. 
CHEN, Z. W., et al. 2001. The TCR repertoire of an immunodominant CD8+ T 
lymphocyte population. J Immunol, 166, 4525-33. 
 
  XXV 
Doctor of Philosophy – The University of Edinburgh – 2015 
CHOI, E. M., et al. 2003. High avidity antigen-specific CTL identified by CD8-
independent tetramer staining. J Immunol, 171, 5116-23. 
CHOTHIA, C., et al. 1988. The outline structure of the T-cell alpha beta receptor. 
EMBO J, 7, 3745-55. 
CHRISTENSEN, J. P., et al. 2000. Profound protection against respiratory challenge 
with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) 
T-cell memory. J Virol, 74, 11690-6. 
CIBOTTI, R., et al. 1994. Public and private V beta T cell receptor repertoires 
against hen egg white lysozyme (HEL) in nontransgenic versus HEL 
transgenic mice. J Exp Med, 180, 861-72. 
COMIN-ANDUIX, B., et al. 2006. Definition of an immunologic response using the 
major histocompatibility complex tetramer and enzyme-linked immunospot 
assays. Clin Cancer Res, 12, 107-16. 
CONNELLEY, T., et al. 2009. Genomic analysis reveals extensive gene duplication 
within the bovine TRB locus. BMC Genomics, 10, 192. 
CONNELLEY, T., et al. 2008. Dissection of the clonal composition of bovine 
alphabeta T cell responses using T cell receptor Vbeta subfamily-specific 
PCR and heteroduplex analysis. J Immunol Methods, 335, 28-40. 
CONNELLEY, T. K., et al. 2014. Genomic analysis offers insights into the evolution 
of the bovine TRA/TRD locus. BMC Genomics, 15, 994. 
CONNELLEY, T. K., et al. 2011. Escape from CD8+ T cell response by natural 
variants of an immunodominant epitope from Theileria parva is 
predominantly due to loss of TCR recognition. J Immunol, 187, 5910-20. 
CORRADIN, G. & LEVITSKAYA, J. 2014. Priming of CD8(+) T Cell Responses to 
Liver Stage Malaria Parasite Antigens. Front Immunol, 5, 527. 
CORSE, E., et al. 2011. Strength of TCR-peptide/MHC interactions and in vivo T 
cell responses. J Immunol, 186, 5039-45. 
CRISPE, I. N. 2014. APC licensing and CD4+T cell help in liver-stage malaria. 
Front Microbiol, 5, 617. 
CUKALAC, T., et al. 2014a. Reproducible selection of high avidity CD8+ T-cell 
clones following secondary acute virus infection. Proc Natl Acad Sci U S A, 
111, 1485-90. 
CUKALAC, T., et al. 2014b. The Influenza Virus-Specific CTL Immunodominance 
Hierarchy in Mice Is Determined by the Relative Frequency of High-Avidity 
T Cells. J Immunol. 
CUNNINGHAM, M. P., et al. 1973. Cryopreservation of infective particles of 
Theileria parva. Int J Parasitol, 3, 583-7. 
DANIEL-MESHULAM, I., et al. 2012. How (specific) would like your T-cells today? 
Generating T-cell therapeutic function through TCR-gene transfer. Front 
Immunol, 3, 186. 
DAVENPORT, M. P., et al. 2007. The T cell repertoire in infection and vaccination: 
implications for control of persistent viruses. Curr Opin Immunol, 19, 294-
300. 
DAVIS, M. M., et al. 2011. Interrogating the repertoire: broadening the scope of 
peptide-MHC multimer analysis. Nat Rev Immunol, 11, 551-8. 
DAVIS, M. M. & BJORKMAN, P. J. 1988. T-cell antigen receptor genes and T-cell 
recognition. Nature, 334, 395-402. 
 
  XXVI 
Doctor of Philosophy – The University of Edinburgh – 2015 
DAY, C. L., et al. 2001. Relative dominance of epitope-specific cytotoxic T-
lymphocyte responses in human immunodeficiency virus type 1-infected 
persons with shared HLA alleles. J Virol, 75, 6279-91. 
DAY, E. B., et al. 2011. Effect of MHC class I diversification on influenza epitope-
specific CD8+ T cell precursor frequency and subsequent effector function. J 
Immunol, 186, 6319-28. 
DE FELIPE, P., et al. 1999. Use of the 2A sequence from foot-and-mouth disease 
virus in the generation of retroviral vectors for gene therapy. Gene Ther, 6, 
198-208. 
DE PLAEN, E., et al. 1997. Identification of genes coding for tumor antigens 
recognized by cytolytic T lymphocytes. Methods, 12, 125-42. 
DENTON, A. E., et al. 2011. Affinity thresholds for naive CD8+ CTL activation by 
peptides and engineered influenza A viruses. J Immunol, 187, 5733-44. 
DERBY, M., et al. 2001. High-avidity CTL exploit two complementary mechanisms 
to provide better protection against viral infection than low-avidity CTL. J 
Immunol, 166, 1690-7. 
DI GIULIO, G., et al. 2009. Live immunization against East Coast fever--current 
status. Trends Parasitol, 25, 85-92. 
DIETRICH, P. Y., et al. 1997. TCR analysis reveals significant repertoire selection 
during in vitro lymphocyte culture. Int Immunol, 9, 1073-83. 
DINTER, J., et al. 2015. Variable processing and cross-presentation of HIV by 
dendritic cells and macrophages shapes CTL immunodominance and immune 
escape. PLoS Pathog, 11, e1004725. 
DOBBELAERE, D. A., et al. 2000. Theileria parva: taking control of host cell 
proliferation and survival mechanisms. Cell Microbiol, 2, 91-9. 
DOHERTY, P. C. 2011. The tetramer transformation. J Immunol, 187, 5-6. 
DOLAN, B. P., et al. 2012. MHC class I antigen processing distinguishes 
endogenous antigens based on their translation from cellular vs. viral mRNA. 
Proc Natl Acad Sci U S A, 109, 7025-30. 
DONG, L., et al. 2010. Public TCR use by herpes simplex virus-2-specific human 
CD8 CTLs. J Immunol, 184, 3063-71. 
DOUEK, D. C., et al. 2002. A novel approach to the analysis of specificity, clonality, 
and frequency of HIV-specific T cell responses reveals a potential 
mechanism for control of viral escape. J Immunol, 168, 3099-104. 
DREJER-TEEL, A. H., et al. 2007. The beyond 12/23 restriction is imposed at the 
nicking and pairing steps of DNA cleavage during V(D)J recombination. Mol 
Cell Biol, 27, 6288-99. 
EMERY, D. L. 1981. Adoptive transfer of immunity to infection with Theileria 
parva (East Coast fever) between cattle twins. Res Vet Sci, 30, 364-7. 
EUGUI, E. M. & EMERY, D. L. 1981. Genetically restricted cell-mediated 
cytotoxicity in cattle immune to Theileria parva. Nature, 290, 251-4. 
FACKLER, M. J., et al. 1995. Full-length but not truncated CD34 inhibits 
hematopoietic cell differentiation of M1 cells. Blood, 85, 3040-7. 
FALK, K., et al. 1991. Allele-specific motifs revealed by sequencing of self-peptides 
eluted from MHC molecules. Nature, 351, 290-6. 
FARBER, D. L., et al. 2014. Human memory T cells: generation, 
compartmentalization and homeostasis. Nat Rev Immunol, 14, 24-35. 
 
  XXVII 
Doctor of Philosophy – The University of Edinburgh – 2015 
FAWCETT, D. W., et al. 1982. Salivary gland of the tick vector of East Coast fever. 
III. The ultrastructure of sporogony in Theileria parva. Tissue Cell, 14, 183-
206. 
FEHSE, B., et al. 2000. CD34 splice variant: an attractive marker for selection of 
gene-modified cells. Mol Ther, 1, 448-56. 
FLESCH, I. E., et al. 2010. Altered CD8(+) T cell immunodominance after vaccinia 
virus infection and the naive repertoire in inbred and F(1) mice. J Immunol, 
184, 45-55. 
FLYNN, K. J., et al. 1998. Virus-specific CD8+ T cells in primary and secondary 
influenza pneumonia. Immunity, 8, 683-91. 
FLYNN, K. J., et al. 1999. In vivo proliferation of naive and memory influenza-
specific CD8(+) T cells. Proc Natl Acad Sci U S A, 96, 8597-602. 
FRAHM, N., et al. 2006. Control of human immunodeficiency virus replication by 
cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol, 7, 
173-8. 
GACHOHI, J., et al. 2012. Epidemiology of East Coast fever (Theileria parva 
infection) in Kenya: past, present and the future. Parasit Vectors, 5, 194. 
GARBOCZI, D. N., et al. 1996. Structure of the complex between human T-cell 
receptor, viral peptide and HLA-A2. Nature, 384, 134-41. 
GARCIA, K. C., et al. 2009. The molecular basis of TCR germline bias for MHC is 
surprisingly simple. Nat Immunol, 10, 143-7. 
GARCIA, K. C., et al. 1996. An alphabeta T cell receptor structure at 2.5 A and its 
orientation in the TCR-MHC complex. Science, 274, 209-19. 
GARCIA, K. C., et al. 1999. Structural basis of T cell recognition. Annu Rev 
Immunol, 17, 369-97. 
GARDNER, M. J., et al. 2005. Genome sequence of Theileria parva, a bovine 
pathogen that transforms lymphocytes. Science, 309, 134-7. 
GASCOIGNE, N. R. & ALAM, S. M. 1999. Allelic exclusion of the T cell receptor 
alpha-chain: developmental regulation of a post-translational event. Semin 
Immunol, 11, 337-47. 
GERMAIN, R. N. 2002. T-cell development and the CD4-CD8 lineage decision. Nat 
Rev Immunol, 2, 309-22. 
GILLESPIE, G. M., et al. 2006. Strong TCR conservation and altered T cell cross-
reactivity characterize a B*57-restricted immune response in HIV-1 infection. 
J Immunol, 177, 3893-902. 
GODDEERIS, B. & MORRISON, W. I. 1988. Techniques for the generation, 
cloning, and characterization of bovine cytotoxic T cells specific for the 
protozoan Theileria parva. Journal of tissue culture methods, 11, 101-110. 
GODDEERIS, B. M., et al. 1986. Bovine cytotoxic T-cell clones specific for cells 
infected with the protozoan parasite Theileria parva: parasite strain specificity 
and class I major histocompatibility complex restriction. Proc Natl Acad Sci 
U S A, 83, 5238-42. 
GODDEERIS, B. M., et al. 1990. Strain specificity of bovine Theileria parva-
specific cytotoxic T cells is determined by the phenotype of the restricting 
class I MHC. Immunology, 69, 38-44. 
GOTCH, F., et al. 1987. Cytotoxic T lymphocytes recognize a fragment of influenza 
virus matrix protein in association with HLA-A2. Nature, 326, 881-2. 
 
  XXVIII 
Doctor of Philosophy – The University of Edinburgh – 2015 
GOULDER, P. J., et al. 1997. Patterns of immunodominance in HIV-1-specific 
cytotoxic T lymphocyte responses in two human histocompatibility leukocyte 
antigens (HLA)-identical siblings with HLA-A*0201 are influenced by 
epitope mutation. J Exp Med, 185, 1423-33. 
GRAHAM, S. P., et al. 2007. A novel strategy for the identification of antigens that 
are recognised by bovine MHC class I restricted cytotoxic T cells in a 
protozoan infection using reverse vaccinology. Immunome Res, 3, 2. 
GRAHAM, S. P., et al. 2006. Theileria parva candidate vaccine antigens recognized 
by immune bovine cytotoxic T lymphocytes. Proc Natl Acad Sci U S A, 103, 
3286-91. 
GRAHAM, S. P., et al. 2008. Characterization of the fine specificity of bovine CD8 
T-cell responses to defined antigens from the protozoan parasite Theileria 
parva. Infect Immun, 76, 685-94. 
HAN, A., et al. 2014. Linking T-cell receptor sequence to functional phenotype at 
the single-cell level. Nat Biotechnol, 32, 684-92. 
HANSEN, S. G., et al. 2011. Profound early control of highly pathogenic SIV by an 
effector memory T-cell vaccine. Nature, 473, 523-7. 
HARING, J. S., et al. 2006. Inflaming the CD8+ T cell response. Immunity, 25, 19-
29. 
HARTY, J. T. & BADOVINAC, V. P. 2008. Shaping and reshaping CD8+ T-cell 
memory. Nat Rev Immunol, 8, 107-19. 
HARTY, J. T. & BEVAN, M. J. 1999. Responses of CD8(+) T cells to intracellular 
bacteria. Curr Opin Immunol, 11, 89-93. 
HARTY, J. T., et al. 2000. CD8+ T cell effector mechanisms in resistance to 
infection. Annu Rev Immunol, 18, 275-308. 
HEATH, W. R. & CARBONE, F. R. 2001a. Cross-presentation in viral immunity 
and self-tolerance. Nat Rev Immunol, 1, 126-34. 
HEATH, W. R. & CARBONE, F. R. 2001b. Cross-presentation, dendritic cells, 
tolerance and immunity. Annu Rev Immunol, 19, 47-64. 
HEATH, W. R. & MILLER, J. F. 1993. Expression of two alpha chains on the 
surface of T cells in T cell receptor transgenic mice. J Exp Med, 178, 1807-11. 
HEUSSLER, V., et al. 2006. Regulation of host cell survival by intracellular 
Plasmodium and Theileria parasites. Parasitology, 132 Suppl, S49-60. 
HOGG, A. E., et al. 2011. Characterization of age-related changes in bovine CD8+ 
T-cells. Vet Immunol Immunopathol, 140, 47-54. 
HOGQUIST, K. A., et al. 1993. Positive selection of CD8+ T cells induced by major 
histocompatibility complex binding peptides in fetal thymic organ culture. J 
Exp Med, 177, 1469-73. 
HOUSTON, E. F., et al. 2005. Analysis of T-cell receptor BV gene sequences in 
cattle reveals extensive duplication within the BV9 and BV20 subgroups. 
Immunogenetics, 57, 674-81. 
HOUSTON, E. F. & MORRISON, W. I. 1999. Identification of seven new TCRBV 
subfamilies in cattle (Bos taurus). Eur J Immunogenet, 26, 349-53. 
HOUSTON, E. F., et al. 2008. Infection of cattle with Theileria parva induces an 
early CD8 T cell response lacking appropriate effector function. Int J 
Parasitol, 38, 1693-704. 
 
  XXIX 
Doctor of Philosophy – The University of Edinburgh – 2015 
IGNATOWICZ, L., et al. 1996. The repertoire of T cells shaped by a single 
MHC/peptide ligand. Cell, 84, 521-9. 
IM, E. J., et al. 2011. Protective efficacy of serially up-ranked subdominant CD8+ T 
cell epitopes against virus challenges. PLoS Pathog, 7, e1002041. 
IRVIN, A. D., et al. 1983. Immunisation against East Coast fever: correlation 
between monoclonal antibody profiles of Theileria parva stocks and cross 
immunity in vivo. Res Vet Sci, 35, 341-6. 
JANSSEN, E. M., et al. 2005. CD4+ T-cell help controls CD8+ T-cell memory via 
TRAIL-mediated activation-induced cell death. Nature, 434, 88-93. 
JENKINS, M. K. & MOON, J. J. 2012. The role of naive T cell precursor frequency 
and recruitment in dictating immune response magnitude. J Immunol, 188, 
4135-40. 
JOFFRE, O. P., et al. 2012. Cross-presentation by dendritic cells. Nat Rev Immunol, 
12, 557-69. 
KABA, S. A., et al. 2005. Novel baculovirus-derived p67 subunit vaccines 
efficacious against East Coast fever in cattle. Vaccine, 23, 2791-800. 
KAECH, S. M. & CUI, W. 2012. Transcriptional control of effector and memory 
CD8(+) T cell differentiation. Nat Rev Immunol, 12, 749-61. 
KAECH, S. M., et al. 2002. Effector and memory T-cell differentiation: implications 
for vaccine development. Nat Rev Immunol, 2, 251-62. 
KARTTUNEN, J. & SHASTRI, N. 1991. Measurement of ligand-induced activation 
in single viable T cells using the lacZ reporter gene. Proc Natl Acad Sci U S 
A, 88, 3972-6. 
KAZATCHKINE, M. D. 1995. Nomenclature for T-cell receptor (TCR) gene 
segments of the immune system. 
KEARNEY, E. R., et al. 1994. Visualization of peptide-specific T cell immunity and 
peripheral tolerance induction in vivo. Immunity, 1, 327-39. 
KEDZIERSKA, K., et al. 2006. Quantification of repertoire diversity of influenza-
specific epitopes with predominant public or private TCR usage. J Immunol, 
177, 6705-12. 
KEDZIERSKA, K., et al. 2008. Tracking phenotypically and functionally distinct T 
cell subsets via T cell repertoire diversity. Mol Immunol, 45, 607-18. 
KEDZIERSKA, K., et al. 2004. Conserved T cell receptor usage in primary and 
recall responses to an immunodominant influenza virus nucleoprotein epitope. 
Proc Natl Acad Sci U S A, 101, 4942-7. 
KESSELS, H. W., et al. 2001. Immunotherapy through TCR gene transfer. Nat 
Immunol, 2, 957-61. 
KHOR, B. & SLECKMAN, B. P. 2002. Allelic exclusion at the TCRbeta locus. Curr 
Opin Immunol, 14, 230-4. 
KIM, D. R., et al. 2000. V(D)J recombination: site-specific cleavage and repair. Mol 
Cells, 10, 367-74. 
KIM, S. K., et al. 2005. Private specificities of CD8 T cell responses control patterns 
of heterologous immunity. J Exp Med, 201, 523-33. 
KISSELEV, A. F., et al. 1999. The sizes of peptides generated from protein by 
mammalian 26 and 20 S proteasomes. Implications for understanding the 
degradative mechanism and antigen presentation. J Biol Chem, 274, 3363-71. 
 
  XXX 
Doctor of Philosophy – The University of Edinburgh – 2015 
KJER-NIELSEN, L., et al. 2003. A structural basis for the selection of dominant 
alphabeta T cell receptors in antiviral immunity. Immunity, 18, 53-64. 
KLARENBEEK, P. L., et al. 2012. Deep sequencing of antiviral T-cell responses to 
HCMV and EBV in humans reveals a stable repertoire that is maintained for 
many years. PLoS Pathog, 8, e1002889. 
KLENERMAN, P., et al. 2002. Tracking T cells with tetramers: new tales from new 
tools. Nat Rev Immunol, 2, 263-72. 
KLOVERPRIS, H. N., et al. 2015. CD8+ TCR Bias and Immunodominance in HIV-
1 Infection. J Immunol, 194, 5329-45. 
KLOVERPRIS, H. N., et al. 2013. HLA-Specific Intracellular Epitope Processing 
Shapes an Immunodominance Pattern for HLA-B*57 That Is Distinct from 
HLA-B*58:01. J Virol, 87, 10889-94. 
KONING, D., et al. 2014. In vitro expansion of antigen-specific CD8(+) T cells 
distorts the T-cell repertoire. J Immunol Methods, 405, 199-203. 
KONING, D., et al. 2013. CD8+ TCR repertoire formation is guided primarily by the 
peptide component of the antigenic complex. J Immunol, 190, 931-9. 
KOTTURI, M. F., et al. 2008. Naive precursor frequencies and MHC binding rather 
than the degree of epitope diversity shape CD8+ T cell immunodominance. J 
Immunol, 181, 2124-33. 
KUSTIKOVA, O. S., et al. 2003. Dose finding with retroviral vectors: correlation of 
retroviral vector copy numbers in single cells with gene transfer efficiency in 
a cell population. Blood, 102, 3934-7. 
LA GRUTA, N. L., et al. 2006a. A correlation between function and selected 
measures of T cell avidity in influenza virus-specific CD8+ T cell responses. 
Eur J Immunol, 36, 2951-9. 
LA GRUTA, N. L., et al. 2006b. A virus-specific CD8+ T cell immunodominance 
hierarchy determined by antigen dose and precursor frequencies. Proc Natl 
Acad Sci U S A, 103, 994-9. 
LA GRUTA, N. L., et al. 2010. Primary CTL response magnitude in mice is 
determined by the extent of naive T cell recruitment and subsequent clonal 
expansion. J Clin Invest, 120, 1885-94. 
LA GRUTA, N. L. & THOMAS, P. G. 2013. Interrogating the relationship between 
naive and immune antiviral T cell repertoires. Curr Opin Virol. 
LA GRUTA, N. L., et al. 2008. Epitope-specific TCRbeta repertoire diversity 
imparts no functional advantage on the CD8+ T cell response to cognate viral 
peptides. Proc Natl Acad Sci U S A, 105, 2034-9. 
LA GRUTA, N. L. & TURNER, S. J. 2014. T cell mediated immunity to influenza: 
mechanisms of viral control. Trends Immunol, 35, 396-402. 
LADELL, K., et al. 2013. A molecular basis for the control of preimmune escape 
variants by HIV-specific CD8+ T cells. Immunity, 38, 425-36. 
LAUGEL, B., et al. 2007. Different T cell receptor affinity thresholds and CD8 
coreceptor dependence govern cytotoxic T lymphocyte activation and 
tetramer binding properties. J Biol Chem, 282, 23799-810. 
LAWRENCE, J. A., et al. 1983. Rhipicephalus zambeziensis as a vector of bovine 
Theileriae. Trop Anim Health Prod, 15, 39-42. 
LE GALL, S., et al. 2007. Portable flanking sequences modulate CTL epitope 
processing. J Clin Invest, 117, 3563-75. 
 
  XXXI 
Doctor of Philosophy – The University of Edinburgh – 2015 
LEFRANC, M. P., et al. 1999. IMGT, the international ImMunoGeneTics database. 
Nucleic Acids Res, 27, 209-12. 
LI, H., et al. 2012. Recombinatorial biases and convergent recombination determine 
interindividual TCRbeta sharing in murine thymocytes. J Immunol, 189, 
2404-13. 
LI, L. P., et al. 2010. Transgenic mice with a diverse human T cell antigen receptor 
repertoire. Nat Med, 16, 1029-34. 
LIEBER, M. R. 1991. Site-specific recombination in the immune system. FASEB J, 
5, 2934-44. 
LIU, F., et al. 2004. The rapidity with which virus-specific CD8+ T cells initiate 
IFN-gamma synthesis increases markedly over the course of infection and 
correlates with immunodominance. J Immunol, 173, 456-62. 
LONCHAY, C., et al. 2004. Correlation between tumor regression and T cell 
responses in melanoma patients vaccinated with a MAGE antigen. Proc Natl 
Acad Sci U S A, 101 Suppl 2, 14631-8. 
LUCIANI, F., et al. 2013. Increasing viral dose causes a reversal in CD8+ T cell 
immunodominance during primary influenza infection due to differences in 
antigen presentation, T cell avidity, and precursor numbers. J Immunol, 190, 
36-47. 
MACHUGH, N. D., et al. 2009. CD8+ T-cell responses to Theileria parva are 
preferentially directed to a single dominant antigen: Implications for parasite 
strain-specific immunity. Eur J Immunol, 39, 2459-69. 
MALHERBE, L., et al. 2004. Clonal selection of helper T cells is determined by an 
affinity threshold with no further skewing of TCR binding properties. 
Immunity, 21, 669-79. 
MARCOTTY, T., et al. 2002. Immunisation against Theileria parva in eastern 
Zambia: influence of maternal antibodies and demonstration of the carrier 
status. Vet Parasitol, 110, 45-56. 
MARKET, E. & PAPAVASILIOU, F. N. 2003. V(D)J recombination and the 
evolution of the adaptive immune system. PLoS Biol, 1, E16. 
MARSOLIER, J., et al. 2015. Theileria parasites secrete a prolyl isomerase to 
maintain host leukocyte transformation. Nature, 520, 378-382. 
MARTIN, D. L., et al. 2006. CD8+ T-Cell responses to Trypanosoma cruzi are 
highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog, 2, e77. 
MARZO, A. L., et al. 2005. Initial T cell frequency dictates memory CD8+ T cell 
lineage commitment. Nat Immunol, 6, 793-9. 
MASOPUST, D., et al. 2001. Preferential localization of effector memory cells in 
nonlymphoid tissue. Science, 291, 2413-7. 
MCHARDY, N., et al. 1985. Antitheilerial activity of BW720C (buparvaquone): a 
comparison with parvaquone. Res Vet Sci, 39, 29-33. 
MCKEEVER, D. J. 2006. Theileria parva and the bovine CTL response: down but 
not out? Parasite Immunol, 28, 339-45. 
MCKEEVER, D. J. 2007. Live immunisation against Theileria parva: containing or 
spreading the disease? Trends Parasitol, 23, 565-8. 
MCKEEVER, D. J., et al. 1994. Adoptive transfer of immunity to Theileria parva in 
the CD8+ fraction of responding efferent lymph. Proc Natl Acad Sci U S A, 
91, 1959-63. 
 
  XXXII 
Doctor of Philosophy – The University of Edinburgh – 2015 
MCMICHAEL, A. J. & PHILLIPS, R. E. 1997. Escape of human immunodeficiency 
virus from immune control. Annu Rev Immunol, 15, 271-96. 
MEDLEY, G. F., et al. 1993. Preliminary analysis of the transmission dynamics of 
Theileria parva in eastern Africa. Parasitology, 106 ( Pt 3), 251-64. 
MESCHER, M. F., et al. 2006. Signals required for programming effector and 
memory development by CD8+ T cells. Immunol Rev, 211, 81-92. 
MESSAOUDI, I., et al. 2002. Direct link between mhc polymorphism, T cell avidity, 
and diversity in immune defense. Science, 298, 1797-800. 
MEYER-OLSON, D., et al. 2004. Limited T cell receptor diversity of HCV-specific 
T cell responses is associated with CTL escape. J Exp Med, 200, 307-19. 
MILLER, J. D., et al. 2008. Human effector and memory CD8+ T cell responses to 
smallpox and yellow fever vaccines. Immunity, 28, 710-22. 
MIQUEU, P., et al. 2007. Statistical analysis of CDR3 length distributions for the 
assessment of T and B cell repertoire biases. Molecular Immunology, 44, 
1057-1064. 
MOFFAT, J. M., et al. 2010. Influenza epitope-specific CD8+ T cell avidity, but not 
cytokine polyfunctionality, can be determined by TCRbeta clonotype. J 
Immunol, 185, 6850-6. 
MOON, J. J., et al. 2007. Naive CD4(+) T cell frequency varies for different epitopes 
and predicts repertoire diversity and response magnitude. Immunity, 27, 203-
13. 
MORGAN, R. A., et al. 2006. Cancer regression in patients after transfer of 
genetically engineered lymphocytes. Science, 314, 126-9. 
MORRISON, W. I. 2009. Progress towards understanding the immunobiology of 
Theileria parasites. Parasitology, 136, 1415-26. 
MORRISON, W. I., et al. 1987. Cytotoxic T-cells elicited in cattle challenged with 
Theileria parva (Muguga): evidence for restriction by class I MHC 
determinants and parasite strain specificity. Parasite Immunol, 9, 563-78. 
MORRISON, W. I., et al. 1996. Pathogenicity of Theileria parva is influenced by the 
host cell type infected by the parasite. Infect Immun, 64, 557-62. 
MORRISON, W. I. & MCKEEVER, D. J. 2006. Current status of vaccine 
development against Theileria parasites. Parasitology, 133 Suppl, S169-87. 
MORZARIA, S. P., et al. 1995. Generation and characterization of cloned Theileria 
parva parasites. Parasitology, 111 ( Pt 1), 39-49. 
MUSOKE, A., et al. 1992. A recombinant sporozoite surface antigen of Theileria 
parva induces protection in cattle. Proc Natl Acad Sci U S A, 89, 514-8. 
MUSOKE, A., et al. 2005. Subunit vaccine based on the p67 major surface protein of 
Theileria parva sporozoites reduces severity of infection derived from field 
tick challenge. Vaccine, 23, 3084-95. 
MUSOKE, A. J., et al. 1984. Evidence for a common protective antigenic 
determinant on sporozoites of several Theileria parva strains. Immunology, 52, 
231-8. 
NACER, A., et al. 2001. Plasmodium falciparum signal sequences: simply sequences 
or special signals? Int J Parasitol, 31, 1371-9. 
NAGATA, T. & KOIDE, Y. 2010. Induction of Specific CD8 T Cells against 
Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches. J 
Biomed Biotechnol, 2010, 764542. 
 
  XXXIII 
Doctor of Philosophy – The University of Edinburgh – 2015 
NAIR-GUPTA, P. & BLANDER, J. M. 2013. An updated view of the intracellular 
mechanisms regulating cross-presentation. Front Immunol, 4, 401. 
NAUMOV, Y. N., et al. 1998. A class I MHC-restricted recall response to a viral 
peptide is highly polyclonal despite stringent CDR3 selection: implications 
for establishing memory T cell repertoires in "real-world" conditions. J 
Immunol, 160, 2842-52. 
NDUNGU, S. G., et al. 2005. In vivo comparison of susceptibility between Bos 
indicus and Bos taurus cattle types to Theileria parva infection. 
Onderstepoort J Vet Res, 72, 13-22. 
NENE, V., et al. 1999. Linear peptide specificity of bovine antibody responses to 
p67 of Theileria parva and sequence diversity of sporozoite-neutralizing 
epitopes: implications for a vaccine. Infect Immun, 67, 1261-6. 
NGUYEN, P., et al. 2011. Identification of errors introduced during high throughput 
sequencing of the T cell receptor repertoire. BMC Genomics, 12, 106. 
NI, P. P., et al. 2014. The ability to rearrange dual TCRs enhances positive selection, 
leading to increased Allo- and Autoreactive T cell repertoires. J Immunol, 
193, 1778-86. 
NIEDERBERGER, N., et al. 2003. Allelic exclusion of the TCR alpha-chain is an 
active process requiring TCR-mediated signaling and c-Cbl. J Immunol, 170, 
4557-63. 
NIJHUIS, E. W., et al. 1990. Activation and expansion of tumour-infiltrating 
lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies. Cancer 
Immunol Immunother, 32, 245-50. 
NIKOLICH-ZUGICH, J., et al. 2004. The many important facets of T-cell repertoire 
diversity. Nat Rev Immunol, 4, 123-32. 
NIKU, M., et al. 2007. Expression of CD34 mRNA and protein in cattle. Vet 
Immunol Immunopathol, 117, 162-72. 
NORVAL, R. A., et al. 1991. Theileria parva: influence of vector, parasite and host 
relationships on the epidemiology of theileriosis in southern Africa. 
Parasitology, 102 Pt 3, 347-56. 
NOVY, P., et al. 2007. CD4 T cells are required for CD8 T cell survival during both 
primary and memory recall responses. J Immunol, 179, 8243-51. 
NOWAK, M. A., et al. 1995. Antigenic oscillations and shifting immunodominance 
in HIV-1 infections. Nature, 375, 606-11. 
O'NEILL, E., et al. 2000. Heterologous protection against lethal 
A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice. J 
Gen Virol, 81, 2689-96. 
OBAR, J. J., et al. 2008. Endogenous naive CD8+ T cell precursor frequency 
regulates primary and memory responses to infection. Immunity, 28, 859-69. 
OETTINGER, M. A., et al. 1990. RAG-1 and RAG-2, adjacent genes that 
synergistically activate V(D)J recombination. Science, 248, 1517-23. 
OKAMOTO, S., et al. 2009. Improved expression and reactivity of transduced 
tumor-specific TCRs in human lymphocytes by specific silencing of 
endogenous TCR. Cancer Res, 69, 9003-11. 
OLARU, A., et al. 2005. Beyond the 12/23 rule of VDJ recombination independent 
of the Rag proteins. J Immunol, 174, 6220-6. 
 
  XXXIV 
Doctor of Philosophy – The University of Edinburgh – 2015 
PADOVAN, E., et al. 1993. Expression of two T cell receptor alpha chains: dual 
receptor T cells. Science, 262, 422-4. 
PEARSON, T. W., et al. 1979. Cell-mediated immunity to Theileria-transformed cell 
lines. Nature, 281, 678-80. 
PELLE, R., et al. 2011. Two Theileria parva CD8 T cell antigen genes are more 
variable in buffalo than cattle parasites, but differ in pattern of sequence 
diversity. PLoS One, 6, e19015. 
PESSA-MORIKAWA, T., et al. 2012. Fetal bovine bone marrow is a rich source of 
CD34+ hematopoietic progenitors with myelo-monocytic colony-forming 
activity. Dev Comp Immunol, 36, 572-7. 
PIRIE, H. M., et al. 1970. Studies on vaccination against East Coast fever using 
macroschizonts. Exp Parasitol, 27, 343-9. 
PRICE, D. A., et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T 
cell populations specific for persistent DNA viruses. J Exp Med, 202, 1349-
61. 
PRICE, D. A., et al. 2004. T cell receptor recognition motifs govern immune escape 
patterns in acute SIV infection. Immunity, 21, 793-803. 
PULENDRAN, B., et al. 2013. Immunity to viruses: learning from successful human 
vaccines. Immunol Rev, 255, 243-55. 
PURNELL, R. E., et al. 1974. Theileria parva: variation in the infection rate of the 
vector tick, Rhipicephalus appendiculatus. Int J Parasitol, 4, 513-7. 
QUIGLEY, M. F., et al. 2011. Unbiased molecular analysis of T cell receptor 
expression using template-switch anchored RT-PCR. Curr Protoc Immunol, 
Chapter 10, Unit10 33. 
QUIGLEY, M. F., et al. 2010. Convergent recombination shapes the clonotypic 
landscape of the naive T-cell repertoire. Proc Natl Acad Sci U S A, 107, 
19414-9. 
RADLEY, D. E., et al. 1975a. East coast fever: 1. Chemoprophylactic immunization 
of cattle against Theileria parva (Muguga) and five theilerial strains. 
Veterinary Parasitology, 1, 35-41. 
RADLEY, D. E., et al. 1975b. East coast fever: 3. Chemoprophylactic immunization 
of cattle using oxytetracycline and a combination of theilerial strains. 
Veterinary Parasitology, 1, 51-60. 
REDDEHASE, M. J. & KOSZINOWSKI, U. H. 1984. Significance of herpesvirus 
immediate early gene expression in cellular immunity to cytomegalovirus 
infection. Nature, 312, 369-71. 
REININK, P. & VAN RHIJN, I. 2009. The bovine T cell receptor alpha/delta locus 
contains over 400 V genes and encodes V genes without CDR2. 
Immunogenetics, 61, 541-9. 
REITS, E., et al. 2003. Peptide diffusion, protection, and degradation in nuclear and 
cytoplasmic compartments before antigen presentation by MHC class I. 
Immunity, 18, 97-108. 
ROBINS, H. S., et al. 2009. Comprehensive assessment of T-cell receptor beta-chain 
diversity in alphabeta T cells. Blood, 114, 4099-107. 
ROCK, K. L., et al. 1994. Inhibitors of the proteasome block the degradation of most 
cell proteins and the generation of peptides presented on MHC class I 
molecules. Cell, 78, 761-71. 
 
  XXXV 
Doctor of Philosophy – The University of Edinburgh – 2015 
RUDOLPH, M. G., et al. 2006. How TCRs bind MHCs, peptides, and coreceptors. 
Annu Rev Immunol, 24, 419-66. 
RUTIGLIANO, J. A., et al. 2007. Relative dominance of epitope-specific CD8+ T 
cell responses in an F1 hybrid mouse model of respiratory syncytial virus 
infection. Virology, 362, 314-9. 
SALLUSTO, F., et al. 1999. Two subsets of memory T lymphocytes with distinct 
homing potentials and effector functions. Nature, 401, 708-12. 
SCHATZ, D. G. & JI, Y. 2011. Recombination centres and the orchestration of 
V(D)J recombination. Nat Rev Immunol, 11, 251-63. 
SCHLISSEL, M. S. 2003. Regulating antigen-receptor gene assembly. Nat Rev 
Immunol, 3, 890-9. 
SCHMIDT, J., et al. 2011. Immunodominance of HLA-A2-restricted hepatitis C 
virus-specific CD8+ T cell responses is linked to naive-precursor frequency. J 
Virol, 85, 5232-6. 
SEDER, R. A., et al. 2008. T-cell quality in memory and protection: implications for 
vaccine design. Nat Rev Immunol, 8, 247-58. 
SERWOLD, T., et al. 2002. ERAAP customizes peptides for MHC class I molecules 
in the endoplasmic reticulum. Nature, 419, 480-3. 
SHAW, M. K. 2003. Cell invasion by Theileria sporozoites. Trends Parasitol, 19, 2-
6. 
SHAW, M. K., et al. 1991. The entry of Theileria parva sporozoites into bovine 
lymphocytes: evidence for MHC class I involvement. J Cell Biol, 113, 87-
101. 
SHUGAY, M., et al. 2014. Towards error-free profiling of immune repertoires. Nat 
Methods, 11, 653-5. 
SIM, B. C., et al. 1998. Preferential expression of TCR V alpha regions in CD4/CD8 
subsets: class discrimination or co-receptor recognition? Immunol Today, 19, 
276-82. 
SINGH, S. K., et al. 2013. The development of standard samples with a defined 
number of antigen-specific T cells to harmonize T cell assays: a proof-of-
principle study. Cancer Immunol Immunother, 62, 489-501. 
SIX, A., et al. 2013. The past, present, and future of immune repertoire biology - the 
rise of next-generation repertoire analysis. Front Immunol, 4, 413. 
SKILTON, R. A., et al. 2002. The persistence of Theileria parva infection in cattle 
immunized using two stocks which differ in their ability to induce a carrier 
state: analysis using a novel blood spot PCR assay. Parasitology, 124, 265-76. 
SMED-SORENSEN, A., et al. 2012. Influenza A virus infection of human primary 
dendritic cells impairs their ability to cross-present antigen to CD8 T cells. 
PLoS Pathog, 8, e1002572. 
SMITH, C. M., et al. 2004. Cognate CD4(+) T cell licensing of dendritic cells in 
CD8(+) T cell immunity. Nat Immunol, 5, 1143-8. 
SNAUWAERT, S., et al. 2014. In vitro generation of mature, naive antigen-specific 
CD8(+) T cells with a single T-cell receptor by agonist selection. Leukemia, 
28, 830-41. 
SPITS, H. 2002. Development of alphabeta T cells in the human thymus. Nat Rev 
Immunol, 2, 760-72. 
 
  XXXVI 
Doctor of Philosophy – The University of Edinburgh – 2015 
SPREULL, J. 1914. East Coast Fever Inoculation in the Transkeian Territories, 
South Africa. Journal of Comparative Pathology and Therapeutics, 27, 299-
304. 
ST LEGER, A. J., et al. 2011. Defining the herpes simplex virus-specific CD8+ T 
cell repertoire in C57BL/6 mice. J Immunol, 186, 3927-33. 
STARR, T. K., et al. 2003. Positive and negative selection of T cells. Annu Rev 
Immunol, 21, 139-76. 
STEMBERGER, C., et al. 2007. A single naive CD8+ T cell precursor can develop 
into diverse effector and memory subsets. Immunity, 27, 985-97. 
STEWART-JONES, G. B., et al. 2003. A structural basis for immunodominant 
human T cell receptor recognition. Nat Immunol, 4, 657-63. 
SUN, J. C., et al. 2004. CD4+ T cells are required for the maintenance, not 
programming, of memory CD8+ T cells after acute infection. Nat Immunol, 5, 
927-33. 
SWAINSON, L., et al. 2008. Lentiviral transduction of immune cells. Methods Mol 
Biol, 415, 301-20. 
TAN, A. C., et al. 2011. Precursor frequency and competition dictate the HLA-A2-
restricted CD8+ T cell responses to influenza A infection and vaccination in 
HLA-A2.1 transgenic mice. J Immunol, 187, 1895-902. 
TARACHA, E. L., et al. 1997. Distinct CD4+ T cell helper requirements in Theileria 
parva-immune and -naive bovine CTL precursors. J Immunol, 159, 4539-45. 
TARACHA, E. L., et al. 1995a. Parasite strain specificity of precursor cytotoxic T 
cells in individual animals correlates with cross-protection in cattle 
challenged with Theileria parva. Infect Immun, 63, 1258-62. 
TARACHA, E. L., et al. 1995b. Parasite strain specificity of bovine cytotoxic T cell 
responses to Theileria parva is determined primarily by immunodominance. J 
Immunol, 155, 4854-60. 
TARIO, J. D., JR., et al. 2015. Dextramer reagents are effective tools for quantifying 
CMV antigen-specific T cells from peripheral blood samples. Cytometry B 
Clin Cytom, 88, 6-20. 
TENZER, S., et al. 2009. Antigen processing influences HIV-specific cytotoxic T 
lymphocyte immunodominance. Nat Immunol, 10, 636-46. 
THOMPSON, L. J., et al. 2006. Innate inflammatory signals induced by various 
pathogens differentially dictate the IFN-I dependence of CD8 T cells for 
clonal expansion and memory formation. J Immunol, 177, 1746-54. 
TILLMAN, R. E., et al. 2004. Regulation of T-cell receptor beta-chain gene 
assembly by recombination signals: the beyond 12/23 restriction. Immunol 
Rev, 200, 36-43. 
TOURDOT, S. & GOULD, K. G. 2002. Competition between MHC class I alleles 
for cell surface expression alters CTL responses to influenza A virus. J 
Immunol, 169, 5615-21. 
TSCHARKE, D. C., et al. 2005. Identification of poxvirus CD8+ T cell determinants 
to enable rational design and characterization of smallpox vaccines. J Exp 
Med, 201, 95-104. 
TURNER, S. J., et al. 2006. Structural determinants of T-cell receptor bias in 
immunity. Nat Rev Immunol, 6, 883-94. 
 
  XXXVII 
Doctor of Philosophy – The University of Edinburgh – 2015 
TURNER, S. J., et al. 2009. Functional implications of T cell receptor diversity. Curr 
Opin Immunol, 21, 286-90. 
UILENBERG, G. 1999. Immunization against diseases caused by Theileria parva: a 
review. Trop Med Int Health, 4, A12-20. 
UNUTMAZ, D., et al. 1999. Cytokine signals are sufficient for HIV-1 infection of 
resting human T lymphocytes. J Exp Med, 189, 1735-46. 
UTZ, U., et al. 1996. Analysis of the T-cell receptor repertoire of human T-cell 
leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes 
from patients with HTLV-1-associated disease: evidence for oligoclonal 
expansion. J Virol, 70, 843-51. 
VAN DER MOST, R. G., et al. 2003. Changing immunodominance patterns in 
antiviral CD8 T-cell responses after loss of epitope presentation or chronic 
antigenic stimulation. Virology, 315, 93-102. 
VARELA-ROHENA, A., et al. 2008. Control of HIV-1 immune escape by CD8 T 
cells expressing enhanced T-cell receptor. Nat Med, 14, 1390-5. 
VENTURI, V., et al. 2008a. TCR beta-chain sharing in human CD8+ T cell 
responses to cytomegalovirus and EBV. J Immunol, 181, 7853-62. 
VENTURI, V., et al. 2006. Sharing of T cell receptors in antigen-specific responses 
is driven by convergent recombination. Proc Natl Acad Sci U S A, 103, 
18691-6. 
VENTURI, V., et al. 2008b. The molecular basis for public T-cell responses? Nat 
Rev Immunol, 8, 231-8. 
VEZYS, V., et al. 2009. Memory CD8 T-cell compartment grows in size with 
immunological experience. Nature, 457, 196-9. 
VON BOEHMER, H. & MELCHERS, F. 2010. Checkpoints in lymphocyte 
development and autoimmune disease. Nat Immunol, 11, 14-20. 
VRISEKOOP, N., et al. 2014. Revisiting thymic positive selection and the mature T 
cell repertoire for antigen. Immunity, 41, 181-90. 
WARREN, R. L., et al. 2011. Exhaustive T-cell repertoire sequencing of human 
peripheral blood samples reveals signatures of antigen selection and a directly 
measured repertoire size of at least 1 million clonotypes. Genome Res, 21, 
790-7. 
WEBBY, R. J., et al. 2003. Protection and compensation in the influenza virus-
specific CD8+ T cell response. Proc Natl Acad Sci U S A, 100, 7235-40. 
WEISS, A. & STOBO, J. D. 1984. Requirement for the coexpression of T3 and the T 
cell antigen receptor on a malignant human T cell line. J Exp Med, 160, 1284-
99. 
WILSON, E. H. & HUNTER, C. A. 2008. Immunodominance and recognition of 
intracellular pathogens. J Infect Dis, 198, 1579-81. 
WILSON, N. S., et al. 2006. Systemic activation of dendritic cells by Toll-like 
receptor ligands or malaria infection impairs cross-presentation and antiviral 
immunity. Nat Immunol, 7, 165-72. 
WOOLDRIDGE, L., et al. 2003. Anti-CD8 antibodies can inhibit or enhance 
peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their 
effects on CTL activation and occurs in the absence of an interaction between 
pMHCI and CD8 on the cell surface. J Immunol, 171, 6650-60. 
 
  XXXVIII 
Doctor of Philosophy – The University of Edinburgh – 2015 
WOOLDRIDGE, L., et al. 2009. Tricks with tetramers: how to get the most from 
multimeric peptide-MHC. Immunology, 126, 147-64. 
WOOLDRIDGE, L., et al. 2006. Anti-coreceptor antibodies profoundly affect 
staining with peptide-MHC class I and class II tetramers. Eur J Immunol, 36, 
1847-55. 
WOOLDRIDGE, L., et al. 2005. Interaction between the CD8 coreceptor and major 
histocompatibility complex class I stabilizes T cell receptor-antigen 
complexes at the cell surface. J Biol Chem, 280, 27491-501. 
YANG, S., et al. 2008. Development of optimal bicistronic lentiviral vectors 
facilitates high-level TCR gene expression and robust tumor cell recognition. 
Gene Ther, 15, 1411-23. 
YEWDELL, J. W. 2006. Confronting complexity: real-world immunodominance in 
antiviral CD8+ T cell responses. Immunity, 25, 533-43. 
YEWDELL, J. W. 2010. Designing CD8+ T cell vaccines: it's not rocket science 
(yet). Curr Opin Immunol, 22, 402-10. 
YEWDELL, J. W. & BENNINK, J. R. 1999. Immunodominance in major 
histocompatibility complex class I-restricted T lymphocyte responses. Annu 
Rev Immunol, 17, 51-88. 
YEWDELL, J. W., et al. 2003. Making sense of mass destruction: quantitating MHC 
class I antigen presentation. Nat Rev Immunol, 3, 952-61. 
YU, X. G., et al. 2002. Consistent patterns in the development and 
immunodominance of human immunodeficiency virus type 1 (HIV-1)-
specific CD8+ T-cell responses following acute HIV-1 infection. J Virol, 76, 
8690-701. 
ZEHN, D., et al. 2012. TCR signaling requirements for activating T cells and for 
generating memory. Cell Mol Life Sci, 69, 1565-75. 
ZEHN, D., et al. 2009. Complete but curtailed T-cell response to very low-affinity 
antigen. Nature, 458, 211-4. 
ZHU, Y. Y., et al. 2001. Reverse transcriptase template switching: a SMART 
approach for full-length cDNA library construction. Biotechniques, 30, 892-7. 
 
